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Riassunto 
 
Sviluppo di tecnologie innovative di RNA interference: nanoparticelle di oro 
funzionalizzate per il silenziamento del proto-oncogene myc  
 
Contesto scientifico 
 
La scoperta dell'RNA interference (RNAi), un importante meccanismo molecolare 
responsabile della modulazione trascrizionale e post-trascrizionale dell'espressione 
genica, ha favorito lo sviluppo di approcci terapeutici basati su modificazioni 
dell’espressione genica. L’RNAi è un meccanismo epigenetico mediante il quale 
molecole di RNA a doppio filamento (dsRNA) interferiscono con l’espressione del 
gene aventi sequenza complementare, mediante degradazione dell’mRNA. Dopo i 
primi studi dei premi Nobel Fire e Mello in C. elegans, che risalgono al 1998 (Fire et 
al., 1998), Tuschl e collaboratori hanno dimostrato che gli small interfering RNA 
(siRNA), frammenti di RNA a doppio filamento di 21-23 nucleotidi, sono in grado di 
indurre degradazione di mRNA in maniera nucleotide specifica  (Schlee et al., 2006). 
Nonostante l’enorme potenzialità dell’RNAi, ci sono ostacoli significativi da superare 
prima di poter applicare tale tecnologia alla clinica, quali la scarsa stabilità dei siRNA 
nei fluidi biologici attraverso cui avviene la somministrazione e la possibilità di effetti 
aspecifici derivanti, per esempio, da una parziale omologia di sequenza in prossimità 
del 3’ UTR, e conseguente induzione di RNAi aspecifico (Kim et al, 2009).  
Con lo sviluppo delle nanotecnologie nell’ultimo decennio sono state progettate e 
sintetizzate numerose nanoparticelle (NP) per applicazioni biologiche, che in base 
alle caratteristiche specifiche sono state utilizzate con successo, come marcatori 
fluorescenti, sistemi di trasporto (di farmaci, proteine, acidi nucleici), agenti di 
contrasto per risonanza magnetica, microscopia elettronica (Giljohann et al., 2010). 
La natura inorganica e spesso metallica di molte classi di nanoparticelle ne ha reso 
necessaria un’attenta analisi tossicologica per escludere eventuali effetti citotossici 
legati alla composizione chimica (Rivera-Gil et al., 2012). Tali studi condotti in vitro in 
colture cellulari e in vivo in modelli animali hanno evidenziato l’alta compatibilità di 
alcune classi di nanoparticelle (per esempio quelle composte da un nucleo di oro) 
con la materia vivente.  
Recentemente sono state sviluppate diverse strategie di RNAi che utilizzano 
nanoparticelle di diversa natura (dendrimeri, liposomi, quantum dots) per il trasporto 
di siRNA (Kim et al, 2009). In genere la loro composizione cationica media l’efficiente 
internalizzazione cellulare, mentre rivestimenti con specifiche molecole, come ad 
esempio il PEG conferiscono un’aumentata stabilità e biocompatibilità rispetto ai 
metodi tradizionali, che prevedono l’uso di agenti trasfettanti spesso tossici. 
Negli ultimi anni le nanoparticelle di oro (AuNP) hanno ricoperto notevole interesse 
scientifico per studi di RNAi mediato da siRNA. Sono state sviluppate da diversi 
autori molteplici metodologie di sintesi e di coniugazione dei siRNA alla superficie 
delle AuNP, che si sono rivelate determinanti nell’induzione di silenziamento genico 
specifico e ad alta efficienza (Lytton-Jean et al, 2011).  
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Scopo del lavoro di tesi 
 
In questo contesto scientifico, il mio lavoro di tesi di dottorato ha avuto come obiettivo 
principale lo sviluppo di nuove metodologie di RNAi basate su small interfering RNA 
(siRNA), utilizzando nanoparticelle di oro multifunzionali. 
Il mio lavoro è parte di un ampio progetto europeo (NANOTRUCK), che ha previsto 
la sintesi di nanoparticelle di oro (AuNP) multifunzionali ottimizzate per RNAi, la 
validazione di tali dispositivi in modelli cellulari e animali e una fase finale di 
sperimentazione preclinica in cui tali nanodispositivi sono stati utilizzati per il 
trattamento di un modello murino di carcinoma polmonare. Il gene selezionato per il 
trattamento di RNAi è il proto-oncogene c-myc, fattore di trascrizione coinvolto in 
numerosi processi cellulari (ciclo cellulare, differenziamento, crescita, apoptosi) e la 
cui deregolazione è associata a molteplici stati tumorali (Vita et al, 2006). La mia 
attività di ricerca, svolta presso l’Istituto di Cibernetica “E.Caianiello” del CNR, ha 
previsto la validazione di AuNP multifunzionali in un organismo invertebrato, il 
celenterato di acqua dolce Hydra vulgaris.  
 
Hydra vulgaris è utilizzata dal gruppo di Nanoscienze e 
Biologia Molecolare come modello per lo sviluppo e la 
validazione di nuovi nanobiodispositivi per studio della 
funzione genica (trasformazione genetica, silenziamento 
genico), l’imaging avanzato, il delivery di molecole funzionali 
(Tortiglione, 2011). La semplicità strutturale anatomica (solo 
due strati di cellule, ectoderma ed endoderma, mancanza di 
organi) e l’alta plasticità tissutale (presenza di mitosi continua 
nei due strati cellulari e differenziamento della linea staminale 
interstiziale in pochi tipi specializzati) rendono Hydra vulgaris 
un modello ideale per gli studi dei processi di differenziamento 
cellulare e rigenerazione tissutale.  
Al fine di testare in Hydra nuovi prodotti di coniugazione (AuNP-siRNA) e relativi 
intermedi di sintesi è stato necessario uno studio preliminare per definire il ruolo del 
gene myc in Hydra (Hymyc1) di recente clonato (Hartl et al., 2010). A tal fine ho 
validato un sistema di RNAi sviluppato nel mio laboratorio, che si basa sulla 
somministrazione di siRNA all’animale attraverso “soaking”, ovvero per immersione 
in una soluzione contenente i siRNA, a concentrazioni definite. Successivamente 
all’identificazione del fenotipo animale e cellulare degli animali sottoposti al 
trattamento di RNAi, e all’avanzamento di ipotesi sul ruolo funzionale di Hymyc1 in 
Hydra, sono iniziati gli studi con le nanoparticelle funzionalizzate, sintetizzate via via 
nel corso del progetto Nanotruck dal gruppo diretto dal Dr. JM de la Fuente, presso il 
Nanoscience Institute of Aragona, University of Zaragoza. La mia attività di ricerca ha 
previsto la caratterizzazione molecolare degli animali interferiti, seguita da uno studio 
cellulare per valutare l’effetto del silenziamento genico di Hymyc1 sui processi di 
proliferazione e differenziamento delle cellule staminali, dove Hymyc1 è espresso. 
Infine, grazie alle straordinarie proprietà delle AuNP di agire come agenti di contrasto 
per la microscopia elettronica, ho effettuato una dettagliata analisi ultrastrutturale dei 
tessuti trattati, per delineare i meccanismi di internalizzazione e distribuzione 
intracellulare delle nanoparticelle funzionalizzate. Gli interessanti risultati ottenuti mi 
hanno portato ad approfondire tali studi mediante analisi effettuate a vari tempi di 
incubazione (da 5 minuti a 48 ore) ed utilizzare altre tecniche microscopiche. A tal 
fine, ho completato la mia formazione nel laboratorio del Prof. Bert Hobmayer, 
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Institute of Zoology, University of Innsbruck, utilizzando la tecnica High Pressure 
Freezing Electron Microscopy. Tale metodologia ha permesso un’analisi fine della 
dinamica di internalizzazione ed esocitosi di AuNP in Hydra, definendo tali 
meccanismi per la prima volta a livello di animale intero.  Durante lo stage nel 
prestigioso laboratorio del Prof. B. Hobmayer, leader riconosciuto nello studio dei 
processi cellulari e molecolari alla base dello sviluppo animale e del 
differenziamento, ed autore dell’identificazione della famiglia dei geni myc in Hydra, 
ho avuto modo di completare e perfezionare le mie conoscenze sui meccanismi di 
differenziamento di cellule staminali in Hydra, utilizzando metodologie per la 
preparazione e l’analisi morfologica di sospensioni cellulari. 
 
Descrizione dettaglia del lavoro sperimentale. 
 
1. Sviluppo e validazione di un protocollo di RNAi mediato da free-siRNA: 
determinazione del ruolo del gene Hymyc 1 in Hydra 
2. RNAi del gene Hymyc1 utizzando AuNP funzionalizzate 
a) Studio di biocompatibilità e biodistribuzione di AuNP 
b) Valutazione dell’efficienza di RNAi: analisi molecolare, cellulare e animale. 
3. Studio del meccanismo di internalizzazione, distribuzione intracellulare e turnover 
di AuNP: analisi ultrastrutturale. 
 
1. Sviluppo e validazione di un protocollo di RNAi mediato da free-siRNA 
 e determinazione del ruolo del gene Hymyc1 in Hydra 
 
Sono stati progettati siRNA complementari al trascritto del gene Hymyc1 (myc-
siRNA) espresso in Hydra nelle cellule staminali in attiva proliferazione. Gli animali 
sono stati incubati nel loro mezzo di coltura in presenza di myc-siRNA e in condizioni 
acidiche, ed analizzati:  
! a livello cellulare, per misurare le attività proliferative dei vari tipi cellulari e 
valutare quantitativamente la distribuzione dei tipi cellulari diversi (cellule 
staminali, cellule “committed” verso il differenziamento di neuroni, nematociti o 
cellule ghiandolari, morfologicamente distinguibili). L’attività di proliferazione 
cellulare è stata misurata mediante trattamento in vivo con BrdU, seguito da 
preparazione di sospensioni cellulari e immunostaining. L’analisi della 
distribuzione dei vari tipi cellulari è stata effettuata analizzando sospensioni 
cellulari di animali trattati e quantificando i vari tipi cellulari riconoscibili. Infine, 
l’analisi microscopica dei tentacoli degli animali interferiti ha permesso di 
quantizzare alterazioni nella morfologia delle cellule costituenti i tentacoli, le 
cellule a batteria, dovute a processi di differenziamento verso un singolo tipo 
cellulare, il nematocita; 
!  a livello molecolare, mediante analisi qualitativa e quantitativa dell’espressione 
del gene codificante per la proteina Hymyc1 (in situ hybridization, qRT-PCR, 
Western blot).  
 
Risultati:  
 
Analisi cellulare: caratterizzazione del fenotipo degli animali myc-RNAi. Nei polipi 
sottoposti a RNAi del gene Hymyc1 è stato riscontrato un incremento della 
proliferazione delle cellule staminali interstiziali, che a sua volta ha determinato un 
aumento dei tipi cellulari (intermedi e definitivi) derivanti dal loro differenziamento.  
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Analisi molecolare: è stata dimostrata una riduzione dei livelli di trascrizione del 
gene Hymyc1 pari al 60% rispetto ai livelli di espressione dei polipi non trattati, 
dimostrando la validità della metodologia di RNAi mediata da siRNA. 
Dall’analisi funzionale condotta mediante RNAi è emerso che una riduzione 
dell’espressione del gene Hymyc1 provoca un aumento dell’attività di proliferazione 
delle cellule staminali della linea interstiziale di Hydra, che si traduce in un aumento 
dei tipi cellulari derivati dal loro differenziamento. Analogamente al ruolo svolto da c-
myc nei vertebrati, gli studi funzionali in Hydra suggeriscono un coinvolgimento del 
gene omologo (Hymyc1) nei processi che regolano l’equilibrio tra proliferazione e 
differenziamento delle cellule staminali, suggerendo il ruolo chiave di questa famiglia 
di fattori trascrizionali nell’evoluzione del regno animale.  
  
2. RNAi del gene Hymyc1 utilizzando AuNP funzionalizzate 
  
La capacità dei siRNA di attraversare le membrane cellulari di Hydra e raggiungere 
le cellule bersaglio (i nematoblasti) dove Hymyc1 è espresso ha supportato lo 
sviluppo di nuovi approcci volti a migliorare l’efficienza di silenziamento genico. A tal 
scopo, nell’ambito di un progetto europeo, sono state utilizzate nanoparticelle di oro 
come veicoli per il trasporto dei siRNA da testare in diversi modelli animali, tra cui 
Hydra. Al fine di valutare l’assenza di potenziali effetti tossici dovuti alla natura 
metallica di tali vettori, sono state condotte analisi tossicologiche preliminari. 
 
a) Studio di biocompatibilità e biodistribuzione  
 
Sono stati utilizzati diversi protocolli, precedentemente sviluppati dal gruppo di 
Nanoscienze e Biologia Molecolare per valutare la tossicità di nanoparticelle 
metalliche in Cnidari (Ambrosone et al., 2012; Ambrosone and Tortiglione, 2013). 
Tali protocolli si basano su valutazioni degli effetti del trattamento di nanoparticelle 
sugli animali, effettuate a diversi livelli: 
! analisi morfologica dell’animale, in vivo; 
! analisi delle capacità rigenerative 
! analisi della velocità di accrescimento della popolazione mediante riproduzione 
asessuata. 
 
Risultati:  
 
Nono sono state riscontrate alterazioni morfologiche negli animali trattati con dosi 
crescenti di AuNP. Non sono state riscontrate anomalie nei processi di rigenerazione 
degli animali sottoposti a trattamento acuto e cronico. Infine, gli individui trattati 
mostrano capacità riproduttive paragonabili a quelle degli individui non trattati, 
generando popolazioni secondo normali ritmi di accrescimento. 
 
b) Valutazione dell’efficienza di RNAi: analisi molecolare, cellulare e animale 
 
In questa fase di lavoro, il protocollo di RNAi sviluppato con i siRNA è stato applicato 
a nanoparticelle di oro funzionalizzate con myc-siRNA. Tali nanoparticelle sono state 
sintetizzate nel laboratorio del Dr. Jesus M. de La Fuente (Nanoscience Institute of 
Aragona, University of Zaragoza), seguendo due differenti strategie di legame dei 
siRNA al nucleo di oro, covalente e ionico. Inoltre per aumentare l’efficienza di 
internalizzazione cellulare, per ciascuna strategia di legame è stato caricato sulla 
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superficie delle AuNP un peptide noto per favorire la penetrazione cellulare, il peptide 
di origine virale TAT.  
Per studiare gli effetti delle strategie di 
coniugazione sull’efficienza del gene silencing, 
i polipi sono stati incubati con le singole AuNPs 
ed analizzati dopo 48 h di incubazione 
mediante:  
! analisi molecolare (qRT-PCR) per valutare e 
confrontare i livelli di espressione genica di 
Hymyc1 ottenuti in seguito a trattamento 
con 8 classi di nanoparticelle diverse, 
funzionalizzate secondo diverse strategie e 
recanti diversi gruppi attivi di superficie.  
! analisi cellulare e tissutale per valutare 
l’effetto myc-RNAi sulla velocità di 
proliferazione e differenziamento delle 
cellule staminali  
 
Risultati 
 
Analisi molecolare: dall’analisi quantitativa 
(via qRT-PCR) dei livelli di espressione del 
gene Hymyc1 eseguita dopo trattamento con 
ognuno dei prodotti di sintesi è stata selezionata una nanoparticella ottimale 
coniugata in maniera covalente a siRNA, capace di indurre una riduzione dell’ 
espressione genica molto più efficace (80%) rispetto agli altri prodotti di sintesi 
derivanti da ambedue le strategie, covalente e ionica. Come atteso, le AuNP 
utilizzate controllo, prive di siRNA, non hanno indotto riduzione dell’espressione 
genica indicando l’assenza di effetti aspecifici provocati dal trattamento delle NP sui 
processi trascrizionali endogeni. Inaspettatamente, AuNP funzionalizzate con siRNA 
e TAT si sono dimostrate inefficaci nell’induzione di silenziamento genico, 
suggerendo un possibile ruolo inibitorio del TAT sul meccanismo di RNAi. 
Analisi cellulare: dall’analisi della distribuzione dei tipi cellulari e della velocità di 
proliferazione delle cellule staminali negli animali sottoposti a trattamento con AuNP-
siRNA (selezionata dai test molecolari) è emerso un fenotipo che riproduce 
completamente quello ottenuto utilizzando siRNA in soluzione e ne aumenta la 
severità. Le cellule interstiziali staminali di tipo 1s e 2s, in attiva proliferazione, 
presentano cicli di divisione più rapidi rispetto agli animali non trattati e la 
distribuzione dei tipi cellulari conferma un aumento delle popolazioni cellulari 
(nematoblasti, cellulare ghiandolari e nematociti) derivati dal differenziamento delle 
cellule dove Hymyc 1 è espresso. Il numero dei nematociti analizzato sui tentacoli di 
animali interirisulta analogamente aumentato. 
 
3. Studio del meccanismo di internalizzazione, distribuzione intracellulare e 
turnover di AuNP: analisi ultrastrutturale.  
 
Lo studio dei meccanismi di internalizzazione, traffico cellulare e turn-over delle 
AuNP nei tessuti degli animali trattati è stato condotto attraverso una dettagliata 
analisi di microscopia elettronica su polipi trattati con AuNP-siRNA e AuNP-N3, 
funzionalizzate rispettivamente con siRNA e catene PEG–azide.  La carica positiva di 
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queste ultime è stata dimostrata 
(utilizzando anche altri approcci, quali 
microscopia in vivo e analisi del 
contenuto in oro dei tessuti trattati) 
responsabile dell’elevata efficienza di 
internalizzazione (Tortiglione et al., 
2009) rispetto a AuNP funzionalizzate 
con gruppi carichi negativamente (come 
nel caso di cargo siRNA). L’analisi 
condotta a tempi diversi di incubazione 
(5min, 30’, 4h, 8h, 14h, 24h, 48h) ha 
dimostrato l’influenza della carica di 
superficie delle AuNP sull’efficienza di 
internalizzazione, e rivelato l’induzione 
alla membrana cellulare di diversi 
meccanismi che affiancano i noti 
processi di endocitosi a meccanismi di trasporto attraverso la membrana e legame a 
vescicole nanometriche (esosomi). Le osservazioni a tempi crescenti di incubazione 
hanno rivelato all’interno della cellula la presenza di AuNP in endosomi e poi 
lisosomi, nei quali si accumulano in maniera massiva dopo 48h. Infine è stato 
possibile visualizzare i processi di esocitosi che determinano l’eliminazione delle 
AuNP dall’animale. Durante il mio stage presso il lab. diretto dal Prof. Hobmayer 
(Istituto di Zoologia, University of 
Innsbruck) sottoponendo gli animali a 
trattamenti pulse and chase ed 
utilizzando la tecnologia HP-cryoTEM 
(Holstein et al., 2010), è stato possibile 
visualizzare l’esocitosi delle AuNP via 
fusione diretta dei lisosomi con la 
membrana o estroflessione di regioni 
estese di membrana. Di grande 
interesse la presenza anche a 48h di 
vescicole nanometriche contenenti 
AuNP al di fuori della membrana 
cellulare, probabilmente identificabili 
come esosomi che potrebbero quindi 
essere coinvolti nei meccanismi di 
entrata e di uscita delle AuNP. La 
conservazione evolutiva dei meccanismi 
di endocitosi nel regno animale rende i risultati di tutti gli studi ultrastrutturali di 
grande valore per tutta la comunità scientifica che sviluppa nuovi nanomateriali e 
dispositivi per applicazioni diagnostiche e terapeutiche. 
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Conclusioni  
 
Il mio lavoro di tesi ha previsto lo sviluppo di nuove metodologie di RNAi, basate 
sull’uso di siRNA per lo studio della funzione del gene Hymyc1 in Hydra. Accanto ad 
approcci già esplorati in altri sistemi animali mediati da siRNA somministrati in 
soluzione, la metodologia mediata da nanoparticelle di oro si è dimostrata capace di 
aumentare l’efficienza di silenziamento genico, determinando un abbassamento dei 
livelli trascrizionali pari all’80%. L’analisi fenotipica e molecolare degli animali 
interferiti ha confermato la specificità della metodologia ed ha delineato il ruolo del 
gene Hymyc1 nei processi che controllano l’equilibrio proliferazione/differenziamento 
delle cellule staminali. Di particolare rilievo nell’ambito del progetto Nanotruck la 
scoperta che una singola particella multifunzionale prodotta con una specifica 
metodica, si sia rivelata efficace nell’indurre silenziamento genico specifico in tre 
sistemi biologici a diversi gradi di complessità: colture cellulari umane, Hydra e topo, 
dimostrando la validità generale del nanodispositivo prodotto nell’indurre RNAi. Al di 
là dell’impatto che tale tecnologia potrà dare in ambito terapeutico, il mio lavoro 
all’interfaccia tra le nanoscienze e la biologia, ha contribuito a validare in vivo nuovi 
nanodispositivi per RNAi, a delineare i meccanismi di interazione AuNP cellula 
vivente (dall’internalizzazione all’esocitosi), a elucidare mediante tale approccio il 
ruolo funzionale di un protooncogene, coinvolto nella cancerogenesi negli organismi 
superiori, con ovvie ricadute applicative nel campo della terapia basate sull’RNAi. 
I risultati del mio lavoro di tesi hanno contribuito in parte o completamente alla 
realizzazione di tre lavori scientifici su riviste specializzate ad alto impatto, pubblicati 
nel 2012 e 2013: Ambrosone et al., 2012, Conde et al., 2012, Marchesano et al., 
2013. 
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Abstract 
Innovative tools for RNA interference: multifunctional gold nanoparticles for 
silencing of myc proto-oncogene 
 
Despite its simple body plan and structural anatomy, the Cnidaria Hydra vulgaris, a 
dipoblastic animal at the base of metazoan evolution, is an excellent model system to 
investigate the mechanisms controlling stem cell proliferation and differentiation and 
the balance between the two phenomena. In vertebrates one of many genes that 
participate in regulating cell homeostasis is the protooncogene c-myc. The MYC 
family of transcription factors controls disparate aspects of cell physiology including 
cell growth, cell cycle progression, biosynthetic metabolism, and apoptosis. As 
expected c-myc deregulated expression occurs in the majority of human cancers, 
making it a seemingly attractive target for therapeutic inhibition. In order to develop 
effective strategies of c-myc gene silencing, two methodologies based on small 
interfering RNAs (siRNA) were developed in this work, using Hydra as model 
organism and targeting the Hydra c-myc orthologue gene Hymyc1. The first 
methodology, based on free myc-siRNA supplied to the polyps by soaking under 
acidic condition was shown to induce specific RNAi and to affect proliferation of stem 
cells and derived cell types. The ability of Hydra cells to uptake double stranded RNA 
and to trigger a RNAi response laid the foundations for the second methodology, 
developed in the frame of a European project and based on the use of gold 
nanoparticles (AuNP) as innovative shuttles for safe and successful delivery of 
siRNA. AuNPs were conjugated to Hymyc-siRNA using different chemical strategies 
and tested for functionality in Hydra by molecular analysis, followed by measurement 
of cell cycling activity and quantitative estimation of cell ratios between stem and 
differentiated cells. Among eight different myc-siRNA-AuNP conjugates, a single 
nanodevice (presenting siRNA covalently conjugated to the gold core) was shown 
able to induce 80% gene silencing. The biological effect of Hymyc1 downregulation 
was elucidated as a strong impairment of the balance between stem cell self-
renewal/differentiation, as shown by the accumulation of stem cell intermediate and 
terminal differentiation products in RNAi animals. The confirmation also in other 
model systems of the bioactivity of such nanodevice to induce efficient and specific 
gene silencing strongly supports its feasibility to be broadly used for therapeutic 
RNAi. 
In addition to the gene silencing performance, and thanks to the unique contrast 
agent behaviour of the gold nanoparticle core for Electron Microscopy, a detailed 
investigation of the mechanisms of internalization of AuNPs was performed by 
comparing different chemical functionalities (siRNA and positively charged groups) 
present on AuNP surface. 
The dynamic and kinetic of the whole journey of gold nanoparticles within a whole 
animal was reported, from the first interaction nanoparticle/cell membrane, to the 
intracellular trafficking and final extracellular clearance. Beside classical routes, new 
portals of entry/exit were captured by imaging Hydra treated tissue, including 
exosome-like structures as novel undescribed nanoparticle shuttles inward and 
outward the cell membrane. The conservation of the endocytic/secretory machinery 
through evolution extends the value of our finding to mammalian systems providing 
new clues to take into account when designing nanomaterials to interface with 
biological entities. 
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1. Introduction 
1.1 Gene therapy by RNA interference (RNAi) 
Most of the diseases for which a genetic base has been demonstrated and 
discovered, are theoretically, suitable for treatments based on gene therapy. This 
approach, that is diffusing more and more, is mainly applicable both for rare genetic 
syndromes or cancer. The idea behind is the manipulation of gene expression in both 
the directions (overexpression or gene knock down). For gene therapy by 
overexpression it is necessary to target to specific cell types a transgene that, once 
integrated into the genome, can replace the lacking or inactive gene. However this 
approach is not free from negative effects; indeed, the wrong integration of the 
transgene could also led to adverse outcomes. This is the reason why many 
research efforts are focusing on transient gene therapy treatments.  Deregulation 
(often upregulation) in gene expression levels has been found in several types of 
cancer, thus that an ideal therapeutic treatment would consists in downregulation the 
expression of those genes (oncogenes) through exploitation of endogenuous cell 
processing, i.e. RNA interference (RNAi).  
The knowledge about this pathway has expanded at a remarkable rate since the 
initial characterization of RNAi in the nematode Caenorhabditis elegans. In fact in 
1998, Fire, Mello and colleagues discovered the ability of double stranded RNA 
molecules to silence gene expression in C.elegans. Soon after this, RNAi was shown 
to occur in mammalian cells in response to double-stranded small interfering RNAs 
(siRNAs), i.e. ~21 long dsRNA molecules that serve as the effector molecules for 
sequence-specific gene silencing. Three years later, Tuschl and co-workers, 
demostrated that synthetic small interfering RNA (siRNA) could achieve sequence 
specific gene knockdown in a mammalian cell line. Mechanistic insights followed 
rapidly during the ensuing years, increasing the possibility to use RNAi pathways for 
the therapeutic intervention of human diseases, at least those in which an alteration 
of gene expression is documented. The principle of RNAi is sequence-specific 
degradation of mRNA induced by a double-stranded RNA (dsRNA) homologues to 
the target sequence. RNAi is shared by a wide variety of eukaryotes, including yeast, 
fungi, plants, and animals (Elbashir et al., 2001), (Gheysen et al., 2007), (Hamlin et 
al., 2003)  
 
1.2 Mechanisms of RNAi-mediated gene silencing 
RNAi pathways are guided by small RNAs that include siRNAs and microRNAs 
(miRNAs), which derive from imperfectly paired hairpin RNA structures naturally 
encoded in the genome. RNAi effector molecules induce gene silencing in several 
ways: they direct sequence-specific cleavage of perfectly complementary mRNAs 
and translational repression and transcript degradation for imperfectly 
complementary targets. The general mechanism is triggered when dsRNA is 
introduced into cells and is processed by the RNase III-like protein Dicer in 21- to 23-
bp RNA fragments with 2-nt 3’-overhangs. Once siRNA is present in the cytoplasm of 
the cell, it is incorporated into a protein complex called the RNA- inducing silencing 
complex (RISC). The RISC–siRNA complex targets complementary mRNA, leading 
to a shutdown of gene expression in a sequence-specific manner. Tuschl’s group 
was the first to demonstrate that synthetic double-stranded 21-bp siRNAs transfected 
into mammalian cell lines mimic the effects of Dicer products, thereby introducing a 
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powerful tool to manipulate gene expression selectively in adult mammalian cells. 
Exogenous siRNAs target complementary mRNAs for transcript cleavage and 
degradation in a process known as post-transcriptional gene silencing (PTGS). In 
nematodes, insects and plants, this pathway functions as an innate antiviral defence 
mechanism, in which viral double-stranded RNA (dsRNA) molecules are processed 
by the RNase III enzyme Dicer into siRNAs that mediate the RNAi response. 
Whether or not siRNA-mediated PTGS exists in mammalian cells for intrinsic 
immunity against viral infections is unclear, and remains an area of further 
investigation. Effective PTGS requires perfect or near-perfect Watson–Crick base 
pairing between the mRNA transcript and the antisense or guide strand of the siRNA, 
and results in cleavage of the mRNA by the RNA induced silencing complex (RISC). 
The endonuclease Argonaute 2 (AGO2) is responsible for the cleavage mechanism 
of RISC, and AGO2 is the only member of the Argonaute subfamily of proteins with 
observed catalytic activity in mammalian cells. RISC activation is initially thought to 
involve AGO2-mediated cleavage of the sense or passenger strand of the double-
stranded siRNA, generating the single-stranded antisense strand that serves to guide 
RISC to complementary sequences in target mRNAs. The cleavage of targeted 
mRNA takes place between bases 10 and 11 relative to the 5! end of the siRNA 
guide strand, leading to subsequent degradation of the cleaved mRNA transcript by 
cellular exonucleases. On activation by the siRNA guide strand, RISC can undergo 
multiple rounds of mRNA cleavage to mediate a robust PTGS response against the 
target gene. PTGS by mRNA cleavage has been exploited as the method of choice 
for potential therapeutic applications of RNAi because of the potency of this catalytic 
gene-silencing pathway (Figure 1) (S.-S. Kim et al., 2009)  
 
 
 
Figure 1.Mechanisms of RNA interference. Short hairpin or long double-stranded RNA (dsRNA) are introduced into the 
cytoplasm, where they are cleaved by Dicer enzyme into a small interfering RNA (siRNA). siRNA can be introduced also directly 
into the cell. Then the siRNA is incorporated into the RNA-induced silencing complex (RISC), resulting in the cleavage of the 
sense strand of RNA by argonaute 2 (AGO2). The activated RISC-siRNA complex seeks out, binds to and degrades 
complementary mRNA, which leads to the silencing of the target gene. Figure 1 adapted from Kim et al., 2009. 
!
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1.3 Applications of RNA Interference 
RNAi technology represents now day the most widely used tool to investigate gene 
function, both on cell culture and in model organisms. RNAi can regulate several 
biological processes, such as signal transduction, cell cycle, macromolecular 
synthesis and degradation, development, cell motility, cell death and viral replication. 
The most obvious clinical use of RNAi targets diseases in which selective depletion 
of one or a few specific proteins is expected to slow or halt the disease process in the 
affected cells, i.e cancer.  
There are two general abnormalities in cancer cells: the deregulation of the cell cycle 
that results in uncontrolled growth and the resistance to death as a result of 
abnormalities in one or more proteins that mediate apoptosis (Nam & Parang, 2003). 
The RNAi approaches for cancer therapy are therefore to knock out the expression of 
a cell cycle gene and/or an anti-apoptotic gene in the cancer cells thereby stopping 
tumor growth and killing the cancer cells. To selectively eliminate cancer cells without 
damaging normal cells, the RNAi would be targeted to a gene specifically involved in 
the growth or survival of the cancer cell, or the siRNAs would be selectively delivered 
into the cancer cells. For many years antisense oligodeoxynucleotide technology was 
pursued in preclinical studies of cancer therapies but with discouraging results overall 
(Jansen & Zangemeister-Wittke, 2002). Recent studies have clearly demonstrated 
advantages of RNAi methods for the growth suppression and killing of cancer cells. 
In one study, siRNA was shown to be greater than an order of magnitude more 
potent than antisense DNA in suppressing gene expression in human hepatoma and 
pancreatic cancer cell lines. Clinical trials using RNAi based strategies are under way 
for viral, ocular neurodegenerative diseases and cancer (table 1). (D. H. Kim et al., 
2007; Pecot et al., 2011). 
 
 
Table 1. siRNA therapeutics in clinical trials. 
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1.4 Challenges in using RNAi for therapeutic application 
 
Small interfering RNAs (siRNA) show significant potential in new molecular 
approaches to down-regulate specific gene expression in cancerous or viral-infected 
cells. However, there are still lots of critical points to risolve before their use as 
anticancer agents in clinical applications (Kim et al, 2007). This is because free 
siRNAs, delivered into the bloodstream, may undergo enzymatic degradation. A still 
open field is the mechanism of internalization of siRNA. In Drosophila cell cultures it 
has been shown that dsRNA is taken up by an active process involving receptor-
mediated endocytosis (Saleh et al., 2006). Pharmacological inhibition of endocytic 
pathways disrupted exogenous dsRNA entry and the induction of gene silencing. 
This dsRNA uptake mechanism seems to be evolutionarily conserved, as knockdown 
of orthologues in Caenorhabditis elegans inactivated the RNA interference response. 
Another crucial point is the correct delivery of siRNAs. To induce gene-silencing, 
intact double-stranded siRNAs have to reach the cell cytoplasm and be loaded onto 
RISC. Although small compared to nucleic acid standards, siRNAs are molecules 
much larger compared to typical small-molecule drugs that can enter easily cells. 
Moreover, siRNAs also have a strong negative charge due to phosphate groups and 
thereby cannot readily cross biological membranes to be taken up by cells. Thus, 
poor cellular uptake is the first major barrier for the use of siRNA, which limits its use 
even for local administration. In some cases siRNA can be taken up spontaneously 
by some cells at a very low efficiency via caveolin-mediated endocytosis. In addition, 
in complex systems, many tissues in vivo can only be reached through the systemic 
administration of siRNA via the blood stream. For an effective systemic delivery, the 
siRNA has to remain intact in the blood stream, extravasate through the vessels, 
diffuse through the extracellular matrix (ECM), penetrate the cellular membranes and 
be released into the cytoplasm. Thus, besides the poor cellular uptake, a series of 
other biological barriers are interposed between siRNAs and their target sites inside 
the cells. Since it is extremely necessary that after its correct delivery, the siRNA has 
to be still intact and active, the stability of siRNA in the extracellular and intracellular 
environments is crucial. Naked siRNAs have a very short half-life, few minutes in 
serum due to degradation by ribonucleases (RNAses), rapid renal excretion, uptake 
by the reticuloendothelial system (RES) and sequestration by serum proteins, thus 
lowering its bioavailability. Some of these issues, such as degradation by 
ribonucleases, can be avoided introducing chemical modifications such as a 
phosphorothioate backbone and 2’-sugar modifications that resist nuclease 
degradation, although their actual benefit for therapy has yet to be demonstrated  
(Lewis et al., 2002). Even if, with the mentioned modifications, siRNA can survive a 
while in the plasma, the next major barrier of siRNA delivery is the tight vascular 
endothelial wall. In general, molecules larger than 5 nm in diameter are not able to 
easily cross the capillary endothelium. However, liver, spleen and some tumors have 
enhanced the vascular permeability that allows the exit of macromolecules and 
nanoparticles up to approximately 200 nm in diameter, known as the enhanced 
permeation and retention (EPR) effect. Once overcome this barrier siRNA must 
diffuse through the ECM, which is a dense network of polysaccharides and fibrous 
proteins that can slow down or block siRNA complex diffusion. Finally, when the 
siRNA complex reaches the target cells, they have to be uptaken via endocytosis 
and, inside the cells they should escape the endosome and reach the cytoplasm 
(figure 2) (Akhtar et al., 2007). 
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Figure 2. The pharmaceutical challenges to effective siRNA delivery and activity in vivo. The challenges for effective 
siRNA delivery and activity in vivo range from the effective empirical or in silico design and selection of an effective siRNA 
sequence to its chemical modification or formulation with delivery vectors to improve biological stability and pharmacokinetics 
(steps i–iv). Optimally designed and formulated siRNA should then efficiently enter target cells and escape endosomal and other 
intracellular compartments to become highly bioavailable inside the cells so as to exert sequence-specific gene-silencing activity 
with no or minimal effects on nontargeted genes or inadvertent stimulation of the immune system (steps v–x). Figure 2 adapted 
from Akhtar et al., 2007. 
 
Although siRNAs are, in many cases, designed to exert therapeutic effects, they can 
also induce toxic side effects, such as the activation of the innate immunity through 
the induction of interferon responses as well as off-target gene silencing. siRNAs can 
potentially induce interferon responses either through the cytosolic dsRNA-activated 
protein kinase PKR or binding to toll-like receptors (TLRs). It has been shown 
(Bridgeet al., 2003; Reynolds et al., 2006), that the interferon and interleukin 
24 
 
production by plasmacytoid dendritic cells seems to be induced by some particular 
nucleotide motifs such as 5’-UGUGU-3’ or 5’-GUCCUUCAA-3’ within siRNAs. Apart 
from immunostimulation, siRNAs can also induce off-target effects. The majority of 
off-target effects are caused by small regions of seed sequence homology to the 3’ 
UTR of cellular mRNAs. Exogenous siRNA in large amounts can also potentially 
affect the activity of cellular microRNA by saturating the RISC. Furthermore, 
nonselective systemic siRNA delivery approaches result in their nonspecific 
distribution, thereby significantly decreasing the local concentration in the desired 
tissue and requiring large amounts of siRNA for gene silencing in vivo. To minimize 
toxicity, off target effects, excessive immunostimulation and to increase the specificity 
of delivery and targeting, in the last years there has been a great deal of interest in 
developing targeted delivery systems that reduce the effective dose as well as 
toxicities. 
To this aim many carriers have been developed in the last years, such as 
macromolecules based on nonviral lipids or protein carriers, including cholesterol, 
liposomes, antibody protomer fusions, cyclodextrin nanoparticles, fusogenic 
peptides, aptamers, biodegradable polylactide copolymers, and polymers. Positively 
charged cationic liposomes and polymers, such as polyethyleneimine, are currently 
the two major carriers used to complex with negatively charged siRNA for systemic 
delivery (Table 2, Kim et al., 2009).  
 
 
Table 2. siRNA  formulations employed for RNAi in different disease models. Table 2 from Kim et al., 2009. 
 
The strategies employed for the delivery of siRNA into cells can be broadly classified 
as either viral or nonviral-based. For the former, lentivirus, adeno-associated viruses 
and retro-viruses have all been used successfully as delivery vehicles of siRNA into 
cells (Morris et al., 2006). However, though effective, there are safety and toxicity 
concerns associated with using viral vectors that prevent their use in humans in vivo. 
On the other hand, nonviral methods of delivering siRNA have also been 
investigated. These include the use of lipid-based vectors such as liposomes, 
peptides, and cationic polymers as well as nanoparticles. Most importantly, tracking 
and monitoring the delivery of siRNA into cells are hard to accomplish without the 
help of a suitable tracking agent. As such, there is an impetus for finding a safe, 
nonviral, highly efficient and self-tracking vehicle for delivering siRNA into 
mammalian cells. 
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Nevertheless, all these systems have several disadvantages: they are difficult to 
synthesize; their composition is not easy to control; they often have low stability in 
biological fluids. 
The spreading of the nanotechnologies over the last decade, and the capability to 
control material size, shape and physical properties at the nanoscale, allowed us to 
use also nanoparticle to increase siRNA delivery and efficiency.  
As the term nanoparticle is generally used to indicate materials with very different 
chemicophysical properties, a brief introduction on different nanomaterials is reported 
below for clarity. 
1.5 Nanobiotechnology and nanomaterials 
Nanotechnologies use materials or engineered nanosized devices, usually from 1 to 
100 nm, with properties depending on their size, shape, chemical composition. 
Nanotechnology include the design, synthesis and characterization of nanomaterials 
and nanodevices. Chemistry, an integral component of nanotechnology deals with 
the manipulation of matter at the nanoscale leading to products with specific intrinsic 
properties that affect their interaction with the environment. Nanomaterials are being 
employed in several fields such as electronics, textiles, construction, sensors, 
chemical industry, automotive industry, medicine and many others. 
Nanobiotechnologies are widely recognized as one of the most interesting areas of 
application of nanotechnology. They use tools, materials and technologies to 
measure the chemistry and physics of nanosystems thought to investigate the 
properties and function of biological systems. The great potential of these methods is 
to reveal the function of biological systems at the molecular level, considering even a 
single (bio) molecule as a machine. The impacts of this research in the biomedical 
field are already evident and hold great potential in drug delivery, imaging and cell 
tracking. Manifold nanoparticle (NP) types have been produced, different in their 
chemical composition, shape, dimension, chemicol-physical properties, which make 
each type best suited for a specific purpose. For example, the fluorescent NP with a 
semiconductor core are chosen for fluorescence imaging in biology, the magnetic NP 
for diagnostic (MRI) or hyperthermia applications, the gold nanoparticles provide best 
contrast for electron microscopy and, given the non-toxic nature, for drugs delivery. 
This highlights the need to consider not only the usefulness of NPs but also the 
potentially unpredictable and adverse consequences of human exposure to them. In 
this context, NP toxicity refers to the ability of the particles to adversely affect the 
normal physiology as well as to directly interrupt the normal structure of organs and 
tissues of humans and animals. It is widely accepted that toxicity may be related to 
physicochemical parameters (size, shape, surface charge and chemistry, 
composition, stability). However the exact underlying mechanism is yet unknown, 
and recent literature suggests manifold pathways possibly involved, from oxidative 
stress to pro-inflammatory gene activation (Ambrosone et al., 2012; Tino et al., 2011; 
Alarifi t al., 2013). 
 
 
 
 
Figure 3. Overview on nanoparticles. Different types of nanoparticles are presented. 
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Among the main properties of nanoparticles suitable for nanomedicine, there is the 
capability to bind to their surface a large plethora of molecules and functional groups. 
NPs functionalization can be designed to achieve better targeting efficiency, better 
cellular internalization and higher bioavailability. It is also possible to add on NP 
surface drugs, bioactive compounds, in order to build nanomachines that can reach 
the target tissue and cells (figure 4). 
!
 
Figure. 4. Scheme of a general nanoparticle structure. Schematic representation of the multiple functional gruops that can 
be linked to NP surface. The core confers physical, electrical and magnetic properties; the surface confers the stabilization in 
aqueous medium, and finally the functionalization of NPs  is important for specific targeting or the delivery. 
 
Iron oxide nanoparticles present magnetic properties. By applying an intense external 
magnetic field, the particles of iron oxide begin to resonate releasing heat. This 
effect, known as magnetic hyperthermia, can be used for selective cell ablation of 
tumor cells, in view of their high susceptibility to heat (Huang et al., 2010). 
Ag nanoparticles are known for their antibacterial properties and are present in many 
products, from fabrics for sportswear. Although the antimicrobial properties of silver 
are known for thousands of years, the increase in the area of engineered silver 
nanoparticles (1-100 nm) makes them more chemically active and increases the 
therapeutic properties (Stani" et al., 2011). 
Fullerenes are molecules composed entirely of carbon, which may take the form of a 
hollow sphere, of an ellipsoid or a tube. They can be single-walled SWNT (single-
walled nanotube), if constituted by a single sheet or multiple wall, MWNT (multiwalled 
nanotube), if formed from sheets positioned as concentric cylinders inserted one 
inside the other. In recent times, the fullerenes have attracted attention for many 
properties they possess: they are six times lighter, but a hundred times stronger than 
steel, yet flexible. Are extremely resistant to high temperatures and can be 
conductors, semiconductors or insulators, depending on the method of production  
(Zinchenko et al., 2013). 
Carbon nanotubes are also finding application in regenerative medicine. In particular, 
in the neurological field, they could be used to reestablish the intricate connections 
between nerve cells. The organic structure, characterized by a remarkable ability to 
conduct electricity makes it possible the transfer of action potentials between nerve 
cells (Yildirimer et al., 2011) 
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The Dendrimers are branched polymers with 3-8 or more branches, starting from a 
central core. The dendrimers have emerged as one of the best vectors for drugs due 
to their biocompatibility, the nanosized dimension and the structure resembling 
certain biomolecules. Specific drugs targeting through dendrimers is based on the 
fact that if a receptor is specifically expressed or is in excess on the surface of a cell, 
the dendrimer carrying the drug (together with the ligand receptor) can travel in the 
blood stream, bind specifically to the cell and release the drug (Gareth et al., 2005). 
The Quantum Dots are fluorescent nanoparticles made of metals semiconductors, 
with singular chemical-physical properties, such as high luminescence, photostability, 
absorption spectra and emission dependent on the composition and size. Compared 
to organic fluorophores the QDs have different optical properties, as evidenced by 
the emission and absorption spectra (Figure 5c) The traditional organic dyes are 
characterized by asymmetric emission spectra and narrow absorption spectra, which 
means that they can only be excited within a narrow window of wavelengths. The 
QDs instead have broad absorption spectra, allowing excitation in a wide range of 
wavelengths and their emission spectra are symmetrical and narrow. They have 
dimensions between 2 and 40 nm in diameter, and after UV excitation, emit at 
different wavelengths ranging from 400 to 800 nm (from near UV to infrared). The 
characteristics of absorption and emission of light are dictated both by the size that 
the chemical composition. Consequently multicolored nanocrystals of different sizes 
can be excited by a single wavelenght. In general the QDs structure present: a core 
of semiconducting material such as CdSe and CdTe, a shell of CdS, ZnS, PbS to 
greatly increase the fluorescence properties and an outer capping important for 
biocompatibility (Younes et al., 2009).  
The Quantum Rods, have rod-shaped and in addition to the properties described for 
the QDs, are endowed with superior brilliance, having intervals of absorption wider, 
making them fluorescent probes of election (Figure 5d). 
 
 
 
 
Figura 5. General scheme of QD and QR. a) schematic representation of the CdTe quantum dot. QDs present a dimension 
between 2 and 4 nm in diameter b) TEM images of QDs; c) emission spectra d) schematic representation of the CdSe/CdS 
rods, highlighting the asymmetrical shape derived from the synthesis procedure. The rod samples present an average of 35nm 
in length and 4 nm in diameter as confirmed by e) the TEM image. f) emission spectra of QR (From Ambrososne et al, 
submitted) 
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1.6 Gold nanoparticles 
Gold nanoparticles are produced with easy and mild conditions by chemical reduction 
of gold salts. They possess, as other types of metal particles, particular properties of 
absorption of visible light (plasmonic absorption) that make them particularly suitable 
for the development of diagnostic tools. Spherical gold nanoparticles exhibit an 
intense red color due to the surface plasmonic absorption, while triangular shaped 
nanocrystals show blue colour. Changes in their shape reflect also changes in their 
property of emitting heat, because of the plasmon resonance. Indeed, some 
nanoparticles, for instance those with a triangular or rod shapes are excellent 
nanoheaters (heat development and emission after NIR light excitation), while the 
spherical NP do not present this property. Another important feature common to 
other nanocrystal is the possibility to functionalize their surface with various 
molecules, such as PEG to prevent aggregation or bioactive molecules (peptide, 
nucleic acid, carbohydrates) to add functionality. The possibility to modify the surface 
of those nanodevices by linking it to drugs or to molecules and release them at 
destination has opened new doors on the development of molecular and 
macromolecular therapies. The highly tunable and multivalent surface architecture of 
gold nanoconjugates offers the potential to incorporate multiple therapeutic agents as 
well as to target and protect molecules on the surface of a single nanoparticle, and 
thus are expected to improve the delivery and efficacy of therapeutic payloads.  
1.6.1 Gold nanoparticles and oligonucleotides 
In the recent years several research groups succeded in the synthesis, 
characterization and production of DNA-funcionalized gold nanoparticles able to 
enter a wide variety of cell types. Their uptake by cells was not predicted, given that 
these structures contain a densely functionalized shell of polyanionic DNA (ca. 100 
DNAs on the surface of each 13 nm gold particle), and that strategies for the 
introduction of oligonucleotides typically require that DNAs are complexed with 
positively charge agents to effect cellular internalizazion. Indeed, because of their 
high negative charge, most researchers at the time would have predicted that the 
nanoparticles would not enter cells (Niidone et al., 2002). The importance of the 
polyvalent arrangement of oligonucleotides to cellular uptake can be further 
emphasized when comparing DNA-AuNPs to other types of AuNPs. Oligonucleotide 
functionalized gold nanoparticles uptake resulted to be cell type independent since 
several cell lines resulted able to take those particles from the media. This property 
has been used to modulate gene expression by means of antisense oligonucleotide 
or siRNA conjugated NPs. The first siRNA delivery paper was published in late 2006. 
In this work 15 nm AuNPs were co-decorate with SH-PEG5000-PAMA  and SH-siRNA 
(A). PAMA is a poly ethil methacrylate polymer bearing terminal amines. In this 
complex, the siRNA is roughly the same size as the coloaded PEG-PAMA. Then, 13 
nm AuNPs were loaded with SH-PEG400 and SH-siRNA (B). In this system the PEG 
is smaller than siRNA thus that the particle surface exposed to the cells displays 
almost entirely siRNA, (Lytton-Jean et al., 2011). This reviews shows the work on 
siRNA-gold nanoparticles delivery for the first 5 years of its existence, mainly based 
on cell culture systems and on the downregulation of reporter genes (beta-gal, GFP). 
In vivo studies targeting physiological important genes are needed to assess the 
applicability of these materials as delivery agents for new therapies. On 2010 Davis 
and coworkes, tested for the firts time the systemic administration of siRNA to 
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patients with solid cancers using a targeted nanoparticle delivery system. Tumor 
biopsies of treated patients, showed the intracellular localization of particles, and a 
reduction in both the specific messenger RNA and protein levels, demonstrating the 
feasibility of using this nanodevice for translation in clinical trials (Davis et al., 2010).  
 
 
 
Figura 6. Gold nanoparticle conjugates used for siRNA delivery formed via a gold–thiol bond. Gold nanoparticles are 
decorated with siRNA and varying lengths of PEG. Adapted from Lytton-Jean et al., 2011.  
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1.7 The NANOTRUCK European project 
The work presented in this PhD thesis is part of the European project “Multifunctional 
gold nanoparticles for gene therapy” (NANOTRUCK), aimed to develop gold 
nanoparticles functionalized with multiple bioactive molecules triggering, in a cell type 
specific manner, gene silencing by RNA interference. The idea is to produce new 
tools for lung cancer treatment, by targeting a gene frequently deregulated in this 
desease: the protooconcogene c-myc. This new nanoplatform emerged from the 
collaboration of 5 research groups spread all over Europe, presenting 
complementary expertises in Chemistry, Biology, Medicine. The project intends to 
develop an innovative kind of multifunctional gold nanoparticles loaded with 
fluorescent and tumoral markers, cell penetrating peptides and siRNA 
complementary to the proto-oncogene myc. These biofunctional products were 
tested in different biological systems, ranging from in vitro cultured human cells to in 
vivo animal models (primitive Hydra and complex vertebrate mouse).  
 
 
 
  Partner 1 (Coordinator): Instituto de Nanociencia de Aragón Zaragoza (Spain): Prof. R. Ibarra; Dr. 
JM. de la Fuente 
 Partner 2: Centre for Cell Engineering. University of Glasgow (UK): Dr.Catherine Berry 
   Partner 3: Istituto di Cibernetica “E. Caianiello” ,Pozzuoli (Italy): Dr. ClaudiaTortiglione 
  Partner 4: Helmholtz Zentrum Munchen. Munchen (Germany): Dr. Furong Tian 
  Partner 5: Faculdade de Ciencias e Tecnologia. Universidade Nova de Lisboa. Caparica 
(Portugal): Dr. P.V.   Baptista 
My PhD thesis contributed to achieve the objectives expected for the Italian 
Research Unit, testing AuNP-siRNA conjugates on Hydra vulgaris. 
 
1.7.1 The myc protooncogene as target  
 
Most of the genes involved in neoplastic transformation and cancer, namely the 
oncogenes, encode for proteins devoted either to transcription or to control DNA 
integrity/cell cycle progression. Among them, the MYC family of transcription factors 
controls disparate aspects of cell physiology including cell growth, cell cycle 
progression, biosynthetic metabolism, and apoptosis. As expected, its deregulated 
expression occurs in the majority of human cancers (Figure 7), as reported in Dans 
et al.,2012.  Activation or upregulation of c-myc is known to cause numerous 
biological effects including cell proliferation and paradoxically induction of apoptosis, 
cell differentiation and stem cell self-renewal. Thus the main rationale for selecting 
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myc as a target for cancer therapy is two fold; (1) the gene is involved in a wide 
variety of human tumors and thus therapies could potentially have an impact on the 
treatment of a broader range of malignancies; (2) myc is involved in both proliferation 
and apoptosis, thus strategies aimed at targeting myc might lead to either inhibition 
of tumor cell proliferation and/or increase in cell apoptosis. 
 
 
 
Figure 7. Cellular processes controlled by myc during normal conditions and during tumorigenesis. 
 
The MYC protein consists of an N-terminal domain (TAD) required for transcriptional 
activation, a central region and a C-terminal domain (CTD), critical point for DNA 
binding and protein interactions. Furthermore, MYC has four conserved region, called 
Myc boxes (MB) that are important for different functions. The TAD domain contains 
MBI, that contributes to gene activations and protein degradation, and MBII, that is 
critical for the several myc functions. The central regions contains the conserved 
domain, MBIII, involved in transcriptional repression, apoptosis, trasformation, and 
lymphomgenesis, and MBIV, that regulates DNA binding, apoptosis, transformation 
and G2 arrest (Figure 8, Cowilng et al., 2006). 
 
 
 
Figure 8. Scheme of the c-myc transcription factor structure. MYC is characterized by the presence of four Myc boxes (MBI 
to MBIV), at the N terminus there is the TAD domain involved in transcriptional activation. At the C terminus there is the DNA 
binding domain and the two sequences of nuclear localization.  
 
Myc expression is regulated by external signals, such as growth factors, but also by 
internal cell cycle control. In the normal cells, myc levels are low, instead they 
increase upon entry into the cell cycle, and then decline to remain at a basal level in 
cycling cell as described in Amati et al., 1998 and Edgar et al., 2001. 
Oncogenic alterations of myc gene are induced by mutations, gene amplification, 
translocation, over-expression, enhanced translation and increased protein stability.  
The role of c-myc in cancer has been exstensively examinated in many studies for 
the past decade; breast cancer, for example is generated by overexpression of c-myc 
(Liao et al., 2000). 
 
32 
 
1.7.2 Multifunctional gold nanoparticles for myc RNAi 
In the frame of the Nanotruck project, in the laboratory headed by dr. Jesus de la 
Fuente, (University of Zaragoza, Spain) stable gold nanoparticles (AuNPs) with a 
diameter of 14 nm were synthesized by reduction of sodium tetracloaurate hydrate 
with sodium citrate dehydrate. The whole synthesis procedure is reported in the 
manuscript by Conde et al, 2012 and the main rationale is here briefly described. To 
improve the stability, biocompatibility, and chemical functionality, AuNPs were 
functionalized with two types of thiolated polyehilen glicol (PEG) spacers: a 
commercial carboxylated spacer, SH-EG (8)-(CH2)2-COOH, and an azide-containing 
spacer custome synthesized, SH-(CH2)3-CONH-EG(6)-(CH2)2-N3. The first spacer 
provides the anchoring moieties foe the covalent binding of amine-containing 
molecules through carbodiimide chemistry, while the azide spacer confers positive 
zeta potential values, which is important for cell uptake. With the aim to elucidate the 
most efficient strategy to bind siRNA molecules to AuNPs, two types of AuNPs 
stabilized by different degrees of PEG chains were selected: 1) NP-ionic with 100% 
PEG coverage (25% azide-containing spacer and 75% carboxylated spacer); 2) NP-
covalent with 25% PEG coverage (composed by 50% of either spacer). These AuNP 
formulations represented the basic nanoparticles for downstream functionalization 
with c-myc siRNA, using either ionic approach (ion) or covalent (cov) approach.  
The moieties selected for AuNP functionalization were the following: cell penetrating 
peptides, to overcome the lipophilic barrier of the cellular membranes and improve 
cell delivery; Quaternary ammonium: to introduce stable positively charged on gold 
nanoparticles surface; small interfering RNAs, to achieve gene silencing. All AuNP 
bioconiugates presenting at the surface siRNA and other groups, TAT peptide, RGD, 
and quaternary ammonium (R4N+), in different combinations, were caracterazed by 
trasmission electron mycroscopy (TEM), UV/vis spectroscopy, surface plasmon 
resonance (SPR) shift, and Zeta potential, as showed in Figure 9. The ionic and 
covalent synthetic strategies are showed in Figure 10. In the covalent approach 
thiolated siRNAs were used given their ability to be conjugated to a non saturated 
PEG layer. Whereas the ionic approach took advantage of the negative charge of 
siRNAs that allows the interaction with quaternary ammonium loaded on the surface 
of the AuNPs. 
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Figure 9. Characterization of AuNPs. TEM analysis of (a-b) NP-cov approach, (c-d) NP-ion approach. The stabilization effect 
of the different functional groups can be observed the optical properties by UV-vis spctroscopy (e-f). The absorpotion band 
appear at 550 nm due to the surface plasmon resonance of the AuNPs. The SPR shown in e and f insets exhibited a red shift 
from 520 to 525 nm. In g is showed the quantification of the PEG chains, TAT and RGD peptides and siRNA  fo all AuNPs, 
together their Z-potential measurements. (Figure from Conde et al., 2012) 
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Figure 10. Covalent and Ionic synthetic approach employed to bind siRNA on AuNPs. Covalent approach, use of thiolated 
siRNA for gold-thiol binding to the nanoparticle; Ionic approach: interaction of the negatively charged siRNA to the modified 
surface of the AuNP through ionic interactions 
 
In the frame of this project my experimental thesis aimed to test biocompatibility and 
efficiency of functional nanoparticles determining in vivo, a whole animal level the 
capability of functional NPs to induce specific gene silencing. Below, a description of 
the animal model I used is reported. 
1.8 Hydra vulgaris as in vivo model sistem 
The freshwater coelenterate Hydra vulgaris represents an interesting model system 
to investigate basic cellular mechanisms. Among the wide range of molecular tools 
available to dissect gene function in model organisms, in Hydra only very few have 
been found efficient.  Hydra vulgaris belongs to the animal phylum Cnidaria that 
arose almost 600 million years ago (Figure 11) (Lenhoff et al., 1968). 
 
 
Figure 11. Cnidaria position in Metazoan phylogeny. 
 
Its body plan is very simple, consisting of a single oral-aboral axis with radial 
symmetry. The structures along the axis are a head, a body column and a foot to 
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anchor to a substrate. It is shaped as a tube, about 5-20 mm long and 0.3-1.0 mm 
wide.The head is divided in two structures, the hypostome or mouth at the apex, and 
the tentacles in number of six-eight (Figure 12). 
 
 
 
Figure 12. Hydra vulgaris. An adult animal with a bud emerging from gastric region. 
 
The body consists of two concentric epithelia, the ectoderm and endoderm separated 
by an acellular basement membrane, the mesoglea. This bilayer structure extendes 
throughout the entire body column, tentacles and buds. A third cell lineage, the 
interstitial stem cells lineage, is located in the interstices, among the 
epitheliomuscular ectodermal cells (Figure 13). Most of Hydra body is occupied by 
the gastric region, where the digestion takes place. In the lower part of the body the 
budding of new animals occurs, and this process accounts for the rapid asexual 
reproduction, which enable massive culturing of the aninal in laboratory conditions.  
 
 
Figure 13. Anatomical structure of Hydra vulgaris. The body wall is composed of two self-renewing cell layers, an outer 
ectoderm and an inner endoderm, separed by mesoglea. Along the body the two epithelial layers are composed by 
epitheliomuscolar cells, while the interstitial cells and their differentiated products are located in the interstices between the 
cells. 
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1.8.1 Cell types in Hydra vulgaris 
 
Of 15-20 identified cell types in Hydra, most can be placed in one of three cell 
lineages. Each lineage contains a population of self-renewing stem cell and 
differentiated cell derived from those stem cells.  
The ectoderm and endoderm contain the major epithelial cell type, called the 
ectodermal and endodermal epitheliomuscular cells, or simply epithelial cells. 
Epithelial cells divide continuosly although after an injury such as a cut or after 
feeding, the duplication rate is slowed down (Holstein, Hobmayer, & David, 1991). 
These epithelial cells are large, vacuolated and usually cuboidal or columnar (Figure 
14, Hobmayer et al., 2012). The epithelial cell in the tentacles develop into battery 
cells.  
Interstial stem cells (i-cells): the i-cells are multipotent stem cells, with a fast-cycling 
activity, evenly distributed along the body and absent in the regions of the head and 
foot (David et al.,1980). They are characterized by a large nucleus and a small 
cytoplasm and occur either as single or as pairs, thus for this reason they are named 
1s and 2s (Figure 15). They are able to differentiate into nematocytes, secretory 
cells, gland cells, neurons and gametes. The interstitial stem cell system constitutes 
an independent cell lineage in Hydra that contributes about 75% of all cells in the 
organism (David 1987 et al., Genetic regulation of development). In Figure 15 the 
proliferation and differentiation pathways of the Interstitial stem cell lineage are 
shown. 
 
 
 
Figura 14. Scheme of the proliferation and differentiation pathways of ectodermal and endodermal epitheliomuscular 
cells. Hobmayer et al., 2012 
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Figura 15. Scheme of the proliferation and differentiation pathways of the interstitial stem cell lineage. Blue, stem cells; 
pink, transit amplifying cells. From Hobmayer et al., 2012. 
 
Nematoblasts include all intermediate cells between the stage of 1s interstitial cell 
and mature nematocyte. They occur in nests or clusters of cells ranging from 4 to 32 
cells. Nematoblast in nest of 4 cells resemble small interstitial cells and can divide 
further. Nest of 8, 16, 32 cells are conspicuously smaller; in fact when isolated and 
viewed with phase microscopy they have a granular appearance and incospicuos 
nucleolus. These 8-32 nest stage have been often called dividing nematoblasts. 
The nematocytes, cells involved in the capture of prey, are located in the ectodermal 
layer and are concentrated in the tentacles. There are 4 different types of 
nematocytes, which differ in the type of secretory vacuole, called nematocyst        
capsule. In general the nematocytes appears as a tube wrapped reversed, able to 
release its contents during the process of prey capture (Holstein T., 1981). Once 
differentiated nematocytes migrate into the tentacles, where they are incorporated as 
aggregates of 10 to 20 units to form battery complexes (Figure 16). The battery cells 
consists of a modified ectodermal epithelial cell and do not undergo mitosis. These 
cells are characterized by several cell type embedded into a single giant cells: 
sensory neurons and nematocytes (Campbell R.D. 1987). In a previously work, using 
the monoclonal antibody NV1 as a marker for tentacle-specific nerve cells  
(Hobmayer et al, 1990) have been investigated formation of tentacle tissue on a 
cellular level. Formation of a NVl-battery cell complex occurs during head formation 
and is stimulated by treatment with the neuropeptide head activator (HA), which has 
been shown to stimulate tentacle (Schaller, 1973) and nerve cell formation (Holstein 
et al., 1986) in Hydra. 
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Other endodermal cells: the basal cells, found near the mesoglea; gland cells which 
divided in two classes: zymogen cell and mucous cell. The zymogen cell is 
characterized by large and dense secretory vesicles. Zymogen cells occur 
throughout the body colomn, but not in the hypostome or basal disk regions. Mucous 
cells are small granules found in the hypostome. In Figure 17 the different cell types 
isolated from macerated Hydra tissue are shown. 
 
 
 
Figure 16. Structure of battery cell in Hydra vulgaris. Three types of nematocytes, a sensory cell and cnidocil form the 
battery cell.  
 
 
Figure 17.Isolated cells from macerated Hydra tissue as viewed using phase microscopy. The cell types illustrated are: 
ectodermal epitheliomuscular cell from body column (ecto); endodermal epitheliomuscular cell (endo); single interstitial cell (1s); 
interstitil cell in nest of two (2s); basal disc gland cell (gc). Kind courtesy from B. Hobmayer. 
 
1.8.2 Regeneration process in Cnidaria 
Regenerative capability of Cnidaria is one of the most interesting aspects of this 
phylum. The regeneration in Hydra species enable amputated polyps, to reform a 
new head from the body and a new body from the head (Figure 18). Morphogenetic 
processes take place during the first 48 h post amputation, followed by cell 
proliferation to restore adult size (Bode et al., 2003); (Holstein at al., 2003).  
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Figure 18. The regeneration process in Hydra vulgaris. After amputation, the two polyps starts immediately an asymmetric 
process at the wound site: the upper half undergoes foot regeneration in about two days, while the lower half initiates the head 
regeneration process, which is completed in three days. 
 
This ability to self-organization is due to the continuous production of adult tissue 
cells and signaling factors. The tissue regeneration shows a directional property 
called polarity, which confer the capability to regenerate a head in the apical part, 
and a food in the basal extremity. The polarity depends on a gradient of molecules, 
which provide positional information (Bosch et al., 2007). In contrast to vertebrates, in 
which the morphogenetic signal is active only during embryogenesis, in Hydra it is 
continuously active (Holstein et al., 2003). 
In summary radial symmetry, and high capacity for regeneration make Hydra an 
excellent model organism to study of stem cell priliferation, differentiation and 
regenerative processes 
 
1.8.3 Reproduction 
 
The biological cycle of Hydra, unlike other cnidarians, includes only one stage of 
polyp that can reproduce by both asexual and sexual means. The epithelial cells 
structuring the boby continuosly divide and contribute to the formatio af new 
individuals, budding of the gastic region, and detaching from the mother in about 3 
days (Galliot et al., 2006). The Hydra in their natural habitat typically reproduce by 
budding during the regular feeding regime, but they produce male gametes and / or 
female in autumn (Figure 19). In laboratory condition, the main method of 
reproduction is budding. Growth rate of Hydra tissue is normally regulated by a 
balance between epithelial cell cycle lengh, phagocytosis of ectodermal cells and bud 
formation (Bosch et al.,1984). Enviromental factors, such as the presence of the 
pullutants or the feeding regime, can affect this balance. 
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Figure 19. Biological cycle of Hydra. The eggs are kept in glass on the epidermal surface of the polyp. After fertilization, they 
undergo segmentation and surround themselves with a protective chitinous capsule. Encapsulated embryos (with a diametre of 
0.5 / 1 mm), which end up by turning away are able to survive periods of drought and winters. The young hydra emerges when 
environmental conditions become favorable.  
 
 
1.8.4 Hydra as model organism to test nanoparticles 
 
Hydra offers several potential advantages as investigation target by means of NPs, 
such as 1) the simplicity of the body structure, which allows easy detection of 
fluorescent probes, 2) the dynamics of the two epithelia, which continuously divide, 
migrate and are eliminated at the apical and basal ends of the polyp, allowing cell 
migration and tracking studies, and 3) the regenerating capability, involving extensive 
remodelling and plasticity phenomena, whose temporal dynamics can be best 
approached by using photostable fluorescent probes. 
In a recent work, QDs functionalized with glutathione (GSH) were synthesised and 
shown able to evoke a particular behavior of the animal, consisting in the opening 
of the mouth: the QDs-GSH reach the gastric region and are uptaken by 
endodermal cells (Tortiglione et al., 2007), Figure 20 
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Figure 20. In vivo fluorescence imaging of Hydra polyps treated with GSH-QDs. a) Bright field image of Hydra showing the 
animal structure. b) Image of 24 hours after treatment shows an intense fluorescence along the gastric region. c) cell 
localization of QDs in Hydra cross section. Endodermal cells (en) , mesoglea (m) and ectodermal cells (ec) are indicated by 
arrows. Adapted from Tortiglione et al., 2007. 
 
GSH-functionalized nanoparticles represent the first example of fluorescent and 
bioactive abduct used by the NanoBiomolecular group (Istituto di Cibernetica, 
CNR, Pozzuoli) for staining of a specific tissue in Hydra. The remarkable results 
opened the road to following studies with nanoparticles of different size, 
composition and shape on living Hydra. For example, it was demostreted that QRs 
with CdSe core and shell of CdS, in nanomolar concentrations, induce in Hydra a 
particular tentacle writhing,, similar to that observed during feeding or induced by 
GSH (Figure 21). The results of these experiments led to the identification of a 
target cell, the sensory neuronal cells of the tentacle. The induction of tentacle 
writhing activity was explained by assuming electric fields generated by permanent 
dipole moments of the nanoparticles, of sufficient intensity to stimulate voltage-
gated channels on tentacle neurons, and therefore capable of triggering the 
sprawling activity. It was also demonstrated that the presence of calcium in 
solution is a necessary condition for the induction of that activity (Malvindi et al., 
2008) 
 
 
 
Figure 21. Elicitation of tentacle writhing by QRs. Hydra polyps were incubated with QRs and motor activity was monitoreted 
by video recording. a) Hydra polyp after adition of QRs to culture medium. The tentacles beging to writhe immediately. b) Hydra 
polyps in physiological condition, with extended tentacles. Adapted from Malvindi et al., 2008. 
 
Another example of interaction of NP and Hydra vulgaris is provided by the use of the 
same CdSe/CdS quantum rods at acidic conditions. (Tortiglione et al., 2009). Indeed, 
at acidic pH, the QRs present positive charge and interact with the negative charge 
of the plasma membrane, stimulating the endocytosis process. At neutral pH, QRs 
present a negative charge and exhibit a low efficiency of internalizazion. Images of 
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labelled polyps at different time post incubation with nanomolar amount of QRs are 
shown in Figure 22, while in Figure 23  the QR tissue localization is shown. 
 
 
 
Figure 22. In vivo fluorescence imaging of Hydra vulgaris exposed to QRs. a) In vivo image of Hydra 30 minutes post  
incubation: QRs labels all the body regions. b) In vivo image of polyp 2h post incubation: QRs label the mouth, the tentacles and 
the foot. c) 24h post incubation QRs are evident also in the body column. Adapted from Tortiglione et al., 2009. 
 
 
Figure 23.  Localization of QRs in Hydra tissue sections. Hydra were treated with QRs at acidic pH for 4h, and 24 h later 
fixed and processed for cryosectioning. The green color is the auto fluorescence of tissue, while the red staining indicate the 
QRs presence. A, B, C) Serial longitudinal cross sections of  head and D) of body, show QRs into the ectodermal layer, but also 
inside endodermal cells. On the right part of the image the labeling pattern befor cryosection is shown. Scale bar A-D 200 #m, E 
500 #m. Adapted from tortiglion et al., 2009. 
 
Another advantage offered by Hydra as model organism to be targeted by metal 
based NP is the possibility to evaluate the potential toxicity of the NPs. Hydra is 
sensitive to a range of pollutants and has been used as a biological indicator of 
water pollution (Pollino and Haldway, 1999). Bioassays measuring Hydra 
population growth by asexual reproduction are rapid, sensitive, and precise when 
E 
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measuring the effect of environmental pollutants. Large numbers of Hydra can be 
cultured due to their small size and rapid reproductive rate (Loomis, 1954). We 
showed the toxic effect displayed by CdTe QDs on Hydra morphology, 
reproductive and regenerative capabilities (Ambrosone et al., 2012) and identified 
also the activation of apoptotic pathways by biochemical and biomolecular 
approaches. 
1.8.5 Gene knock out by RNAi in Hydra.  
In recent years the number of methodologies to induce gene silencing in Hydra is 
increasing. In fact using electroporation, particle gun and embryo injection is 
possibile to introduce into Hydra cell nuclei a green fluorescent protein (GFP) 
expression under the control of both homologous and heterologous promoters 
(Böttger et al., 2002); (Miljkovic et al., 2002); (Bosch, 2006). Gene silencing mediated 
RNA interference has been successfully obtained in a number cases and using 
different delivery methods by both double strand RNA producing plasmids or 
oligonucleotides (Lohmann et al., 1999); (Chera et al, 2006); (Amimoto et al, 2006). 
In the first case bacteria carrying plasmid producing RNA are taken up into the body 
cavity upon mouth chemically opening, and many cycles of exposure are needed to 
knock out a specific gene. In the second case, a LEP procedure (Localised 
electroporation) has been developed to allow oligonucleotides to enter cells of a 
restricted body region. These techniques present several disadvantages, as the 
invasivity of electroporation and the introduction of massive bacteria doses into 
animal cavity. For these reasons, it would be necessary to develop alternative 
strategies for study of RNAi 
 
1.8.6 Caracterization of c-myc protoncogene in Hydra vulgaris 
 
A c-myc homologue (Hymyc1), has been recently characterized in Hydra 
magnipapillata (Hartl et al., 2010), and by genomic analysis three additional myc 
releted genes have been predicted. Among them, HyMYC1 and HyMYC2 protein 
sequences, displayed the principal topography of MYC proteins. The bHLH-Zip 
domains and MYC boxes I to III are orthologues of vertebrate myc, while the other 
two proteins HyMYC3 and HyMYC4, present the bHLH zip domains with a difference 
in the N-terminal region (Figure 24). Hymyc1 is expressed in proliferating interstitial 
stem cells and gland cells. In Figure 25 was showed the amino acid sequences of 
Hymyc1 and alignment with their vertebrate homologs. 
             
 
 
 
Figure 24. The Hydra protooncogene Hymyc1 
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Figure 25. Amino acid sequences of Hydra myc1 and alignment with their vertebrate homologs. (A) Alignment of human 
(Hu) c-Myc, chicken (Ck) c-Myc, and Hydra (Hy) Myc1 sequences (GenBank accession nos.: hu c-Myc, NP_002458; ck c-Myc, 
NP_001026123; hy Myc1, GQ856263). Identical residues are shaded in Blue, gaps are indicated by Dashes. The positions of 
the Myc boxes (MB) I–IV in the transactivation domains of the vertebrate proteins and of the bHLH-Zip region in the Myc are 
indicated. Conserved heptad repeat residues in the leucine zipper regions are marked by Asterisks. The positions 
corresponding to exon-exon junctions are indicated by Arrows above (HU, CK) and below (HY) the alignments. Figure from 
Heartl 2010. 
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1.9 Aim of PhD thesis 
 
In the frame of NANOTRUCK project my thesis work was aimed to test and validate 
effective protocols of RNAi using Hydra vulgaris as model system. In order to achieve 
this goal, I developed two strategies, one based on free myc-siRNA administration to 
living polyp by soaking, the other based on the incubation with myc-siRNA 
conjugated gold nanoparticles (AuNP). As a myc homologue gene has been 
identified in Hydra, I determinated its functional role on cell proliferation and 
differentiation through downregulation by RNAi. In addition to the gene silencing 
studies, I also investigated the mechanisms of AuNPs internalization, intracellular 
trafficking and clearance by means of transmission electron microscopy, uncovering 
new dynamics and inward and outward routes, which should be taken into account 
when designing NP based devices for biomedical application
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2 Materials and methods 
 
2.1 Animals 
 
Hydra Vulgaris (strain Zurich, originally obtained from Pierre Tardent), Figure 1. 
 
 
Figure 1. Adult Hydra vulgaris 
 
2.2 Nanoparticles tested 
 
Stable gold nanoparticles (AuNPs) with a diameter of 14 nm were sinthesized by 
reduction of sodium tetracloaurate hydrate with sodium citrate dehydrate by the 
group of Jesus M. De la Fuente at Institute of nanoscience in Zaragoza, according to 
Turkevich et al, 1951. To improve the stability, biocompatibility, and chemical 
functionality, these AuNPs were functionalized with two types of thiolated polyehilen 
glicol (PEG) spacer: a commercial carboxylated spacer, SH-EG (8)-(CH2)2-COOH, 
and an azide-containing spacer custum synthesized in laboratory, SH-(CH2)3-CONH-
EG(6)-(CH2)2-N3. The first spacer provides the anchoring moieties foe the covalent 
binding of amine-containing molecules through carbodiimide chemistry, while the 
azide spacer confers positive zeta potential values, which is the principal factor for 
cell uptake. 
 
2.3 Hydra vulgaris culturing 
 
Sea salt Solution (for shrimp hatching): sea salt 4% and deionized water. The 
solution was filtered and sterilized 
Hydra medium (Sol Hy): 1 mM di CaCl2 and 0.1 mM NaHCO3 in di H2O Milli Q 
(bidistilled water) adjusted to pH 7. 
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NaHCO3Solution: 0.1mM NaHCO3 in 1mM Tris HCl a pH 7.4 
CaCl2 Solution in 1mM Tris HCl a pH 7.4 
Tris HCl Solution: 1mM Tris HCl a pH 7.4  
 
2.4 Preparation of Artemia salina nauplii  
 
The freeze-dried cysts were stored at +4°C. To get their hatching they were put in 
suspension in a beacker containing saline solution until the convergence of the 
Artemia salina nauplii towards the center. Then the beacker was illuminated in order 
to obtain greater convergence of artemia and thus facilitating their harvesting. At 
room temperature, the eggs hatch in about 48 hours. The collected artemia, were 
washed with double-distilled water, to remove salts which are toxic for the freash 
water polyp Hydra vulgaris.  
 
2.5 Feeding procedure 
 
Artemia were collected, transferred to filter meshed and after rinsing in fresh water, 
were added to the polyps. The removal of residual larvae, occurred after 4-6 hour of 
feeding. If the containers are clean enough just rinse and change a couple of times a 
Hydra solution, otherwise you need to transfer the animals into new containers with 
fresh solution. To avoid losing too many animals during the rinsing a filter mesh 
(about 0.4 mm) has been used to retain the hydras and eliminate the artemia 
residues. To handle both the brine shrimp and Hydra glass Pasteur pipettes were 
used. 
 
2.6 In vivo RNA interference through small interfering RNAs 
 
For RNA interference groups of 25 polyps were collected in plastic multiwells, 
allowed to equilibrate at room temperature in 1mL of Hydra medium at pH 4. The test 
was initiated by adding 70nM siRNA to each well containing the animals, since then 
continuosly exposed to the siRNA oligonucleotides, under normal feeding regime. 
After the washing new siRNA oligonucleotides were supplied. 21 bp long siRNA 
targeting Hymyc1 were designed using on line siRNA design service and purchased 
by QIAGEN. Both unlabelled and 3’ – Alexa fluor 488 siRNA were designed on the 
Hymyc1 DNA target sequence: 5’ – AAGATGCTCACGCGTCAAGAA – 3’. As control 
of silencing specificity, siRNA oligonucleotides targeting the Luciferase GL2 gene 
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were purchased by QIAGEN. siRNA uptake was monitored in vivo, using a Camedia-
digital camera (Olympus) conneted to a stereomicroscope (Olympus ZSX-RFL2). In 
vivo imaging was accomplished at several magnification by using both a 
stereomicroscope and an inverted microscope (Axiovert 100, Ziess) equipped with a 
digital colour camera (Olympus, DP70). For imaging acquisition and analysis the 
software system Cell F (Olympus) was used. 
 
2.7 Toxicological studies with intact and  regenerating animals 
 
Groups of 20 animals were collected in plastic multiwells, allowed to equilibrate at 
room temperature in 300 µl of Hydra medium. The test was initiated by adding gold 
nanoparticles (AuNPs) and Hymyc1 to each well containing 20 polyps and incubating 
as necessary. AuNPs and Hymyc1 uptake was monitored in vivo, unless otherwise 
stated, by continuous video recording using a Camedia-digital camera (Olympus) 
connected to a stereomicroscope (Olympus ZSX-RFL2). Following extensive 
washes, in vivo imaging was accomplished at several magnification by using both a 
stereomicroscope and an inverted microscope (Axiovert 100, Ziess) equipped with a 
digital colour camera (Olympus, DP70). For imaging acquisition and analysis the 
software system Cell F (Olympus) was used. For regeneration experiments, treated 
polyps were bisected in the gastric region and in vivo imaged at various time points 
post amputation. The number of regenerating tentacles was monitored every 24hr. 
Experiments were performed in air-conditioned environment at 22°C, and repeated 
three times for each condition tested. In order to evaluate acute toxicity, the 
morphological changes induced by AuNPs treatment were monitored, by using a 
scoring procedure of the progressive changes in structure. This procedure allows 
examining the ability of animals to recover from NP-induced damage. Every day, 
using a steromicroscope, recognizable physical changes in response to different NP 
ranges were recorded, according to score values (ranging from 1-10) described by 
Wilby (Wilby, 1988; Wilby and Tesh, 1990).  
 
2.8 Hydra vulgaris growth rate 
 
The determination of the Hydra growth rate has allowed us to determine the following 
parameters: 
• Duplication time of the population (T) 
• Bud detachment 
• Constant population growth (K), determined by: 
 
K= ln (n/n°)/T 
 
where: 
n°: the initial number of individuals 
n:  the number of individuals at time T 
T: the time expressed in days taken for the population to switch from n to n° 
 
Hydra polyps were exposed to a chronic treatment with sub-lethal concentrations of 
nanoparticles, to study the possible effects on population growth rate. Subsequently 
they were arranged in groups of 4 in 3 24 well-plates in Hydra solution (0.1 mM 
NaHCO3, 1 mM CaCl2) and incubated at +18°C and fed with artemia salina.  
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On day 0 the growth rate measurements initiated by marking with A1, A2, A3, A4 
animals treated with AuNP-N3 which have undergone a treatment of 100 nM; B1, B2, 
B3, B4 animal treated with  AuNP-COOH with a concentration of 100 nM; C1, C2, C3 
and C4 the control animals. Starting from the founder population, each time a bud 
detached from an adult it was transferred to a new well and let grow and reproduce. 
This process was repeated daily for two weeks and at the end all the adults were 
counted. 
 
2.9 Hydra cell and tissue analysis 
 
Analysis of treated animals was done both on whole animals and isolated fixed cells. 
Animals were anaesthetized in 2% uretane in Hydra medium for 2 minutes. Than the 
animals were fixed with Lavdowsky’s fixative (ethanol-formalin-acetic acid-water 
50:10:4:40), rehydrated and mounted on microscope slides in Glicerol 50% in PBS 
50% (8 g/l NaCl; 0.2 g/l KCl; 1.44 g/l Na2HPO4.7H20; 0.24 g/l KH2PO4). For analysis 
of cell tipe distribution whole animals were macerated into a suspension of fixed 
single cells as described in David et al., 1973. Five polyps for condition were 
macerated at the indicated time of treatment and scored for single and pairs of 
interstitial cells (1s+2s), nests of four-sixteen proliferating or differentiating 
nematoblasts (4s-16s), zymogen and mucous cells, epithelial cells (EPI).  
 
2.10 Proliferation rate 
 
For analysis of proliferation rate, animals were incubated with 5 mmol/l 
bromodeoxyuridine (BrDU) (Sigma) for 1, 12, 24, 48 and 72 hr, immediately fixed and 
macerated. BrDU, an analogue of nucleotides is incorporated in proliferating cells 
and detected by immunolocalization using mouse anti BrdU monoclonal antibody 
(1:500, Sigma) and Novolink Polymer detection System (Novocastra Laboratories 
ltd).  
 
2.11 Tissue sectioning  
 
For tissue sectioning, test animals were soaked overnight in 30% sucrose in PBS 
and then embedded in the frozen section medium Neg-50 (Richard-Allan Scientific). 
Cryo-section of 10#m thickness were obtained by a cryostat. Collected on adhesion 
microscope slides (SuperFrost Plus, Menzel) slides and mounted in D.P.X (Sigma) 
before imaging. 
 
2.12 Gene and protein expression analyses 
 
2.12.1 in situ Hybridization and Western Blot analysis 
 
Whole mount in situ Hybridization using DIG-labelled RNA probe was carried out as 
described previously in Grens et al., 1996, using NBT/BCIP (Roche) as substrate for 
staining. The myc riboprobe was synthesized using the plasmid Hymyc1 as template 
and used at a concentration of 0.1 ng/mL for hybridization. The Hymyc1 plasmid was 
produced as described in Hartl M et al. 2010.  
For Western Blot analysis, total protein were extracted from groups of 25 polyps, 
using the triple detergent buffer according to Sambrook et al. 1989. The homogenate 
was centrifuged for 15 min at 14000 g and the proteins contined into the 
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supernatatnts collected and quantified by the Bradford method using BioRad reagent 
with BSA as standard. The protein were separated on 12% SDS- polyacrylamide gel 
and transferred onto nylon membranes (BioRad, San Diego, CA). MYC protein levels 
were detected using anti HyMYC1 antibody (1:500, kindly provided by Innsbruck 
University) and compared to actin proteins using an anti-actin primary antibody 
(1:100, sigma) to probe an identical blotted gel. 
 
2.12.2 Total RNA extraction 
 
RNA extraction is a very delicate multi step procedure because of RNases that would 
degraded RNA molecules. The use of gloves, pipette tips, Eppendorf and falcon 
sterile (autoclaved), together with the decontamination of work areas and equipment 
used with alcohol and water previously treated with diethylpyrocarbonate (DEPC), 
can greatly reduce the presence and enzymatic activity of RNase. RNA was 
extracted from treated and untreated animals by purification in TRIZOL (Invitrogen) 
according to protocol recommended by the manufacturer: 25 Hydras were 
homogenized in 500#l of Trizol and left for 5 minutes at room temperature (RT); to 
each tube 100 #l of chloroform were added. The samples were then incubated for 2-3 
minutes at RT and then centrifuged at 12,000 g for 15 minutes at 4°C, thus allowing 
the separation of the phases. Subsequently, the aqueous phase containing the RNA 
was collected and 250 #l of isopropanol were added.  In order to precipitate the RNA 
molecules, the samples were centrifuged at 12,000 g for 10 min at 4° C; the RNA 
pellet was then washed with 200 #l of 75% ethanol, centrifuged again (at 7500 g for 
5' at 4 ° C) and finally resuspended in an appropriate volume of sterile water (30µl). 
The concentration of RNA samples extracted was determined by reading in a 
spectrophotometer. The absence of any contaminants, such as proteins, 
polysaccharides and phenol, was estimated by measurement of the ratio Absorbance 
O.D.260/Absorbance OD280. The samples were considered for further analysis when 
the ratio A OD260 / A OD280 had a value between 1.7 and 2.0.  
 
2.12.3 Agarose gel electrophoresis for the evaluation of RNA integrity. 
 
The RNA samples were analyzed by electrophoresis on agarose gel (1.2%) to verify 
the absence of any degradation and contamination of residual genomic DNA.  
 
Buffer MOPS 10X 
 
3-(N-morpholino)propanesulfonic acid pH 7 0,2 M 
Sodium acetate 80 mM 
EDTA 10 mM 
 
Denaturating buffer 
 
Formammide 750 µl 
10X MOPS 120 µl 
37% formaldehyde 250 µl 
10 µg/µl Etidium Bromide 1 µl 
 
Samples resuspended in denaturating buffer were incubated at 65°C for 5 min and 
then loaded onto 1.2% denaturating agaorse gel and the migration was at 70 V in 
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MOPS 1X buffer. RNA integrity was then evaluated by checking the presence of 
rRNA 28S and 18S that in a non degraded RNA are in a 2:1 ratio. 
 
2.12.4 RNA reverse transcription 
 
Before starting the reverse transcription RNA samples were treated with DNaseI 
(Amplification Grade, Invitrogen) according to manufacturer’s instruction. The RNA, 
now without any DNA contamination was subjected to a reaction in which a reverse 
transcriptase is able to copy a complementary DNA strand (cDNA) using RNA as 
template. To selectively target mRNA, oligodT were used as primers for the 
Superscript II DNA polymerase (Invitrogen). The reaction was set up as follows: 1#g 
RNA, 1X RT Buffer, 0.5 mM di dNTPs, 10 mM di DTT, 1,5 #M Oligo(dT)12-18 
(Invitrogen), 50 uL di Superscript II, DEPC treated H2O to 20 uL. The termocycler 
profile used was 42°C 1h, 95°C for 5’. The cDNA obtained was then used for further 
analysis. 
 
2.12.5 Quantitative Real-time reverse transcription- polymerase chain reaction 
(qRT-PCR) 
 
A specific pair of primers has been designed for each gene using the Primer3 
program (http://frodo.wi.mit.edu). These primer pairs were chosen to amplify products 
of 100–200 bp in length. Blast searches against the whole Hydra genome were 
performed to verify primers specificity. The Real Time PCR (qRT-PCR) experiment 
measures the number of cycles needed to attain a threshold concentration of Q-PCR 
product (Ct). The threshold value is chosen to fall within the exponential amplification 
phase, before limiting reagents become a factor in the efficiency of each cycle.  
This method requires a known reference gene with constant expression in all tested 
samples and whose expression is not changed by the treatment under study. A pair 
of primers for Hydra Elongation 1 alpha (HyEF1!) housekeeping gene has been 
used as standard reference. The number of cycles needed for the standard to reach 
a specified Ct is used to normalize the Ct for the selected genes. A higher Ct for the 
gene of interest implies a lower initial concentration in the sample, and vice versa.  
To capture intra-assay variability all qRT-PCR reactions were carried out in triplicate. 
For triplicate samples, Ct is calculated as the average value among the replicates.  
Diluted cDNA was used as template in a reaction containing a final concentration of 
0.3 µM for each primer and 1x FastStart SYBR Green master mix (total volume of 25 
µl). PCR amplifications were performed in triplicate in a Step One (Applied 
Biosystem) using the following thermal profile: 95°C for 2 min, one cycle for cDNA 
denaturation; 95°C for 15 sec and 60°C for 1 min, 40 cycles for amplification. The 
expression of the following genes was assessed by Real time PCR: c-myc 1 
(Hymyc1) and Hydra Elongation 1 alpha (HyEF1!) as control. Gene sequences were 
obtained from the Hydrazome database (http://Hydrazome.metazome.net). 
The expression profiles were analyzed by applying the $$Ct method were the values 
of the gene of interest (Hymyc1) were normalized for the values of reference control 
gene (HyEF1!).  
 
2.13 Ultrastructural analysis trought Trasmission Electron Microscopy (TEM) 
 
Hydra polyps were treated with 2% urethane in Hydra medium (1 mM CaCl2, 0.1 mM 
NaHCO3, pH 7.0) to prevent contractions during fixation and then fixed for 2hrs in 2% 
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glutaraldehyde in SolHy. Samples were then washed at least four times with SolHy 
and postfixed for 45’ with 1% buffered OsO4. After a series of four washes in SolHy, 
animals were dehydrated in a graded ethanol series (30%-50%-70%-90%-100%). 
Samples were incubated 2x15’ with Propylene oxide and then over-night in a 1:1 
mixture Propylene oxide/Epon 12 Resin. Before flat embedding, animals were 
incubated 2 x 2 h in Epon 12 Resin. Sample serial thin (70nm) section of tentacles 
and hypostoma were cut with a diamond knife and mounted onto 150-200 mesh 
hexagonal tem grid (G200TT-Ni, Electron Microscopy Sciences). Thin sections were 
stained with uranyl acetate and lead citrate. Ultrathin sections were examined with 
Leo 912 AB transmission electron microscope operating at 80 kV. 
 
2.14 Sample preparation for High-Pressure Freezing Procedure (HPF) 
 
Hydra polyps immersed in SolHy were dissected into appropriate pieces to fit into 
cup-shaped HPF specimen carriers. Tissue pieces were pipetted with SolHy into a 
0.2 or 0.3 mm deep carrier and covered with an additional carrier. Finally, the 
obtained sandwiches were cryo-immobilized by HPF. Frozen sandwiches were 
transferred into appropriate containers for storage in Liquid N2 for later use or 
subjected to freeze substitution (FS). The frozen samples were transferred under 
liquid N2 into cryovials containing frozen FS cocktails (anhydrous acetone plus 1% 
OsO4 and 0.1–0.2% uranyl acetate). Subsequently, the lids were screwed loosely 
onto the vials to permit safe evaporation of excess N2 gas. The vials were placed into 
the precooled FS device and after about 1 h the lids tightened and FS was performed 
for at least 8 h at -80 to -90°C; warming up to -55°C at a rate of 5-10°C per hour, 
subsequent post-fixation and staining at -55°C for 6 h, followed by warming up to -
30°C at a rate of 5–10°C per hour where samples were left for an additional 3 h 36. 
Finally the samples were washed 3x with acetone (10 min each), 16 h in 10% epoxy 
resin (epon) in acetone, 6 h in 30% epon in acetone, 16 h 70% epon in acetone, 6h 
100% epon in acetone, 16 h 100% epon in acetone. Thenthe sampleswere placed 
infresh resinand placedin oven at 60° C overnight. Sample serial thin (70nm) section 
of tentacles and body regions were cut with a diamond knife and mounted onto 150-
200 mesh Hex grids. Ultrathin sections were examined with transmission EM Libra 
120 EFTEM (Zeiss, Oberkochen, Germany) at 80 eV (Holstein et al., 2010) 
 
2.15 Elemental analysis by Inductively coupled plasma atomic emission 
spectroscopy (ICP-AES) 
 
To estimate the extent of endocytosis and exocytosis of AuNP-N3 in Hydra, living 
polyps were treated 24h with AuNP, washed, and processed for elemental analysis 
to evaluate the amount of Au present inside the animals and released in the medium.  
1500 Hydra polyps were incubated in 3 ml of Hydra medium with 25 nM AuNP-N3 for 
24h. At this time point 150 polyps were extensively rinsed and homogenized for ICP-
AES. The remaining animals were kept in fresh medium and saved at 24h and 48h 
post washing. For each time point the same amount of polyps (150) and incubation 
media were saved. Experiments were done in duplicate. For ICP-AES 
measurements, all the samples were treated with 400 #l of aqua regia overnight and 
then diluted with MilliQ water to 20 ml to reach a final concentration of acid 2% (v/v). 
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3 Results 
 
3.1  RNA interference mediated by free siRNA in Hydra vulgaris 
With the aim to downregulate Hymyc1 gene we tested the possibility to perform RNA 
interference mediated by small interfering RNAs (siRNA). 21 bp long RNA 
oligonucleotides with symmetric 2nt 3’ overhangs targeting the coding region of the 
Hymyc1 gene (myc-siRNA) were designed according to specific rules determined to 
enhance the silencing effect of siRNA, and chemically synthesized (in Figure 1 the 
sequence selected on the mRNA sequence is shown) (Elbashir SM et al., 2001, 
Naito et al., 2009; Reynolds A. et al,. 2004). Recently, specific rules for siRNA design 
have been developed to improve siRNA efficiency. These algorithms combine 
specific rules (low GC content, lack of internal repeats, an A/Urich 5’ end) and other 
features enhancing the silencing effect of siRNA. The sequence of the Hymyc siRNA 
selected was used to BLAST Hydra genome (http://hydrazome.metazome.net/cgi-
bin/gbrowse/hydra/) to identify possible off-targets.  Selected siRNA duplex were 
synthesised by one of the several commercial entities involved in siRNA 
manufacturing. The addition of an organic fluorophore to either the 3’ or the 5’ of the 
protruding RNA strand allowed monitoring its uptake and cell targeting, in vivo.  
 
 
Figure 1. Hydra specific siRNA duplex (Hymyc-siRNA) composed of 21-nt sense and 21-nt antisense strands, paired in manner 
to have 2-nt 3’ overhang, were designed on both coding- non coding HyMyc DNA sequence with the help of specific  on line 
tools to overcome hurdles such as the correct target identification and the minimizazion of potential off target effect. In red are 
shown the coding nucleotides, in blu the 3’ untranslated region and in black the siRNA nucleotides.!
 
Given the capability of Hydra polyps to uptake at high efficiency positively charged 
compounds, we performed an estimation of siRNA surface charge by Zeta potenzial 
measurement, and showed that they present positive net charge at pH 4 in Hydra 
culture medium, while at physiological pH they are negatively charged (Figure 2) The 
silencing effect was tested at pH 4, soaking the animal in culture medium in presence 
of 70 nM siRNA. Alexa fluor 488 end-labeled myc-siRNAs were used to track 
internalization by mean of in vivo fluorescence microscopy. The capabilty of siRNAs 
to penetrate Hydra cell membrane was higher at pH 4 than at pH 7, as showed in 
Figure 3, indicating that siRNA delivery was enhanced by acidic conditions.  
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Figure 2. Zeta potential measurement of siRNA duplexes in Hydra medium at different pH. They present positive net 
charge at pH 4 in Hydra culture medium, while at physiological pH, as expected, they are negatively charged. From Ambrosone 
et al., 2012 
 
 
 
Figure 3. In vivo imaging of siRNA uptake. Living polyps were challenged with 70 nm Alexa fluor 488 end-labelled myc-
siRNA, in Hydra medium either at pH 4 (A-B) or at pH 7 (C-D). After 24 hrs of incubation with myc-siRNA a strong punctuated 
fluorescence labels uniformly the whole animal, from the head (A) along body (B) of animal treated at acidic pH, indicating the 
siRNA uptake. In C and D are shown the same regions of animals treated at neutral pH. The absence of signals indicates that 
the acid pH enhances siRNA delivery in Hydra. Scale bars 200 #m. From Ambrosone et al., 2012. 
 
Confocal microscopy analysis confirmed siRNA presence within nests of 
nematoblasts, which represent the cell type where Hymyc1 is expressed (Figure 4). 
 
500#m 
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Figure 4. Confocal laser scanning imaging (A–C) of living Hydra treated 24 hr with Alexa488-labelled myc-siRNA 
revealed localization of oligonucleotides into interstitial cells. In (A), nuclear staining of interstitial cell nest with TOPO; in 
(B) siRNA green fluorescence appears as faint staining or more evident granules; in (C), the overlay of bright field and 
fluorescence images revealed that siRNAs localize prevalently into the cytoplasm of interstitial cells. Scale bars: 10 #m. 
 
The silencing effect was evaluated at molecular level by quantitative Real time PCR 
(qRT-PCR). When Hydra polyps were treated with myc-siRNA for two days a 
significant reduction of Hymyc1 transcript levels at pH 4, but not at pH 7, was 
observed. This suggested that the acidic condition enhanced siRNA uptake enabling 
silencing. About 60% of downregulation of Hymyc1 was observed in siRNA treated 
animals after two days of incubation at pH 4 (Figure 5A). Increasing the period of 
treatment up to 9 days did not enhance the gene silencing, probably due to the fast 
cell turnover of the interstitial cell lineage (Figure 5B), renewing the healthy cells 
repertoire, restablishing normal transcripts levels and saturation of silencing 
machinery. The post-transcriptional silencing induced by myc-siRNA was confirmed 
also at protein level by Western Blot analysis. Using polyclonal antibodies raised in 
rabbit against HyMYC1 recombinant protein (kindly provided by B.Hobmayer, 
University of Innsbruck), a drastic decrease of HyMYC1 protein was detected in myc 
RNAi animals (two days treatment), compared to endogenous levels of Hydra actin 
(Figure 6). The specificity of the RNAi approach was assessed by testing unrelated 
siRNAs, such as Luciferase siRNA (luc-siRNA), designed on the firefly luciferase 
GL2 gene, not present in the Hydra genome. Results showed that Hymyc1 
transcription and translation were unaffected in luc-siRNA treated animals (Figure 5), 
demonstrating the specificity of the RNAi approach. 
 
 
Figure 5. Molecular characterization of Hymyc1 RNAi. Quantitative RT-PCR show Hymyc1 downregulation under acidic 
condition .Hydra polyps treated with myc-siRNA at pH 4 showed 60% decrease of Hymyc1 transcript levels compared to Hydra 
elongation factor HyEF1! mRNA, used as control. The treatment at pH 7 was not effective. (B) Kinetics and specificity of 
Hymyc1 downregulation. qRT-PCR was performed on total RNA extracted from 25 animals either untreated or incubated with 
the indicated siRNA for different periods. The most effective downregulation is detected at 48h and it is specific for myc-siRNA 
oligonucleotides. Adapted from Ambrosone et al., 2012. 
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Figure 6. Post-transcriptional silencing induced by myc-siRNA was confirmed by Western Blot. (B) Hymyc1 RNAi affect 
also MYC protein levels. MYC protein levels were detected using anti-HyMYC1 antibody (1:500, Kindly provided by Innsbruck 
University) ad compared to actin proteins, using an anti-actin primary antibody (1:100, Sigma) to probe an identical blotted gel. 
Adapted from Ambrosone et al., 2012. 
 
In order to detect differences in the expression pattern of myc RNAi polyps, whole 
mount in situ hybridizations using a Digoxigenin-labelled Hymyc1 RNA probe were 
performed.  
Despite the downregulation of Hymyc1 detected at molecular level, we did not 
observe a significant difference in the expression pattern between untreated and 
RNAi animals (Figure 7A), probably due to the methodology, which does not detect 
quantitative differences. Cryosection of stained animals confirmed the expression 
pattern in proliferating interstitials cells, i.e. single and pairs of interstitial cells 
(1s+2s), nest of nematoblasts (4s-16s) and gland cells, according to previous reports 
(Hartl M et al. 2010), as showed in Figure 7C. 
 
 
Figure 7. Hymyc expression pattern. in situ Hybridization on healthy animals shows the expression of Hymyc1 in proliferating 
interstitial cells, distribuited along the gastric region (fig. A).(B) Higher magnification of whole mount gastric region. C) 
Crysection confirms the expression pattern in pairs of interstitial cells (1s+2s) and nest of nematoblasts (4s-16s). Adapted from 
Ambrosone et al., 2012. 
 
 
 
C 
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3.1.1 Characterization of myc RNAi animals 
• Analysis of cell proliferation  
A morphological analysis both at cellular level and in intact animals was performed to 
investigate the effect induced by gene silencing on the cell proliferation activity and 
cell type relative distribution. In Figure 8 different cell types present in Hydra tissues 
are shown: epitheliomuscular cell (ectodermal and endodermal cells), gland cell (gc), 
single interstitial cell (1s), pairs of interstitial cell (2s). The analysis of the different cell 
types may be performed by macerating animals in single cell suspension, which are 
morphologically distinguishable and that can be quantified.  
!
 
Figure 8. Isolated cells from macerated Hydra tissue as viewed using phase microscopy. The cell types illustrated are: 
ectodermal epitheliomuscular cell from body column (ecto); endodermal epitheliomuscular cell (endo); single interstitial cell (1s); 
interstitil cell in nest of two (2s); basal disc gland cell (gc). ).!From Ambrosone et al., 2012.  
 
Evaluation of cell proliferation activity: As Hydra epithelial cells proliferate with a 
cell cycle of 3,5 days (David et al. 1972, Holstein et al. 1991) and interstitial cells 
much faster with a cell cycle of 1 day, the cycling activity of cells was assayed by 
BrdU-labelling, over 3 and 2 days respectively. BrdU, an analog of nucleotide, is 
incorporated instead of Thymine in the DNA of proliferating cells, and detected by 
immunostaining using anti-BrdU antibody. Cell cycling activity of epithelial and 1s+2s 
cells were obtained in control and treated animals by continuous incubation with 
BrdU, for 1, 12, 24, 48 and 72 hours, followed maceration at the indicate time points 
and immunostaining. In Figure 9A the proliferation rate of epithelial cells appears not 
affected by myc-siRNA, while the proliferation of interstitial cells 1s+2s was enhanced 
in myc RNAi animals, indicating an effect of myc on the stem cell cycling activity 
(Figure 9B).  
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Figure 9. Effect of myc siRNA on cell cycling activity. Cell cycling activity of epithelial  cells (A) and 1s+2s stem cells (B) 
were obtained in control animals and in treated animals by continuos incubation with BrdU, followed maceration of ten animals 
at indicated time point and immunostaining. 
 
• Analysis of  cells type distribution 
To investigate the effect of Hymyc1 downregulation on the whole interstial cell 
lineage, the, cell type distribution was analyzed in macerates at two time points, i.e. 
at day 4, to ensure that treated polyps completed a whole cell cycle, and at day 9 to 
observe eventual effects also on later differentiation processes. As shown the Figure 
10A, after 4 days of treatment we observed an increase both in proliferating and 
differentiating cell types, thus 1s+2s, nematoblasts (4s-16s), zymogen and mucous 
cells were found more abundant in myc RNAi animals compared to control untreated 
animals. At day 9 no further increase in 1s+2s population was observed compared to 
untreated and also compared to the myc-siRNA treated cell after 4 days, meaning 
that the effect of myc silencing on the proliferative rate of 1s+2s was not constant 
throught the treatment. Altogether these evidence suggest a Hymyc1 specific role in 
nematocyte and gland cell differentiation pathways (Figure 10B).  
 
 
Figure 10. Effect of myc siRNA on differentiation activity after 4 and 9 days. In A and B the distribution of different cell 
types was assayed after 4 and 9 days of myc RNAi, respectively.  Bars indicate standard errors. 1s+2s= single and pairs of 
interstitial cells; nematoblast = nest of 4s-16s proliferating and differentiating nematoblast; EPI= epithelial cells. Adapted from 
Ambrosone et al., 2012. 
 
A schematic model of the effect of Hymyc1 gene silencing on 
proliferation/differentiation rate is showed in Figure 11. These results suggested a 
role of Hymyc1 in the negative regulation of the stem cells where it is expressed: the 
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decreased expression enhances stem cell proliferation and turn the differentiation of 
intermediates and terminal derivates.  
 
 
 
Figure 11. Effect on stem cell proliferation/differentiation induced by Hymyc1 downregulation. Myc siRNA treatment 
induce a moderate increase in the 1s and 2s stem cell self-renewal and proliferation activity (red arrows). This in turn generates 
a higher number of both differentiating intermediates (nematoblast) and terminal differentiated products such as nematocytes 
and gland cells (blue arrows). Dashed arrows indicate he absence of morphological distinct cellular intermediates. Hymyc1 
downregulation does not affect the nerve differentiation pathways, consistent with the absence of Hymyc1 expression in this cell 
type. Adapted from Ambrosone et al., 2012. 
 
 
• Whole mount analysis of tentacles morphology 
Populations of mature nematocytes embedded in the battery cells were analysed in 
tentacles of intact fixed animals. Battery cells are large modified tentacle epithelial 
cells containing embedded in the cytoplasm different type of nematocytes 
(stenothele, desmoneme and isorhiza), and are easily recognizable by phase 
contrast optical microscopy. For this experiment I analyzed 5 battery cells located on 
5 tentacles of 5 different animals, for a total of 125 battery cells. As shown by the 
graph of Figure 12 myc RNAi animals presented an increase in the number of 
nematocytes per battery cell, compared to untreated and siRNA (luc-siRNA) treated 
Hydra, which confirm the enhanced nematoblast differentiation in mature 
nematocytes. 
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Figura 12. Hymyc1 induces an increase in the nematocyte content per battery cell. (A) At time 4 d and 9 d of treatment 
with the indicated siRNA, the number of nematocytes embedded in the battery cells was, counted by microscopic observations 
obtained from the same focus plane.  (B) Representative battery cells imaged from untreated, myc-siRNA and luc-siRNA treated 
animals, on whole mounts. Scale bars 20 #m. 
 
This part of the study, focused on Hymyc1 silencing through a novel RNAi strategy, 
describe how Hymyc1 knockdown affects the developmental dynamics of stem andd 
interstitial cell in polyps (Ambrosone et al., 2012), causing a clear cellular an 
molecular phenotype. The approach we employed, based on free siRNA supplied by 
soaking under acidic condition, represents a new tool to study gene function in 
Hydra.  
 
In the second part of my experimental work a nanoparticle mediated approach of 
RNAi will be described, and the effects analysed at whole animal, cell and molecular 
level. Moreover, the uptake mechanism, cell trafficking and final clearance of 
nanoparticle in Hydra cells, extensively characterized by electron microscopy, will be 
presented.  
!
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3.2 RNA interference mediated by gold nanoparticle in Hydra 
3.2.1. Synthesis of Gold Nanoparticles  
Stable gold nanoparticles (AuNP) with an average diameter of 14 ± 1 nm were 
synthesized by Dr. Jesus de la Fuente (University of Zaragoza) by the reduction of 
sodium tetrachloroaurate (III) hydrate with sodium citrate dehydrate, following a 
standard protocol (Turkevich et al., 1951). The functionalization of AuNP was carried 
out using bifunctional PEG spacers, i.e. PEG chains carrying a carboxyl group for the 
binding of molecules containing amine groups, and PEG chains ending with an azide 
group for the binding of molecules with alkyne groups. A combined functionalization 
of the nanoparticles with a single or both bifunctional chains generated two kinds of 
AuNP: AuNP-COOH/N3 coated by 25% PEG chains (50% PEG COOH and 50% 
PEG-N3) and AuNP-N3, surface saturated by PEG-N3 chains (figure 13).  
 
 
Figure 13. Schematic illustration of the AuNPs. A) a schematic illustration of the AuNPs shows the nanoparticle structure, 
coated by PEG-COOH.); B) Nanoparticle scheme illustrating the homogeneous PEG-azide coating the Au core. C) A 
nanoparticle scheme shows the nanoparticles structure coated by two different PEG spacers (PEG-COOH, and PEG-N3). 
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3.2.2 Biocompatibility and toxicity of AuNP on Hydra: impact on morphology 
reproduction and regenerative capabilities 
• AuNP impact on Hydra morphology 
 
Hydra is a suitable in vivo model system to study the biological response to 
nanoparticles. Here, this model was used to assess the potential toxicity of AuNP 
before the addition of functional groups on the surface.  
 
   
 
Figure 14. Representative scheme of physiological process of Hydra allowing estimating the toxicological impact of 
any medium suspended compounds: morphology alteration, impairment of reproductive and regeneration capabilities.  
 
Groups of animals were independently incubated with AuNPs either uncoated (i.e. 
exposing citrate on the surface) or functionalized with either PEG-COOH or PEG-N3 
chains, at different concentration from 50 up to 100 nM. According to Hydra Health 
Index (HHI) based on distinguishable morphological alterations induced by medium 
suspended compounds supplied in homeostatic or regenerative conditions, there was 
not induction of any significant morphological change in animals treated with the 
highest possible concentration of AuNP PEG-COOH (100 nM). Low dosage (18 nM) 
of citrate-coated AuNPs, by contrast, manifested aggregation and precipitation in 
Hydra medium (Figure 15). They were shown attached to the animal outer surface, 
forming a film-like structure enveloping the whole animal. In light of this instability, 
Au-citrate NPs were not further used. AuNP-PEG-COOH, appeared instead well 
dispersed in Hydra medium but showed a low efficiency of internalization, probably 
due to the negative charge, Z potential - 38 mV (Figure 16). As expected AuNP-PEG-
N3 showed a strong internalization (Figure 17), mediated by their positive Zeta 
potential (+13,39 mV). This behaviour is in line with previous study by our group 
(Tortiglione et al., 2009), demonstrating the high rate of internalization of positively 
charged CdSe/CdS quantum rods. In Figure 18 the similar behaviour of the two 
positive NPs respect to the uptake by Hydra cells is shown.  
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Figure 15. Interaction of AuNP-citrate and Hydra. A) Au citrate capped NPs aggregate into Hydra medium, and appear as 
dark precipitates into the well. B) after several washes, Hydra ectoderm appears labelled (pink staining), but this interaction is 
not strong, as big patches of materials detaches progressively from the animal.  
 
 
 
Figure 16. In vivo imaging of Hydra polyps treated with 100 nM AuNP-PEG- COOH. In A) body and B) tentacles of Hydra 
vulgaris exposed to AuNP-PEG-COOH. After 24 h of incubation no NP labelling was detected.  
  
 
 
Figure 17.  In vivo imaging of Hydra polyps treated with 100 nM Au NP-N3. (A) Bright field imaging of Hydra vulgaris 
exposed to AuNP-PEG-N3. After 24 h of continuous incubation, a dark punctuated staining due to gold nanoparticles labelled 
uniformly the whole animal. B) A Higher magnification of (A) indicates AuNP-N3 located in the outer epithelial cell layer.  
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Figure 18. Internalization Pattern of AuNP-N3 and CdSe/CdS QRs. These pictures showed the same pattern of 
internalization for both types of NPs.  
 
3.2.3 AuNP impact on Hydra reproduction and regenerative capabilities 
In Hydra, the growth rate is normally regulated by a balance between epithelial cell 
cycle length, phagocytosis of ectodermal cell in excess, and bud formation (Bosch et 
al., 1984). Environmental factors, such as the presence of pollutants, the feeding 
regime, can affect this balance. Thus, the population growth rate is an indirect 
measure of the Hydra tissue growth rate and cell viability.  
The growth rate of polyps treated with AuNP was compared to untreated animals. 
Four adult Hydras (the population founders), were treated for 24 hrs and then the 
medium was changed to allow a complete removal of the AuNPs. The sample were 
considered the founder generation and were then transferred into a new multiwell 
plate Their reproductive capability was monitored for tree weeks, to estimate the 
impact of internalized NP on the reproduction rate. As shown in the graph in Figure 
19 the growth rate of the two populations were not significantly different, suggesting 
that the NP treatment did not affect the animal reproductive potential. Interestingly, 3 
weeks after treatment the NPs were still detected, althought rarely, in the endodermal 
tissue of founder individuals. Nevertheless, reproduction rate were not affected. This 
indicates an active proliferation of NPs containing cells and preservation of the 
budding process.   
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Figure 19. Influence of AuNP treatment on Hydra population growth rate. (A) Population growth test started with a 
population of four full-grown Hydra, incubated 24 h with 100nM AuNPs, rinsed and monitored every day for bud detachment. 
The individuals were inspected daily and counted under a stereomicroscope. There are not significant differences between 
Untreated (blue line) and treated (red and yellow lines) population growth rates. The logarithmic growth rate constant (k) is the 
slope of the regression line using the standard equation of logarithmic growth: ln(n/n0) = kt. In vivo imaging 3 weeks post-
incubation revealed the presence of AuNP(arrowed) in the body of founder animals (B, C).  
 
 
Next, the toxicological impact on the regenerative capability of Hydra was analyzed. 
The head regeneration is a critical process of Hydra biology and the development of 
new tentacles can be monitored by a stereomicroscope to asses the effects of toxic 
agents. Regeneration efficiency was estimated by cutting the animals under the 
hypostoma after 24 hrs of incubation with AuNPs and analysing the efficiency of the 
regeneration process. Polyps incubated with AuNP-PEG-N3 were shown 
regenerating head and tentacles with the same efficiency as untreated animals, 
suggesting that there were not adverse effects played by AuNPs on the regeneration 
process.  
 
!
3.2.4  Internalization of AuNP in Hydra vulgaris: the role of the NP surface 
charge. 
• Analysis at whole animal, tissue and cellular levels  
In order to evaluate the efficiency of internalization of AuNPs, polyps were incubated 
for 24 hrs with AuNP-COOH/N3 and AuNP-N3 (70 nM). The two NPs present different 
surfaces, being the first functionalized with 25% of the maximum possible loadable 
Peg chain amount (in turn composed by half PEG COOH chains and half PEG N3 
chains), and representing the starting NP for siRNA functionalization; the second, 
AuNP-N3, presenting the surface completely saturated by PEG-N3 chains (Figure 20 
A and 21 A). The analysis under an optical microscope revealed that AuNP-N3 were 
internalized at high rate into ectodermal cells, while AuNP-COOH/N3 showed a less 
efficient uptake (Figure 20B-C-D). Under bright field observation a strong punctuated 
labeling all over the animal (head, body and tentacles) was detected, while AuNP-
COOH/N3 (Figure 21 B-C-D) showed a weak punctuated pattern over the body and 
tentacles. To deeper investigate the NP uptake mechanism, the animals were 
incubated for 24 h with AuNPs, fixed, cryosectioned and macerated into single-cell 
suspensions. Cryosections of polyps treated with AuNP-N3 showed that the uptake 
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occurs rapidly and efficiently in the ectodermal cells, while 24h after treatment, 
groups of nanoparticles were found also in the endodermal layer (Figure 21 E). The 
same analysis on animals treated with AuNP-COOH/N3 did not revealed any evident 
staining (Figure 20 E). Maceration of treated polyps confirmed the presence of Au 
NPs in the cytosol (Figure 20-21 F). These data suggest that the positive charge of 
AuNP-N3 allows a high efficiency of internalization and confirms the crucial role 
played by the NP net charge in the interaction with the cell membrane (Tortiglione et 
al. 2009) and driving of the uptake process. 
 
 
 
 
Figure 20. In vivo uptake and biodistribution of AuNP-COOH/N3 in Hydra: in A) a schematic illustration of the AuNPs shows 
the nanoparticle structure, coated by two different PEG spacers (PEG-COOH, and PEG-N3). B) Bright field image of a living 
Hydra, treated 24h with 70nm AuNP-PEG-COOH/N3. Internalized nanoparticles are hardly detectable by whole animal imaging. 
Zooming into C) foot and D) tentacle regions show nanoparticle as dark granules located on ectodermal cells E) tissue 
cryosections prepared from treated animals. AuNPs are not detectable on such preparation, while on F) single cells 
preparations AuNPs are visible (arrowed) into the cytosol of ectodermal cells. Scale Bars: 200 #m in B-C-E, 100 #m in D, 50 #m 
in F. 
 
 
 
 
Figure 21. In vivo uptake and biodistribution of AuNP-N3 in Hydra. in A) Nanoparticle scheme illustrating the homogeneous 
PEG-azide layer coating the Au core. B) Bright field image of a living Hydra treated 24h with 70nm AuNP-PEG-N3 shows a 
strong punctuated dark labeling present uniformly all over animal. The pattern is clearly evident on separate imaging of C) foot 
and D) tentacles of treated polyps. E) Cryosections from labeled polyps show massive AuNP-N3 accumulation into the ectoderm 
(ect) and the endoderm (end). F) Fixed single cell suspension reveal AuNP-N3 location into vesicle-like structures of different 
sizes. Scale Bars: 200 #m in B-C-E, 100 #m in D, 50 #m in F. 
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3.2.5 Internalization of AuNP-N3 in Hydra vulgaris  
• Analysis at ultrastructural level 
In order to investigate the mechanisms of internalization an ultrastructural study by 
mean of transmission electron microscopy (TEM) was performed on animals treated 
with AuNP-N3, showing highest internalization rates, at different incubation times. 
The histological semithin section (Figure 22) of Hydra tissue, stained with toluidine 
blue, shows the structure of animal tissue. In the picture are visible the ectoderm and 
endoderm, separated by mesoglea. The black spot in the epitheliomuscolar layers 
are gold nanoparticles accumulated into large vacuoles. Figure 23 shows that after 5 
minutes of incubation AuNP-N3 are bound to the glycocalix, a cuticle layer of 
mucopolisaccarids covering the animal outer surface. In a recent paper the molecular 
components of the cuticle were identified, as glycoproteins and glycosaminoglycans 
(Bottger et al., 2012). The strong interaction between the positive azide group of NPs 
and the negative cuticle components caused, within 30 minutes, the massive 
accumulation of nanoparticles all around the animal tissue. In fact, after 30 minutes 
of incubation, NPs were found at the level of the glycocalyx, surrounding the 
ectoderm, but even within large vacuoles, also containing the glycocalyx, as showed 
in figure 24 and 25. Furthermore, the nanoparticles were found in the act of moving 
outside these structures, reaching the cytosol. Finally, at 24 h time point, AuNPs 
were found accumulated in large cytoplasmic vesicles, mixed to 
glycocalix/subcellular debris components, probably originating from multiple fusion 
events (Figure 26), and giving rise to micrometer sized granular structures, visible 
also in semithin section (figure 22). 
 
 
 
 
Figure 22. Semithin cross section of Hydra treatd with AuNP-N3. NP appeared accumulated as microsized granules within 
both  the ectoderm and endoderm. 
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Figure 23"!Ultrastructural analysis of Hydra tissue treated with AuNP-N3. Hydra polyps were exposed to AuNP-N3 for 5 
min, then extensively washed and processed for TEM. A-B) At 5 min time points, AuNP-N3 were found attached to the 
glycocalix, uniformly decorating the animal outer surface (black arrows). 
 
 
Figure 24. Ultrastructural analysis of Hydra tissue treated with AuNP-N3 . Hydra polyps were exposed to AuNP-N3 for A-B-
C-D) 30 min, then extensively washed and processed for TEM. A) At 30 min time point, AuNP-N3 were found attached to the 
glycocalix, uniformly decorating the animal outer surface (black arrows), but also inside large vacuoles. B-C-D).  At higher 
magnifications the inner side of this structure appears lined by the glycocalix layer, suggesting the origin from membrane 
invagination (black arrows). C) A close view of the  AuNP-N3 entrapped into the vacuoles together with the glycocalix 
components.  
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Figure 25. Ultrastructural analysis of Hydra tissue treated with AuNP-N3. . Hydra polyps were exposed to AuNP-N3 for 30 
min. In the figure is showed NPs surrounding ectodermal layer, attached to the glycocalix (Black arrows) and some of them 
freely crossing the  plasma membrane (red arrows). 
 
 
Figure 26. Ultrastructural analysis of Hydra tissue treated with AuNP-N3. Hydra polyps were exposed to AuNP-N3 for A-B-
C-D) 24 hrs, then extensively washed and processed for TEM. A) At 24h time point a massive accumulation of AuNP-N3 into 
micrometer-sized vesicles was found. In B-C and D, higher magnifications of such structures clarify the presence of membrane 
components in between the packed NPs, suggesting multiple self-fusion and invagination events.
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3.3 Gene silencing mediated by myc siRNA functionalized AuNPs  
3.3.1 In vivo assessment of uptake 
 
The following bioactive molecules were selected for AuNP functionalization:  
1) 21-nt siRNA oligonucleotides (Hymyc-siRNA) were designed on the sequence 
coding for Hymyc1 (Figure 1 of Results section ) .  
2) the TAT peptide (GRKKRRQRRRPQ), a virus derived peptide known to increase 
the cellular uptake.This peptides can bind throught N-terminal group the PEG-COOH 
moieties by mean of a EDC coupling reaction.  
In order to bind the siRNA, two methodologies were applied: the binding of the 
negatively charged siRNA through ionic interaction to positively charged group 
present on the NP surface (i.e quaternary ammonium groups), or the binding of 
thiolated siRNA to the gold nanoparticles through covalent bond gold-thiol (Figure 
27). For each approach four different AuNP abducts were synthesized, carrying 
either the siRNA (siRNA-AuNP), or the TAT peptide (TAT-AuNP), or both 
functionalities (siRNA-TAT-AuNP), and compared to the unfunctionalized AuNP, 
used as starting material. In this way the specificity of the RNAi effect could be 
analysed, together with TAT effect, which has not been reported in Hydra, to date. 
Polyps were challenged in vivo with all Au NPs types reported in Figure 28 and the 
level of Hymyc1 expression was monitored after 48 h of continuous incubation using 
qRT-PCR.  This incubation time was selected as inducing the highest downregulation 
by using free siRNA. 
 
 
 
 
Figure 27. (A) Ionic and (B) Covalent approaches employed to bind siRNA to the Au core. 
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Figure 28. Scheme of multifunctional nanoparticles synthesized by using two different approaches. Upper panel: siRNA 
molecules were covalently conjugated to PEG-COOH/N3 coated Au NPs.  Lower panel: siRNA duplexes were attached to R4N+ 
present on NP surface by electrostatic interaction. The TAT peptides were added by covalent binding. 
 
The optical microscopy analysis showed that myc-siRNA-AuNPs displayed a low 
efficiency of internalization compared to AuNP-N3. As shown in Figure 29B-C, body 
and tentacles of animals displays only few dark granular staining (indicated by 
arrows) suggesting that siRNA functionalization decreases the efficiency of cell 
uptake in Hydra.  
 
 
Figure 29. Differential uptake of AuNP. (A) Polyps treated with AuNP-N3. show a strong internalization. (B-C) Body and 
tentacles of animals treated with myc-siRNA- AuNP appeared not efficiently labelled, indicating that siRNA functionalization 
decreases the efficiency of cell uptake in Hydra vulgaris.  
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3.3.2. Molecular assessment of Hymyc1 downregulation by myc-siRNA-AuNPs 
Hymyc1 expression levels were assessed by qRT-PCR in polyps treated 
independently with each type of nanoparticle. The effects of myc-siRNA-AuNPs were 
compared to those produced by free siRNA under acidic or neutral conditions, TAT-
AuNP and siRNA-TAT-AuNP (Figure 30). Among this NP series (produced by using 
the covalent approach) myc-siRNA-AuNP (COV) conjugate induced a 80% decrease 
of Hymyc1 expression level (Figure 30), while the other NPs were shown unable to 
induce effective gene silencing. Remarkably TAT-AuNPs, produced with the aim to 
increase cell penetration and in turn RNAi efficiency, were shown ineffective, 
suggesting either toxicity of the viral derived TAT peptide in Hydra cells, or potential 
activity of TAT to suppress the RNAi machinery, as reported for other systems (Qian 
et al, 2009). The other set of AuNPs, synthesised by using the ionic approach to bind 
siRNA on the gold core, were also analysed for their activity to induce myc RNAi by 
qRT-PCR, following 48h of incubation. Results, reported in Figure 31, show the 
capability of siRNA-AuNP (ION) to induce a significant repression of Hymyc1 (about 
50%), while the other AuNP conjugates were ineffective. Once again the TAT peptide 
was shown to repress the RNAi effect, confirming results obtained by the same 
conjugates (produced by the COV approach). A Summary of the results obtained, 
using the two approaches is presented in Figure 32. 
Of considerable importance is the evidence that all the sets of particles not carrying 
siRNA did not produce alterations of Hymyc1 expression, indicating the absence of 
non-specific effects caused by NP.  
 
 
 
Figure 30. Molecular analysis of Hymyc downregulation by siRNA-conjugated Au NPs (covalent approach) To quantify 
silencing efficiency, 50 nM siRNA Au NPs were added to groups of 25 polyps in 100 ul hydra medium. After 24 h the medium 
was replaced and the NP treatment refreshed. Total RNAs were extracted 48 h post-incubation and the mRNA levels of Hymyc 
were determined using qPCR and Elongation Factor 1! (EF1!) as internal reference gene. HyMyc1 relative expression upon 
incubation with covalent conjugated NPs and ionic conjugated NPs were reported. Unfunctionalized NPs were used to check 
undesired effects of AuNP on myc expression. Naked siRNA were administered at pH4 and pH 7 to compare silencing 
efficiency.  
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Figure 31. Molecular analysis of Hymyc downregulation by siRNA-conjugated Au NPs (ionic approach) To quantify 
silencing efficiency, 50 nM siRNA e Au NPs were added to groups of 25 polyps in 100 ul hydra medium. After 24 h the medium 
was replaced and the NP treatment refreshed. Total RNAs were extracted 48 h post-incubation and the mRNA levels of Hymyc 
were determined using qPCR and Elongation Factor 1! (EF1!) as reference gene. Unfunctionalized NPs were used to check 
undesired effects of AuNP on myc expression. Naked siRNA were administered at pH4 and pH 7 to monitor silencing efficiency.  
 
 
Figure 32. Molecular assessment of RNAi efficiency by qRT-PCR using 50 nM AuNPs and 25 polyps in 100 ul hydra 
medium. Hymyc1 relative expression upon treatment with NP ion an NP cov, was compared to naked siRNA. Among all the 
NPs tested the best in Hymyc1 silencing were the ion AuNP-siRNA without TAT and cov AuNP-siRNA without TAT.
siRNA-conjugated Au NPs (ionic approach) 
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3.3.3 RNAi induced by myc-siRNA AuNP:  a dose-response evaluation 
Since the covalent approach produced the most efficient Hymyc1 downregulation a 
dose response was determined by treating the animals with increasing 
concentrations (0, 5, 25, 50 nM) of myc-siRNA AuNP for 48 h and then analyzing by 
qRT-PCR the Hymyc1 expression levels. Results showed efficient RNAi induced by 
25 nM and 50nM NP dose, while 5 nM dose was uneffective (Figure 33). 
 
 
 
Figure 33. RNAi induced by AuNP-myc-siRNA: a dose response evaluation. To characterize the silencing efficiency of myc 
siRNA-AuNP conjugated NPs, 5nM, 25nM and 50 nM AuNP-siRNA were added to groups of 25 polyps in 100 ul of Hydra 
medium. After 24 h the media was replaced and the NP treatment refreshed. Hymyc1 gene expression levels were determined 
upon 2 days of  incubation using qRT-PCR and Elongation Factor 1! (EF1!) as reference gene. 
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3.3.4  Mechanisms of AuNP-siRNA uptake and intracellular fate 
 
Ultrastructural analysis was performed to investigate the mechanism of 
internalization employed by siRNA-AuNP to enter Hydra cells and reach the 
cytoplasm, the site where RNAi occurs. A time course analysis over different 
incubation times was performed, to capture the interaction of siRNA-AuNP 
nanoparticle with the cell membrane, the intracellular distribution and the final 
clearance. TEM analysis showed that after five minutes of incubation no appreciable 
interactions occurr between NPs and cell membranes, while after 30 min, single NPs 
or in cluster of a few units were found close to the plasma membrane or in the act of 
passing through it (Figure 34A, 34B). After 24 hours of treatment, siRNA-AuNPs 
were detected within a dense region cytosolic likely representing a late 
endosome/lysosome structure (Figure 35A, 35B, 35C). Remarkably, free 
nanoparticles were also found on membranes of interstitial cells, laying in the 
interstices between ectodermal cells, proving the capability of NP to deliver their 
siRNA cargo far from the administration site to the interstitial cell, where Hymyc1 is 
expressed (Figure 35D). 
 
 
 
 
Figure 34. Ultrastructural analysis of AuNP-siRNA uptake. Polyps were treated with myc-siRNA-AuNP for 30 min, then 
carefully washed and processed for TEM. Thin sections were obtained cutting the animal at the mid gastric or sub-hypostomal 
(below the mouth) level. After 30min, single NPs or clusters of 2-3 units are detected in close proximity of the plasma membrane 
or within it (indicated by black arrows).  
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Figure 35. Intracellular distribution of siRNA-AuNP after 24 h of incubation. Polyps were treated with myc-siRNA-AuNP for 
24h, then carefully washed and processed for TEM. Thin sections were obtained cutting the animal at the mid gastric or sub-
hypostomal (below the mouth) level, as shown schematically in the upper part of image A. In A, B and C images at increasing 
magnification show AuNP located within a dense cytosol region, likely representing a lysosome. In this environment, NPs are 
not degraded. D) AuNP-siRNA are detected after 24hr of incubation on membrane of interstitial cells (is). This single stem cell is 
located in the interstices between ectodermal cells close to the mesoglea (m), which separates ectoderm (ect) from the 
endoderm (end). AuNP-siRNA are found also on the mesoglea (indicating the capability of the NP to reach districts distant from 
the original delivery site, which is the ectoderm. 
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3.3.5 Characterization of mycRNAi animals  
• Exploring the balance between proliferation and differentiation in myc-
siRNA-AuNPs treated animals.  
 
By using free siRNA administred to living animals by soaking, we previously showed 
that Hymyc1 downregulation impairs the balance between stem cell proliferation and 
differentiation, promoting proliferation and in turn the differentiation of nematocytes 
and gland cells. In order to evaluate similar effects induced by myc-siRNA-AuNP, cell 
suspensions obtained from treated animals were analysed for the content in the 
different cell types.  
As result of a single experiment, we found in treated animals an increase in the 
population of nematoblasts (4s-16s), gland and mucous cells, suggesting an 
alteration in the stem cell population self renewal capability and a corresponding 
boost in the differentiation pathways leading to abnormal intermediate and terminal 
differentiated population sizes (Figure 36). As these phenotypical traits mirror the 
results obtained by using free myc-siRNA we showed i) the specificity of the RNAi 
methods, ii) the functional role of the Hymyc 1 in the control of the stem cell 
proliferation. 
 
 
Figure 36. A) Effect of AuNP-mycRNAi on cell type distribution. An increase in the cell population where the Hymyc1 gene 
is expressed is shown. B) Isolated cells from macerated Hydra tissue as viewed using phase microscopy.  
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3.4 Ultrastructural analysis of AuNP uptake and clearance 
 
To get deeper insights in the mechanisms characterizing the uptake and the fate of 
NPs in Hydra vulgaris, we performed an electron microscopy study using the AuNP-
N3 nanoparticles, shown to be uptaken at high efficiency by ectodermal cells. The 
concentration of AuNP was lowered from 70 to 25 nM, avoiding massive 
accumulation of nanoparticle on the cell glycocalix and allowing detection of single 
nanoparticle dynamics. High-Pressure cryo TEM was selected as innovative 
methodology for these studies. The advantages of this technique are the lack of ice 
crystals and of artifacts of fixation, enabling best preservation of cell and tissue 
structures. The experiments were performed at University of Innsbruck, where I was 
hosted in the laboratory of Prof. Bert Hobmayer, and assisted by Dr. Willi 
Salvemonser. The animals were incubated with the AuNP from 4h to 48h to widen 
the temporal window respect to previous studies and better understand the dynamics 
of internalization.  
In figure 37 TEM images show at 4h of incubation single nanoparticles attached to 
nanosized vesicles outside the cell membrane, whithin the glycocalix. Later on, after 
8h-14h of incubation, vesicles are found traversing the cell membrane to reach the 
cytoplasm (figure 38A-B-C-D). At 24h and 48h time points most of the AuNP-N3 are 
detected inside lysosomes (figure 39A-B). Surprisingly, at 48h nanosized vesicles 
loaded by NPs are also found outside cell membrane (Figure 39C-D), making it not 
clear wheather these nanovesicle are in the act of moving in or out the cell. This 
finding opened the possibility that beside their role as carriers of AuNP from the 
external medium inside the cell, those vesicles could also represent endosome 
recycled material brought back to the cell membrane (Figure 40). An estimation of 
the lysosome containing NPs (recorded from five different animals (and an average 
of twenty observations) show their increase from 8h to 48h time points (Figure 41), 
indicating that most of uptaken NPs are delivered to lysosomes for degradation.   
 
 
 
 
Figure 37. High-pressure cryo-TEM of Hydra tissue treated with AuNP-N3 (4h time points). In A and B single 
distinguishable AuNP-N3 appear attached to nano-sized vesicles outside the cell membrane, within the glycocalix (Glx) 
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Figure 38. High-pressure cryo-TEM of Hydra tissue treated with AuNP-N3 (8h - 14h time points). A-B) after 8h of 
incubation vesicles are found traversing the cell membrane to reach later (C-D) the cytoplasm.  
 
 
 
Figure 39. High-pressure cryo-TEM reveals additional internalization pathways. Polyps were incubated for the indicated 
periods with 25nM AuNP-N3. A-B) At 24h and 48h time points most of the AuNP-N3 are detected inside lysosomes (Lys). C-D) 
At 48h nanosized vesicles loaded by NPs are also found outside cell membrane. Scale bars: 1#m in A, 0.2#m in B, C, D. 
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.  
Figure 40. Nanovesicle-mediated exocytosis of AuNP-N3 A) Nanovesicles underlying the cell membrane may release their 
content outside upon fusion with the phospholipidic layer. Gold nanoparticles may be shuttled in and out the membrane through 
binding to these nanovesicles. The membrane appears interrupted on different regions to enable cell release, and empty 
vesicles (arrowed) are clearly detected on the cytosolic region below the external electron dense material. B) Another example 
of an empty nanovesicle in close proximity of external one decorated by gold nanoparticle. !
 
 
 
 
Figure 41. An estimation of the lysosome containing NPs (expressed as percentage ± SE) show that they increase from 8h to 
48h of incubation, when most of up taken NPs are delivered to lysosomes for degradation. The estimation was done at each 
time point on 20 TEM images collected from three different animals 
 
 
To further confirm the exocytosis pathway, a “pulse and chase” experiment was 
carried out. Living animals were incubated 24h with AuNP-N3, extensively washed 
and incubated in fresh medium for further 24h and 48h before processing for TEM 
and elemental analysis. TEM images in Figure 42A show that 24h post incubation, 
vesicles containing NP are in the apical part of the cell, underneath the cell 
membrane, embedded into the glycocalix layer and in the act being released outside 
the cell (Figure 42B-C-D). In Figure 43A a low magnification image shows the whole 
animal tissue section in the act of AuNP-N3 clearance. Other images showed 
exocytosis by shedding vesicles densely packed with AuNPs or mediated by multiple 
vesicle release through larger membrane areas (Figure 43B-C-D).  
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Figure 42. Exocytosis of AuNP-N3. Polyps were “pulsed” 24h with AuNP-N3, extensively washed and “chased” by incubation 
for additional 48h in fresh medium, before processing for TEM analysis. A) AuNP-N3 are found on the apical part of the cell, 
entrapped into nanosized vesicles that are released out of the animal (B C and D).   
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Figure 43. Exocytosis of AuNP-N3. Polyps were “pulsed” 24h with AuNP-N3, extensively washed and “chased” by incubation 
for additional 48h in fresh medium, before processing for TEM analysis. In A a low magnitude image shows the whole animal 
tissue section in the act of AuNP-N3 clearance. Other similar membrane sheddings without NP are present on the animal 
surface, proving the normal occurrence of this phenomena. The same region at higher magnification is shown in B. In C and D) 
Other tissue regions showing NP clearance. In this case a larger membrane area is involved, probably reflecting lysosome 
exocytosis. 
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3.4.1 Elemental analysis confirms kinetic of uptake and clearance of AuNP 
 
In order to calculate the amount of AuNP-N3 internalized by Hydra vulgaris, elemental 
analysis by ICP-AES (Inductively coupled plasma atomic emission spectroscopy) 
was performed on animals pulsed 24h with 25 nM AuNPs (corresponding to 1.25 
mg), than washed and chased in fresh medium for 24h and 48h. The Au content 
(calculated on 150 treated animals) at the end of the pulse (24h) was estimated as 
93,7 #g, namely 7.5% of the total dose used for treatment. 
After 24hrs of incubation in fresh medium, the Au content decreases down to 26,1 #g 
and 23,1 #g, respectively at 24h and 48h time points, indicating a 75% release of the 
internalized material.  
From analysis of the supernatants collected during the chase phase, a low but 
appreciable amount of Au (0,8 #g) was found only at 24h post washing, confirming 
AuNP exocytosis mainly occurring within this temporal window (Table 1). Overall 
these findings confirm the kinetics of AuNP entry/exit suggested by the TEM images: 
AuNPs are moderately recruited into vesicles within the first 24h of incubation, and 
then sorted out 1) to lysosomes for external release during the following 24h, 2) to 
more stable structures, possibly representing storage vacuoles, discharging their 
content over a longer period. The unavailability of molecular markers specific for 
different types of Hydra storage vesicles makes it impossible to further characterize 
the nature of such structures. 
 
h post washing                    Intracellulatr Au content (!g)                     Extracellular Au (!g) 
        0 h                                           93,74  ±  1.55                                                             0 
       24 h                                          26,14  ±   1.20                                                 0,819   ±  0.012 
       48 h                                          23,14  ±  0.42                                                            0 
Table 1. ICP-AES analysis. ICP-AES was performed on animals pulsed 24h with 25 nm AuNPs(1,25 mg), then washed and 
chased in fresh medium for 24 h and 48 h. At each time point 15 animals (and 1ml of their incubation medium) were collected 
and processed for ICP AES analisis. Experiments were performed in triplicate. 
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4 Discussion. 
 
In 1998, Fire and Mello uncovered the mechanisms of RNA interference opening the 
new fascinating research field on gene silencing. For this groundbreaking discovery 
they were awarded the 2006 Nobel Prize in Physiology and Medicine. Very soon it 
became clear that beside its profound effect on the study of gene function, RNAi 
could provide a new class of therapeutic agents based on dsRNAs (Kim et al., 2007). 
The progression from basic discovery to applications in medicine ran really fast; 
nowadays, few years later its discovery, there is a growing interest to exploit RNAi as 
a therapeutic strategy for degenerative diseases and cancer (Davis et al., 2010), 
which led to a dozen of phase I to III clinical studies. Despite this promising potential, 
some hurdles must be overcome before RNAi technology can be widely employed in 
clinical practice. In particular, physicochemical features of siRNA molecules such as 
small size, hydrophilicity, net negative charge and high sensitivity to nuclease 
activities pose severe challenges to gene silencing. More in detail, one of the most 
critical points to achieve an effective gene silencing concerns the safe and efficient 
delivery of siRNA into the cytoplasm, where the RNAi process takes place. In fact, 
cell membranes and endosomal compartments may represent a stumbling block for 
siRNA entrance into the cytoplasm limiting or even inhibiting RNAi-based approaches 
(Akhtar et al., 2007). To facilitate intracellular delivery of siRNAs many biochemical 
and biotechnological strategies have been developed, including the use of 
transfection agents or viral systems. In addition, recent technological tools have also 
facilitated cell-specific targeting of RNAi reagents through the use of ligands such as, 
receptor-targeting aptamers or ligand-coated nanostructures (Davis et al., 2010) 
driving specific delivery to desired cell population. Although these significant 
advances contributed notably to enhance gene silencing efficacy, the design of 
forefront strategy to further improve RNAi methodologies is of outstanding 
importance in biological research as well as for therapeutic purposes. 
 
4.1 RNA interference mediated by free siRNA in Hydra vulgaris. 
 
The possibility to perform gain or loss of function approaches to analyze gene 
function may add new values to the widespread use of Hydra vulgaris as model 
organism. While the generation of transgenic polyps by embryo microinjection has 
been exploited by several groups as a feasible methodology to study gene function 
by overexpression in Hydra tissues, the development of reliable and reproducible 
RNAi methodologies was faced for many years by several groups by using different 
approaches including: embryo microinjection (Wittlieb et al., 2006), whole animal 
electroporation (Lohmann et al. 1999), localized electroporation (Smith KM et al. 
2006). Subsequently, new milder strategies for dsRNAs delivery were introduced. 
Hydra was fed with dsRNA producing bacteria (Chera S. et al, 2006), allowing the 
silencing of both endodermal and ectodermal genes. The soaking method using long 
dsRNA has been employed for efficient RNAi of key developmental genes in the 
marine hydroid Hydractinia echinata (Duffy DJ. et al. 2010). Despite these efforts, 
RNAi is not yet a robust, widely used technology for functional studies in Hydra.  
During the first part of my PhD thesis, I studied the possibility to downregulate the 
expression of the protoncogene c-myc, introducing a new approach of RNA 
interference in Hydra vulgaris, based on soaking adult polyps with siRNAs. As the net 
negative charge of siRNA molecules may prevent them from interaction with 
biological membranes and cell internalization, we established conditions to improve 
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siRNA uptake. Previous study from our group showed that the positive net charge of 
colloidal nanoparticles influences the cell uptake (Tortiglione et al, 2009). Thus we 
used mildly acidic condition to soak Hydra with siRNA. Under these conditions we 
showed that siRNA undergo charge reversal and cell uptake was greatly enhanced. 
Alexa fluor 488-labelled myc-siRNAs, indeed, were detected at pH 4, but not at pH 7, 
into the cytoplasm of Hydra ectodermal cells, within both epitheliomuscular and 
interstitial cells, as granular structures of different sizes, confirming the role of the 
positive surface charge for cell delivery (Tortiglione et al., 2009, Howard et al., 2009).     
Hymyc1 is the Hydra homologue of the c-myc proto-oncogene, a gene conserved 
throughout the animal kingdom (de la Cova C. et al. 2006), which governs key 
cellular processes such as cell growth, proliferation, apoptosis. Although Hymyc1 
showed a structural conservation in bHLH-Zip domain and myc-boxes I to III, as in 
the vertebrates, its physiological role in Hydra has not been fully elucidated. 
By challenging living Hydra polyps with myc-siRNA, Hymyc1 mRNA and protein 
levels were downregulated. At cellular level, an analysis of single cells prepared by 
maceration revealed abnormal distribution between cellular types of the interstitial 
cell lineage. Hymyc1 downregulation did not affect epithelial cell rate, while it induced 
an increase in stem cell proliferation rate, which produced dramatic effects on the 
related cell population sizes. These results are in line with previous studies relating 
stem cell self-renewal to the cell density, and showing that nematocyte commitment 
increases as stem cell concentration increase (David et al., 1980). In particular David 
and coworkers demonstrated using cell aggregates, that the rate of nematocyte 
differentiation increases as the concentration of stem cells increases; under the same 
conditions the rate of nerve differentiation remains essentially constant. Here, by myc 
RNAi, the 1s+2s amount was increased after 4 days.  This lead to a huge increase in 
the zymogen,mucous cell and nematocyte population After 9 days of treatment, the 
stem cell density was restored to physiological levels, suggesting a negative 
feedback between stem cell, as elsewhere suggested (Holstein et al., 1990). Holstein 
and coworkers demostrated, using Hydra oligactis, for the first time, changes in the 
cell cycle parameters of interstitial cells associated with altered population growth 
rates. 
The specificity of the phenotype induced by myc-siRNAi was confirmed by Tortiglione 
and coworkers by treating animals with a biochemical c-MYC inhibitor, the 
thioxothiazolidinone10058-F4, that affects also the myc gene transcription level. 
Treatment of living polyps with 10058-F4 for 2 days induced 50% reduction of 
Hymyc1 expression levels, as assayed by qRT-PCR (Figure 1A). Cell type 
distribution analysis revealed increased proliferation of  stem cells, and increased 
amounts of intermediates and terminal differentiation products (nematoblasts, 
nematocytes, secretory cells), Figure 1B. As detected in Hymyc1 RNAi polyps, also 
the phenotype of the battery cells was affected, containing an abnormal number of 
nematocytes (Figure 1C), indicating the specificity of the Hymyc1 downregulation 
effects. Taken together, these findings suggest that Hymyc1 conditional knock down 
enhanced stem cell proliferation, and in turn unbalances the differentiating products. 
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Figure 1. Molecular and morphological alteration induced by the c-myc inhibitor 10058-F4. A) Living polyps were treated 
with the c-myc inhibitor 10058-F4 for 48 h at two different concentrations (30 mM and 90 mM) before RNA extraction for qRT-
PCR analysis. Expression levels, relative to HyEF1!, indicate Hymyc1 silencing in a dose dependent manner, reaching 47% 
downregulation at the higher dose tested. Error bars indicate standard deviations calculated from three independent 
experiments, each performed in triplicate. B) Single cell suspensions were prepared from polyps treated as in A and the relative 
cell types counted by phase contrast microscopy. C) Polyps treated with the c-myc inhibitor as in A were fixed and whole 
mounted for analysis of the nematocyte content into the tentacles (as described in Figure 12, chapter Results).  
 
The involvement of c-myc in controlling cell proliferation and differentiation processes 
has been shown in many systems, by both gain and loss of function approaches. For 
example in murine hematopoietic stem cells (HSC), it was showed that c-myc 
depletion resulted in the accumulation of HSCs in situ due to their failure to initiate 
normal stem cell differentiation (Laurenti et al., 2009) (Wilson et al., 2008). In human 
pancreatic endocrine cell lines c-myc downregulation by siRNAi induces the exit of 
the cell from proliferating phase and to enter in the differentiation pathways, thus c-
myc plays a role in the switch mechanism that controls the inverse relationship 
between proliferation and differentiation (Demeterco et al., 2002). In Hydra we 
showed for the first time the role of myc proto-oncogene in controlling the balance 
between stem cell renewal/differentiation suggesting that in the ancient progenitor of 
animal evolution the myc factor was already at work to control crucial processes of 
stem cell biology. 
On the top of the elucidation of the functional role played by Hymyc1 in the 
maintainement of the cell homeostasis, the development of an efficient tool to 
downregulate gene expression demonstrates the conservation in Hydra of the RNAi 
cell machinery and the conserved role of siRNA, Although the molecular mechanisms 
underlying RNAi have not been exhaustively elucidated in Cnidaria, we provide 
evidences that siRNAs enter Hydra cells and trigger a RNAi response, similarly to 
many metazoans (Ambrosone et al., 2012). The strong molecular downregulation 
observed in siRNA treated animals suggest that the RNAi response may result from 
both direct delivery to interstitial cells and spreading effect of the RNAi response, 
similarly in other vertebrates (Timmons et al., 2003). This hypothesis is supported by 
the presence in Hydra genome of predicted genes encoding for components required 
for amplification and systemic spread of an RNAi signal.  
 
4.2 RNA interference mediated by gold nanoparticle in Hydra. 
 
Gold nanoparticles (AuNP) have attracted much interest over the last decade owing 
to excellent physicochemical properties such as their reduced sizes, rendering them 
capable of interacting with biomolecules in a one to - one scale, and the high surface-
to-volume ratio allowing for surface functionalization with a plethora of molecules for 
specific targeting and drug payloads. Noteworthy, among the array of nanomaterials 
designed to improve biomolecule delivery, Au NPs have shown to be safe in in vitro 
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and in vivo tests minimizing the risks of their use in biomedical research (Giljohann et 
al., 2010).  
Therefore, in the second part of this study, we developed and tested a new RNAi 
method, based on siRNAs conjugation to AuNPs. More in detail, stable gold 
nanoparticles were synthesized and functionalized with two different PEG spacers. 
These PEGylated AuNP formulations represented the basic nanoparticles for 
downstream functionalization with c-myc siRNA, using either ionic interaction (ION) 
or covalent binding (COV). In the ION method, elettrostatic interactions between the 
negatively charged siRNA backbone and both the azide and quaternary ammonium 
positively charged groups ensured binding of siRNA onto the NP surface for the 
whole pH range. In the COV method, thiolated siRNA was bound via a thiol bond to 
AuNPs with a nonsaturated PEG layer. Further functionalization of these AuNPs with 
the HIV-derived TAT peptide was performed to increase the cell penetration of 
functional NPs. Considering the possible combinations of different chemical groups 
on the nanoparticle surface, we tested in total 8 different functionalised NPs.  
Multiparametric analysis of AuNP toxicity showed that this kind of NPs has no or 
negligible effects on animal morphology, reproduction and regeneration indicating 
their safe use in Hydra, even at high concentrations (4 mg/ml).  
Molecular analysis by qRT-PCR showed that in terms of RNAi, the best performing 
nanovector, the AuNP harboring Hymyc1 siRNA covalently bond to the NP surface 
(cov approach), markedly reduces (80%) the expression level of myc protooncogene. 
Interestingly, the functionalization with TAT, initially added to enhance the cell 
permeability, caused probably an inhibition of RNAi, confirming that TAT may exert a 
conserved RNAi suppressor activity, as reported in Qian et al., 2009.  
In this work, in fact, it has been demostrated that both in human and plant cells the 
underlying mechanism of RNA silencing suppression by human virus HIV-1 TAT 
peptide  and plant virus P19 are related. TAT and P19 resulted not to be able to 
reduce maturation of dsRNA duplexes but they exert their effects downstream, 
indicating a common mechanism to prevent guide strand programming of RISC.  
Furthermore, our results proved that siRNA conjugation through ionic approach 
provides nanovectors with a lower silencing efficiency. This could be explained 
considering the different release mechanisms of covalently and ionically produced 
AuNP-myc-siRNA. Indeed the ionic approach, relying on the interaction of positively 
charged AuNPs and negatively charged siRNA, could be affected by changes of the 
chemical physical properties of environment, that could weak the electrostatic 
interaction between the siRNA and the AuNP core. The lower downregulation 
efficiency compared to the corresponding covalent conjugates could suggest that 
siRNA molecules might be released from NP surface before reaching the cytoplasm. 
By contrast the AuNPs-myc-siRNA functionalized by covalent approach might 
efficiently deliver siRNA to the cytoplasm. With this method siRNA could not be 
released before their cellular uptake because they are linked to the AuNPs surface 
through a thiol bond. The breakdown of this kind of covalent bonds could be 
achieved only in reducing environments, such as the cytoplasm. However, besides 
the mentioned release mechanism of siRNA duplexes, another way through which 
cov AuNPs-myc-siRNA can induce myc downregulation is by releasing only the 
antisense strand with the sense strand permanently linked to the AuNP surface. The 
chemical basis of NPs production could thus provide an explanantion of the different 
silencing efficiencies.  We argued whether RNAi may be triggered also by siRNA still 
linked to NPs. In the case of ion AuNPs we do not have data that can allow us 
neither to accept or refuse this possibility. For the cov AuNPs, as they have been 
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produced in this work, it is quite impossible that the silencing may be induced with 
the siRNA attached to NPs because the sense strand is bound to the NP with the 
antisense free to be released. To better investigate this issue we should produce 
AuNPs with the antisense strand covalently bound to the surface, with a bond 
insensitive both to pH and reducing environments. In conclusion, we demonstrated 
that Au NPs function as a safe and potent tool for siRNA delivery in living animals. 
Moreover, our data successful contributed to optimize the design of smart 
nanodevices which are currently employed in pre-clinical studies focused on lung 
cancer treatment in murine models. 
 
 
4.3 Ultrastructural evidence of dynamic of internalization of Au-NP-N3 and Au-
NP-myc-siRNA 
 
Beyond the important goal to achieve advanced functional materials designed for 
RNAi, it is of great interest in nanomedicine to gain knowledge on mechanisms 
controlling the uptake of nanoparticles in living organisms, in order to control the 
delivery of nanotools into living targeted cells. Thanks to their well-known 
biocompatibility and their large use as contrast agent in trasmission electron 
microscopy, Au NPs are excellent candidate to understand the routes followed by 
nanomaterials to enter the cells (Chithrani et al., 2010; Kim et al., 2009). For these 
reasons, we investigated the dynamics and kinetics of events occurring at the 
bio/non-bio interface, from the early NP/cell membrane interactions to the 
intracellular trafficking and the final extracellular clearance. To this aim, we analized 
the positively charged AuNP-N3, and the AuNP-myc-siRNA and performed a time 
course analysis to track step by step their cell internalization. By optical microscopy 
polyps treated with these AuNP-N3 showed a punctuated staining throughout the 
animal body (Marchesano et al., 2013), confirmed also by tissue cryosections and by 
analysis of isolated cells. Tissue sectioning showed internalized AuNPs both within 
the ectoderm and few endodermal cells, confirming previous evidence on dynamic 
processes occurring between the two cell epithelia, causing displacement or 
migration of labeled cells or free NPs from ectoderm to the endoderm (Tortiglione et 
al., 2009). Indeed, optical microscopy observations showed that covalent and ionic 
AuNP-myc-siRNA were internalized at low rate by Hydra ectodermal cells compared 
to positively charged AuNP-N3. 
To investigate the events that characterized the NPs uptake and fate, we performed 
a trasmission electron microscopy study following two different methodologies: 
standard TEM and High pressure cryo TEM, which avoids ice crystal formation and 
potential fixative artifact, enabling ultrastucture description as close as possible to the 
living state (Holstein et al., 2010).  
Transmission electron microscopy analysis was performed to understand the 
subcellular distribution of AuNP-myc-siRNA. TEM observations showed that in the 
treated animals the AuNPs bound the glycocalix after few minutes while later, after 
24 hours of incubation, NPs localised in the cytoplasm, clustered or monodispersed, 
demonstrating their capability to cross cell membrane and deliver siRNA into the 
cytoplasm. On the other hand, standard TEM analysis of AuNP-N3, showed that NPs 
bound to the glycocalix after 5 min of incubation. The strong interaction between the 
positive azide group of the AuNP and the negative cuticle components caused in 30 
minutes the massive accumulation of nanoparticles all around the animal tissue. 
Interesting, large vacuoles cotaining NP were often found in the apical part of the 
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ectodermal cells, whose probable origin from membrane invagination and fusion is 
indicated by the presence of the glycocalix in the inner side of the limiting membrane. 
These data are supported by previous study from Brust et al., 2011. In this work Hela 
cells were incubated with TAT modified AuNPs and ultrastructure analysis showed 
NPs to freely negotiate intracellular barriers, moving from vesicles to cytoplasm in 
either ways by direct membrane traslocation. Noteworthy, datum was found at 24h 
time point analysis, where AuN-N3 were found packed into micrometer sized granular 
structure, mixed to glycocalix/subcellular debris components. These structures are 
responsible for the punctuated pattern observed by optical microscopy and are very 
similar to granules obtained after the interaction of QRs with Hydra vulgaris 
(Tortiglione et al., 2009), suggesting that the mechanism of internalization is the 
same and that the positive charge of Au azide and QRs determine the high efficiency 
of uptake by Hydra ectodermal cells.  
To better understand the mechanisms that govern the uptake of AuNP, the 
nanoparticles with a positive charge (AuNP-N3) were chosen and supplied to Hydra 
at a  concentration of 25 nM, lower than the former, in order to avoid massive NP 
accumulation on the cell glycocalix. Moreover, thin section were analysed by a 
different technique of electron microscopy, which provides, through a cold sealing, an 
extremely fast fixation: High-Pressure cryo TEM (Serp et al., 2002). High pressure 
time course analysis (from 4h to 48h) showed that NPs cross cell membrane within 
vesicles-like structure after 4-8h; later on the AuNP-N3 reach the cytoplasm and 
finally after 24-48h time points, NPs were found in lysosomal compartment, as single 
units or cluster, suggesting that the lysosomal compartmentalization is the main 
intracellular fate of Au NPs. Surprisingly, the presence of nanozised vesicles loaded 
with NPs outside the cell membrane at 48h post-incubation opened the possibility 
that beside their role as carriers of AuNP from the external medium inside the cell, 
they could also represent endosome recycled material brought back to the cell 
membrane.  
This results might support what occurs in mammals, where the fusion of 
multivesicular bodies with the cell membrane, may induce the release of exosomes in 
the extracellular space (Keller et al., 2006). However from the deep analysis of all 
images taken by HPF, we could not find any MVB containing AuNP, thus at moment 
this remain an hypothesis and the nature of these nanosized vesicles able to load 
AuNp and shuttle them into the cells remain to be elucidated. 
 “Pulse and chase” experiment confirmed that the exocytosis take place within 48 h 
post incubation mainly through two mechanisms: by shedding of vesicles densely 
packed with AuNPs or mediated by multiple vesicle release through larger membrane 
areas.  
Our data are perfectly in agreement with a previous study (Krpeti" et al., 2011), 
where  it has been demostrated that TAT modified gold nanoparticles after 
internalizion in Hela cells can rapidly escape from the endocytic system and be 
distributed in other cell compartments by direct translocation across the intracellular 
membranes, before membrane rupture as showed in figure 2. 
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Figure 2. TEM images of HeLa cells incubated for different times with TAT-modified gold nanoparticles: TEM images 
showed that  particles are found after 10-24 h in a dense  vesicles, releasing particles by membrane rupture (A) and by direct 
membrane translocation (B), and massively packed vesicles found after 24 h (C) and after 48 h (D). 
 
 
Comparing the TEM images of this previous work with ours (chapter 3, par 3.2.5) we 
observed the same patterns, suggesting the presence of a conserved mechanism 
exploited by eukariotic cells to sort out foreign materials, by accumulating them in 
vacuoles. In Hydra they may represent storage/garbage vacuoles, possibly due to 
the saturation of the lysosome machinery unable to sort out high NP concentration. 
 
To summarize, in Figure 3 we report a schematic representation of inwards and 
outwards trafficking routes of AuNPs observed in our study. Briefly, NPs 
internalization in Hydra can occur through different mechanisms: direct membrane 
translocation, loading on nanovesicles, endocytosis (macropynocytosis) of large 
membrane invaginations. These processes occur within 30 min-24h, when the NP 
are localized into a vesicle/vacuole in the cytoplasm. From 24h to 48 h were found in 
different cell compartment, such as late endosome/phagosome or lysosome. After 48 
h of incubation NP were localized into lysosomes, but also secreted chiefly by 
secretory vesicles, exoxomes-like structures (Keller et al., 2006)  or sorted by direct 
membrane exocytosis. 
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Figure 3. Schematic representation summarising inwards and outwards trafficking routes of AuNPs. Following AuNP 
exposure to Hydra, several inwards routes may be exploited by ectodermal cells, leading to AuNP internalization, illustrated on 
the left panel: i) direct membrane translocation ii) loading on nanovesicles iii) endocytosis (macropynocytosis) through large 
membrane invaginations. These processes occur within 30min-24h, when a massive recruitment of particles from different 
cytoplasmic districts into vesicle/vacuole structures is observed. From 24h to 48h a dynamic exchange of particles between 
different cell compartments (late endosome/phagosome -lysosome) takes place and AuNPs appear also moving out vesicle 
membranes. After 48h of incubation AuNPs are found at a great extent into lysosomes, but also on exosome-like vesicles. We 
suggest that following endosomal recruitment several outward routes may take place, i) through exosomes (possibly derived by 
late endosomes) ii) direct membrane exocytosis of NP-loaded vesicles iii) fusion of lysosomes with cell membrane. In the 
scheme the black and red arrows indicate the inward and outward routes, respectively, the dotted arrows indicate possible 
intracellular trafficking. 
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5 Conclusion 
 
In conclusion, the work presented here shows the development of new methods of 
siRNA mediated RNAi. The approach that took advantage of the use of 
functionalized gold nanoparticles resulted to be much more efficient than the other 
based on free siRNA administration. siRNA functionalized AuNPs lead to a 80% 
Hymyc1 downregulation, allowing to better dissect the functional role played by this 
gene  in Hydra vulgaris. Myc has been highlighted as a gene deeply involved in the 
processes controlling the homeostasis of stem cells, regulating thus the balance 
between self-renewal and differentiation. The elucidation of its role in Hydra, could 
provide new insights in the definition of myc role in physiological and pathological 
condition of higher vertebrates.  
The great impact of this work relies on the potential translation of the new 
nanodevice to preclinical models. The screening of the AuNP-siRNA through cell 
culture and Hydra led to select a myc siRNA-AuNP conjugate that is currently used to 
rescue the lung tumor of a mouse lung xenograft. 
This nanodevice, able to induce RNAi in three biological systems, represents an 
excellent platform on which therapeutic strategies could be modeled. Of course by 
changing the specificity of siRNA it would be possible to target different genes for 
treatment of different pathologic conditions. Beside the new RNAi methodologies, this 
PhD project led also to the fine dissection and characterization of the mechanism of 
internalization, trafficking and exocytosis of AuNPs in Hydra. These data, along with 
the molecular evidences confirming myc silencing, suggest that the siRNA-AuNPs, 
once uptaken, are able to reach the cytoplasm, elicit their function, and then reach 
the lysosomes for degradation and final excretion outside the cells.  
The results obtained by this PhD work wants to stress the importance of using simple 
model systems as valuable tool for applied and basic research: while the Hydra high 
reproductive rate and fast life cycle allow analysis of statistically relevant specimens 
for each experimental condition, the conservation in this species of key regulayory 
cell and developmental pathways, make our results of general value for higher 
organisms. 
The results obtained by this PhD thesis contributed to the realization of three 
scientific papers, published on high impact specialized journal, in 2012 and 2013. 
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T
he plasma membrane is a dynamic
10 structure that functions to separate
11 the cytoplasm from the extracellular
12 environment by regulating and coordinat-
13 ing the entry and exit of small and large
14 molecules. Small molecules, such as amino
15 acids, sugars, and ions, can traverse the
16 plasma membrane through the action of
17 integral membrane protein pumps or chan-
18 nels. Macromolecules must be carried into
19 the cell in membrane-bound vesicles de-
20 rived by the invagination and pinching-oﬀ
21 of pieces of the plasma membrane in a
22 process termed endocytosis. The endocytic
23 pathways (phagocytosis, (macro)pynocitosis)
24 diﬀer with regards to the size of the endocytic
25 vesicle and the chemistry of the cargo trig-
26 gering eithermembrane proteins (hormone
27mediated-signal transduction, cell!cell
28communication, immune surveillance, cell
29motility)1 or cytosolic compartments. With-
30in the endosome the cargos are sorted to
31distinct destinations, being either recycled
32back to the plasma membrane or sorted
33into intraluminal vesicles for lysosomal de-
34struction via multivesicluar bodies.2 The
35macromolecular nature of the material trans-
36ported by endocytosis makes this route one
37of the most important targets for nano-
38medicine.3!5 Indeed, many nanoparticle
39formulations are customized to bypass cell
40membranes and deliver the cargo within
41the cell.6!8 However, not much is known
42about the intracellular traﬃcking and fate of
43nanomaterials following cargo delivery,9,10
44and only a few studies report on their whole
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ABSTRACT Gold nanoparticles have emerged as novel safe and
biocompatible tools for manifold applications, including biological ima-
ging, clinical diagnostics, and therapeutics. The understanding of the
mechanisms governing their interaction with living systems may help
the design and development of new platforms for nanomedicine. Here we
characterized the dynamics and kinetics of the events underlying the
interaction of gold nanoparticles with a living organism, from the ﬁrst
interaction nanoparticle/cell membrane, to the intracellular traﬃcking and
ﬁnal extracellular clearance. By treating a simple water invertebrate (the
cnidarian Hydra polyp) with functionalized gold nanoparticles, multiple
inward and outward routes were imaged by ultrastructural analyses,
including exosomes as novel undescribed carriers to shuttle the nanoparticles in and out the cells. From the time course imaging a highly dynamic picture
emerged in which nanoparticles are rapidly internalized (from 30 min onward), recruited into vacuoles/endosome (24 h onward), which then fuse, compact
and sort out the internalized material either to storage vacuoles or to late-endosome/lysosomes, determining almost complete clearance within 48 h from
challenging. Beside classical routes, new portals of entry/exit were captured, including exosome-like structures as novel undescribed nanoparticle shuttles.
The conservation of the endocytic/secretory machinery through evolution extends the value of our ﬁnding to mammalian systems providing dynamics and
kinetics clues to take into account when designing nanomaterials to interface with biological entities.
KEYWORDS: gold nanoparticles . cell uptake . intracellular traﬃcking . exocytosis . transmission electron microscopy .
model organism
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45 journey into the cell up to external clearance. Gold
46 nanoparticles (AuNPs) hold great interest in this ﬁeld
47 thanks to properties such as monodispersity, stability,
48 minimal toxicity, excellent contrasting agent proper-
49 ties for transmission electron microscopy (TEM) anal-
50 ysis, which enable to track with unprecedented re-
51 solution dynamic of uptake, intracellular sorting, and
52 potential secretion.11!13 Recent results gathered on
53 the interaction of AuNP with diﬀerent synthetic lipid
54 membranes14 or cell lines demonstrated that proper-
55 ties such size, charge, chemical functionalities, but also
56 the arrangement of organic ligands on nanoparticle
57 surface, dictate the internalization route.15,16 More-
58 over, surface functionalization may inﬂuence the fate
59 of AuNP upon cell uptake: HUVEC cells treated with
60 AuNP coated by diﬀerent peptides display distinct
61 exocytosis proﬁles.9 Here we investigated the inward
62 and outward traﬃcking of AuNPs at whole animal level
63 using the small invertebrate Hydra vulgaris (Cnidaria,
64 Hydrozoa), a recently emerged amenable system to
65 study nanoparticle!cell interactions.17,18 Shaped like a
66 simple hollow cylinder with a single apical opening
67 (mouth) surrounded by a tentacle crown and a basal
68 foot to anchor a substrate (Figure 1F1 A).19 Hydra is a
69 freshwater polyp successfully used to test diverse
70 nanoparticles, for example, for evaluation of toxicity
71 of CdTe quantum dots,20,21 to study cell dynamics
72 using ﬂuorescent quantum rods,22 or to analyze animal
73 behavior in response to nanoparticle exposure.23 The
74 possibility to uniformly expose thewhole animal to any
75given substance by simple soaking makes it ideal to
76study the mechanism of nanoparticle uptake and fate.
77In fact, the tissue structure, organized as just two cell
78layers (ectoderm and endoderm) facing respectively
79the animal external side and the gastric cavity, enables
80us to ﬁnely track NPs interaction with Hydra cells upon
81pulsed or prolonged exposure at any desired time
82point. We have recently shown that the capability of
83Hydra cells to uptake solublemacromolecules is greatly
84enhanced by the positive net charge. CdSe/CdS poly-
85(ethylene glycol) (PEG) coated quantum rods, display-
86ing negative zeta potential as-synthesized, under the
87condition of charge reversal (i.e., acidic pH) acquire
88positive charge and capability to enter Hydra cells at
89high eﬃciency.22 Similarly, short dsRNA, if protonated
90at acidic pH, are uptaken at a high rate into the cytosol
91and are able to initiate an RNAi response,24 showing
92the pivotal role played by the positive charge in
93enhancing cell permeability to several structures, che-
94mically unrelated. Our group has recently shown that
95multifunctional gold nanoparticles, stabilized by PEG
96and conjugated to several bioactive molecules (siRNA,
97TAT, charged groups) are capable of cytosol delivery of
98small interferingRNAs (siRNA) and inductionof a speciﬁc
99RNAi process.25 The selected siRNA targeted the proto-
100oncogene c-myc, a key gene controlling disparate as-
101pects of cell physiology including cell growth, cell cycle
102progression, biosynthetic metabolism, and apoptosis
103and, as expected, found deregulated in the majority
104of human cancers. Remarkably, these multifunctional
Figure 1. Characterization of AuNPs. The high monodispersity of the gold core of AuNP-N3 (A) and AuNP-siRNA (D) was
conﬁrmed by transmission electron microscopy (TEM, T20 200KeV; FEI) showing an average size of 14 nm. (B) Analysis of the
stability of AuNP-N3: the ratio A519 (contribution of stable AuNPs)/A600 (contribution of aggregated AuNPs) was measured
by UV!vis. (C) Infrared spectra (FTIR, JASCO FT/IR 4100) conﬁrmed the presence of the azide groups covering the gold cores,
showing a characteristic peak at 2100 cm!1. Quantiﬁcation by Ellman'smethod of the PEG-COOH chains attached in a second
addition after (E) increasing amount of PEG-COOHwith (circles) and without (squares) PEG-N3, (F) increasing amount of PEG-
N3 at constant PEG-COOH added. Data were collected from a single experiment. Whole characterization of AuNP-siRNA is
reported elsewhere.25
A
RTIC
LE
MARCHESANO ET AL . VOL. XXX ’ NO. XX ’ 000–000 ’ XXXX
www.acsnano.org
B
105 myc-siRNA AuNPs induced speciﬁc and eﬃcient RNAi
106 in three diﬀerent biological systems (human cell cul-
107 ture, Hydra, and mouse) thus representing a broadly
108 valid nanotool to achieve gene silencing. In Hydra the
109 downregulation of the myc gene (previously isolated by
110 Hartl et al.26) mediated bymyc-siRNA-AuNP induced 80%
111 downregulation25 and the same eﬀects caused by free
112 siRNA,24 conﬁrming the speciﬁcity of the new approach.
113 Brieﬂy, Hymyc1 inhibition caused increased proliferation
114 of interstitial stem cells, suggesting a role in maintaining
115 the balance between stem cells self-renewal and dif-
116 ferentiation, as found in other systems. Ultrastructural
117 analysis by TEM showed the capability of myc-siRNA
118 nanostructures to directly penetrate Hydra cell mem-
119 branes,25 while in human cells and mouse lungs classic
120 endocytic routes were found. Considering the broad
121 potential of the new nanotool to enter RNAi-based
122 clinical trials, basic knowledge of the rule governing the
123 interaction of such smart nanoparticles with a cell mem-
124 brane is of fundamental importance, together with the
125 understanding of kinetics of the gold clearance following
126 siRNA delivery. To get deep insights on these mechan-
127 isms, here we used an ultrastructural approach to
128 analyze all steps of AuNP cell/interaction using the
129 Hydra model. By comparing diﬀerent chemical func-
130 tionalities (siRNA and positively charged groups), ad-
131 ministration dose, and incubation times we identiﬁed
132 novel inward and outward routes, capturing for the
133 ﬁrst time at whole animal level AuNP exocytosis. The
134 strong evolutionary conservation of the endocytic/
135 secreting machinery in the animal kingdom makes
136 our ﬁndings of broad value not only for nanomedicine/
137 pharmacological aims, but also to unravel, in vivo, basic
138 mechanisms and parameters regulating cell portals of
139 entry, negotiation, and secretion.
140 RESULTS AND DISCUSSION
141 Synthesis and Surface Modification of Gold Nanoparticles.
142 Two types of AuNPs were employed in this study:
143 surface-modified by azide group (AuNP-N3) and by
144 siRNA targeting the c-myc gene (AuNP-siRNA). AuNPs
145 used as starting material for both functionalizations
146 were synthesized following the straightforward meth-
147 odology reported.27 The obtained AuNPs had an aver-
148 age size of 14 nm (Figure 1A,D). Citrate protective layer
149 was exchanged by a hepta-ethylenglycol spacer in-
150 cluding a thiol and an azide functional groups. Thiol
151 moiety was used to react with Au atoms of the AuNP
152 and to establish a strong Au!S pseudo-covalent bond.
153 The azide group was incorporated for further functio-
154 nalization of the nanoparticles by “click chemistry”
155 reactions with alkynemoieties (data not shown). More-
156 over, surface modification with PEG resulted in pro-
157 longed stability of the nanoparticles in the animal
158 growing media, minimizing unwanted aspecific protein
159 interactions and decreased toxicity of the nanoparti-
160 cles. Removal of citrate groups from the surface of the
161nanoparticle caused changes of Z potential changes,
162from !38 mV to þ21 mV, which could drastically
163modify the cellular uptake. The best conditions for
164obtaining stable and derivatized AuNPs were obtained
165by adding different AuNP/PEG-N3 ratios. The most
166stable nanoparticles were obtained with AuNP/PEG-
167N3 ratios between 1:2000 and 1:5000, and around 2600
168PEG-N3 chains/AuNP were estimated at the maximum
169point. The addition of higher or lower amounts of PEG-
170N3 decreased drastically the stability of nanoparticles
171(Figure 1B). The presence of N3 moieties on the AuNP
172surface was proved by FTIR analysis (Fourier transform
173infrared spectroscopy), showing a characteristic peak
174at 2100 cm!1 (Figure 1C). MALDI TOF of AuNP-N3 fur-
175ther confirmed the presence of PEG-N3 (M!Hþ 451.1).
176In the case of the AuNPs-siRNA, the functionalization
177was made as previously described,25 decreasing the
178total amount of PEG for further incorporation of thio-
179lated siRNAs. To overcome the low stability of partially
180pegylated nanoparticles using PEG-N3 chains, 50% of
181carboxylated PEG chains was added. Quantification of
182PEG-COOH and PEG-N3 chains bound to AuNPs was
183performed as previously reported.25 Briefly, PEG-COOH
184chains weremeasured directly by the determination of
185the excess of thiol groups on the supernatant by
186Ellman's method, while in the case of PEG-N3 chains,
187an indirect methodology was designed. An accurate
188description of the quantification of degree of saturation
189for the PEG chains on AuNP is reported in ref 25, and
190the results shown in Figure 1E,F. The number of PEG
191chains on AuNP-siRNA was estimated as 1250.5 (
192279.8. The addition of siRNA also improved the stability
193of the AuNP due to their negative charge.28 Quantifica-
194tion of myc siRNA strands following covalent binding
195to AuNPs (see Material and Methods) led to estimate
19641.3 ( 0.8 siRNA strands loaded on AuNPs. The addi-
197tion of siRNA on NP surface causes a zeta potential
198switch toward negative values like !25.5 ( 1.2 mV. In
199Table 1 T1a summary of the AuNP features is reported,
200while a scheme of the structure of two nanoparticles is
201shown in Figure 2 F2panels A and H.
202Influence of Surface Chemistry on NP Uptake: Biodistribution
203and Ultrastructural Analysis of AuNP-siRNA and AuNP-N3. A
204preliminary toxicological evaluation was performed
205to ensure the absence of harmful effects elicited by
206AuNPs treatments. Living polypswere soaked 24 hwith
TABLE 1. Quantification of the PEG Chains, and siRNA
Strands for AuNP-N3 and AuNP-siRNA Bioconjugates,
Together with the Z-Potential and Dynamic Light Scatter-
ing (DLS) Measurements
AuNP
conjugate
PEG
chains/NP
siRNA
strands/NP zeta potential (mV) DLS (nm)
AuNP-N3 ∼2600 þ21 15.5
AuNP-siRNA 1250.5 ( 279.8 41.3 ( 0.8 !25.5 ( 1.2 138.7
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207 70 nM AuNP-siRNA, a concentration previously shown
208 to induce efficient gene silencing25 and with the same
209 amount of AuNP-N3. Polyp morphology was not af-
210 fected by NP exposure, neither their reproductive
211 capability, as shown by the growth rates of treated
212 animals, not significantly different from control un-
213 treated animals (Supporting Information, Figure S1).
214 The bright field images of Figure 2 show a weak
215 punctuated labeling pattern over the body and tenta-
216 cles (Figure 2D,E), confirming a low rate of internaliza-
217 tion of AuNP-siRNA. These NPs were not detectable on
218 cryosections prepared from treated polyps (Figure 2F)
219 while on single cell suspensions a pink colored labeling
220 was found on a small percentage of cells (Figure 2G).
221 Polyp treatment with AuNP-N3, by contrast, produced
222 a strong punctuated labeling all over the animals
223 (head, body, and tentacles) (see Figure 2 I!N). Cryo-
224 sections of treated specimens (Figure 2O) showed
225 internalized AuNP-N3 both within the ectoderm and
226 few endodermal cells, confirming previous evidence
227 on dynamic processes occurring between the two
228cell epithelia, causing displacement or migration of
229labeled cells or free NPs from the ectoderm to the
230endoderm.22 Single cell analysis confirmed the loca-
231lization of these AuNPs into large cytoplasmic struc-
232tures (Figure 2P). To investigate the mechanisms
233underlying this different internalization efficiency,
234polyps were incubated for increasing periods (5 min,
23530 min, and 24 h) with both AuNP types before
236processing for TEM analysis.
237AuNP-siRNA Cell Uptake Dynamics. While a short incuba-
238tion time (5 min) was not sufficient to detect AuNP-
239siRNA (Figure 3 F3A), the first clear interactions between
240AuNP-siRNA and the cell membranewas detected after
24130 min of incubation. At this time point (Figure 3B,C)
242AuNP-siRNA are found very close to the cell membrane
243and also in the act of passing through it, indicating
244the capability of AuNP-siRNA to directly penetrate the
245plasma membrane of Hydra ectodermal cells. While
246most of the literature data report on the endocytic-
247endolysosomal pathway as the main route mediating
248the entry and fate of NP inside the cells (and often
Figure 2. In vivo uptake and biodistribution of AuNPs in Hydra. Upper panel: interaction of Hydra with AuNP-siRNA. (A)
Schematic illustration of the AuNP-siRNA shows the nanoparticle structure, coated by two diﬀerent PEG spacers (PEG-COOH,
and PEG-N3), and functionalized with siRNA molecules.
25 (B) Bright ﬁeld image of a living Hydra, carrying two developing
buds, treated 24hwith AuNP-siRNA. Internalized nanoparticles are hardly detectable bywhole animal imaging. Zooming into
(C) head, (D) foot, and (E) tentacle regions shows nanoparticles as dark granules located on ectodermal cells; (F) tissue
cryosections prepared from treated animals. AuNPs are not detectable on suchpreparation,while (G) single cells preparations
AuNPs are visible (arrowed) into the cytosol of ectodermal cells. Scale bars: (B) 500 μm; (C,F,D) 200 μm; (E) 100 μm; (G) 50 μm.
Lower panel: Interaction of Hydra with AuNP-N3. (H) Nanoparticle scheme illustrating the homogeneous PEG-azide coating
the Au core. (I) A strong punctuated dark labeling is present uniformly all over animal. The pattern is clearly evident on
separate imaging of (L) head, (M) foot, and (N) tentacles of treated polyps. (O) Cryosections from labeled polyps showmassive
AuNP-N3 accumulation into the ectoderm (ect) and the endoderm (end). (P) Fixed single cell suspension reveals AuNP-N3
location into vesicle-like structures of diﬀerent sizes. Scale bars: (I) 500 μm; (L,O,M) 200 μm; (N) 100 μm; (P) 50 μm.
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249 limiting the cytoplasmic delivery),29 the direct passage
250 of the gold nanoparticle through the cell membrane
251 has been rarely reported, and in a few cases has been
252 associated to the ordered surface structure.30,31 TEM
253 analysis performed after 24 h of incubation detected
254 AuNP-siRNA within a dense cytosol region. Figure 3D,E
255 show free nanoparticles or as clusters of a few units
256 within a dense region of an ectodermal cell, likely re-
257 presenting a late endosome. Interestingly, AuNP-siRNA
258 were also found on membranes of interstitial cells,
259 laying in the interstices between ectodermal cells,
260 proving the capability of NP to freely traverse cell
261 layers, delivering their siRNA cargo far from the admin-
262 istration site (Figure 3F).
263 AuNP-N3 Cell Uptake Dynamics. A different dynamic of
264 internalization emerged from the TEM analysis of
265 AuNP-N3 incubated over the same periods with Hydra
266 polyps (Figure 4F4 ) at the same concentration (70 nM).
267 Supporting Information, Figure S2 shows, after 5min of
268 incubation AuNP-N3 bound to the glycocalix, a thick
269 “cuticle layer” composed by glycoproteins and glyco-
270 saminoglycans, covering the animal's outer surface
271 (Supporting Information, Figure S3), This molecular
272composition of this cuticle layer has been recently id-
273entified.32 The strong interaction between the positive
274azide group of the AuNP and the negative cuticle
275components caused in 30 min the massive accumula-
276tion of nanoparticles all around the animal tissue. The
277ectoderm appeared as a typical scalloped surface with
278branching crypts extending into the epithelium be-
279tween cells or groups of cells, uniformly labeled by
280electron densematerial (Figure 4A). Interestingly, large
281vacuoles in the act of fusing/dividing (Figure 4A and
282Supporting Information, Figure S4) were often found in
283the apical part of the ectodermal cells, whose prob-
284able origin from membrane invagination and fusion
285(macropynocytosis) is indicated by the presence of the
286glycocalix/cuticle lining the inner side of the limiting
287membrane. Single AuNPsmoving through the glycocalix
288to reach the cytoplasm revealed the dynamic state of
289such structures (Figure 4B, arrows). Remarkably, this
290phenomena has been recently described in HeLa cells
291incubated with TAT-modified AuNPs: ultrastructural
292analysis showed NPs to freely negotiate intracellular
293barriers, moving from vesicles to cytoplasm in either
294way by direct membrane translocation.33 Our study
Figure 3. Ultrastructural analysis of AuNP-siRNA uptake. Polyps were treated with AuNP-siRNA for (A) 5 min, (B,C) 30 min,
(D!F) 24 h, then carefully washed andprocessed for TEM. Thin sectionswere obtained cutting the animal at themid gastric or
subhypostomal (below the mouth) level, as shown schematically in the upper part of image A. After 5 min, the ﬁrst
interactions between AuNP and Hydramembranes are not detectable, while after 30 min, at higher magniﬁcation (B and C),
single NPs or clusters of 2!3 units are detected in close proximity of the plasma membrane or within it (indicated by black
arrows). In panels D and E images at increasing magniﬁcation show AuNP-siRNA located within a dense cytosol region, likely
representing a lysosome. In this environment, NPs are not degraded. (F) AuNP-siRNA are detected after 24 h of incubation on
the membrane of interstitial cells (is). This single stem cell is located in the interstices between ectodermal cells close to the
mesoglea (m), which separates ectoderm (ect) from the endoderm (end). AuNP-siRNA are found also on the mesoglea,
indicating the capability of the NP to reach several tissue districts from the original ectodermal delivery. Scale bars: (A) 2 μM;
(B) 0.5 μM; (C) 0.2 μM; (D) 5 μM; (E) 0.5 μM; (F) 2 μM.
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295 also shows AuNP-N3 directly crossing intracellular or
296 plasma membranes (Supporting Information, Figure
297 S5), as observedwith AuNP-siRNA, suggestingmultiple
298 mechanisms governing the permeability of cell mem-
299 brane to AuNPs, and the possibility of identical routes
300 for different chemical functionalities. The most intri-
301 guing finding was observed at the 24 h time point
302 analysis (Figure 4D!F), where AuNP-N3 were found
303 massively packed into micrometer-sized granular struc-
304 tures,mixed toglycocalix/subcellular debris components.
305 These structures, responsible for the punctuated pattern
306 observed by optical microscopy (see Figure 1I!P), may
307 arise from inward budding of themembrane limiting the
308 endosomal-like structures, as described in mammals.2
309 Theoccurrenceof self-folding and fusion events between
310 multiple unitsmay account for the presence of glycocalix
311 components interspersed between theAuNP aggregates
312 (Figure 4E,F). Similar vesicles densely packed by AuNPs
313 have been described also in HeLa cells,33 suggesting a
314 conserved mechanism exploited by eukaryotic cells to
315 sort out foreign material. In Hydra they may represent
316 storage/garbage vacuoles, possibly due to the satura-
317 tion of the lysosomemachinery unable to sort out high
318 NP concentration. The current view of endosome and
319 lysosomes as dynamic organelles that repeatedly fuse
320each other and with cell membrane to either degrade,
321store, or secrete their content,34 makes at this stage
322several hypothesis possible. Our ultrastructural analysis
323of AuNP-siRNA or AuNP-N3 uptake indicates that the
324surface chemistry of the gold nanoparticles controls
325the efficiency of internalization but not themechanism
326itself. The positive surface charge does mediate the
327intimate contact between the nanoparticles and the
328cuticle (due to high binding affinity) greatly enhancing,
329together with the high dose, the uptake. Following this
330initial interaction, the same mechanisms of entry into
331the cells can be exploited by both nanoparticle func-
332tionalizations, either through endocytosis (including
333macropynocytosis) or direct membrane translocation.
334The active/passive nature of themechanismmediating
335NP penetration through the membrane and its depen-
336dence from the NP surface structure remains to be
337elucidated.
338Ultrastructural Evidence of AuNP-N3 Exocytosis. To get
339deeper insights into the events characterizing the up-
340take and fate of AuNP, we focused on AuNP-N3, avoid-
341ing the potential effect played by additional biomole-
342cules (size, structure, chemistry properties) on the uptake,
343and also because these NPs represent starting material
344for further functionalizations. A lower dose of AuNP-N3
Figure 4. Ultrastructural analysis of AuNP-N3 uptake. Hydra polyps were exposed to AuNP-N3 for (A!C) 30 min, (C!E) 24 h,
then extensively washed and processed for TEM. (A) At 30 min time points, AuNP-N3 were found attached to the glycocalix,
uniformly decorating the animal outer surface (gray arrows), but also inside large vacuoles (black arrow). (B) At higher
magniﬁcations the inner side of this structure appears lined by the glycocalix layer, proving the origin from membrane
invagination (gray arrows). AuNP-N3 are also captured coming out this structure (black arrow) by direct membrane
translocation toward the cytosol. (C) A close view of the AuNP-N3 entrapped into the vacuoles together with the glycocalix
components. (D) At 24 h time point a massive accumulation of AuNP-N3 into micrometer-sized vesicles is found. In images E
and F, higher magniﬁcations of such structures clarify the presence of membrane components in between the packed NPs,
suggesting multiple self-fusion and invagination events. Scale bars: (A,D) 10 μM; (B) 1 μM; (C,F) 0.5 μM; (E) 2 μM.
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345 was employed for animal treatment (25 nM) and the
346 analysis, extended along a wider temporal window,
347 performed by mean of high-pressure cryo-TEM, which
348 avoids ice-crystal formation and potential fixative arti-
349 facts, enabling ultrastructural description as close as
350 possible to the living state. In Figure 5F5 , representative
351 TEM images of a time course analysis (4!48 h) show
352 after 4 h incubation the selective binding of the nano-
353 particles to dense material within the inner glycocalix
354 layer, lining the round-shaped surface of a vesicle-like
355 structure (Figure 5A). At 8 h these NP-decorated vesi-
356 cles are found crossing the cell membrane (Figure 5B,C),
357 reaching at 14 h time point the cytosol (Figure 5D). The
358 cytosolic location of AuNP-N3 decreases after longer
359 incubation times. Indeed, at 24 and 48 h time points
360 AuNP-N3 were mainly found inside morphologically
361 distinguishable lysosomes, as single units or small clus-
362 ters (Figure 5E), indicating the lysosomal pathway as the
363 main intracellular fate. By counting the NP-containing
364 lysosomes, their percentage was found directly corre-
365 lated to the increase of the incubation time, reaching
366 90% of the total analyzed lysosomes at 48 h (Figure 5H).
367 Surprisingly, the finding at 48 h of nanozised vesicles
368 loaded with NPs outside the cell membrane (Figure 5F)
369 opened the possibility that beside their role as carriers
370 of AuNP from the external medium inside the cell, they
371 could also represent endosome recycled material
372 brought back to the cell membrane. In mammals the
373 fusion of multivesicular bodies with the cell membrane
374 may induce the release of 30!100 nm sized exo-
375 somes into the extracellular space.35,36 Extensive
376 investigations at this time point performed on at
377least five different animals (and an average of 20 ob-
378servations) confirmed AuNP-N3 associated to dense
379nanovesicles laying just outside the plasma mem-
380brane. This material appears secreted by ectodermal
381cells, as indicated by the frequent presence of empty
382vesicles of identical size on the cytosolic side of the
383cell membrane (Figure 5G and Supporting Informa-
384tion, Figure S6). The occurrence of secretory events is
385suggested also by the cell membrane morphology,
386appearing interrupted at different sites due to the
387external release of nanovesicles (see Figure S6). To
388further confirm the exocytosis pathway, a “pulse and
389chase” experiment was carried out. Living animals
390were incubated for 24 h with AuNP-N3, extensively
391washed, and incubated in fresh medium for a further
39224 h and 48 h before processing for TEM andelemental
393analysis. TEM images in Figure 6 F6clearly reveal, 24 h
394postincubation, vesicles containing NP in the apical
395part of the cell (Figure 6A), on the glycocalix layer
396(Figure 6B), and in the act of being released outside the
397cell (Figure 6C). Other images captured exocytosis by
398the shedding of vesicles densely packedwith AuNPs or
399mediated by multiple vesicle release through larger
400membrane areas (Figure 6D!F). As the lysosome con-
401tent can be directly released outside the cells (Sup-
402porting Information, Figure S7A), we conclude that
403multiple pathways may be employed for AuNPs secre-
404tion. A hypothetical scheme summarizing our experi-
405mental findings is presented in Figure 7 F7.
406Elemental Analysis Confirms Kinetic of Uptake and Clearance
407of AuNP. To quantitatively estimate the amount of
408AuNP-N3 internalized by Hydra and possibly the extent
Figure 5. High-pressure cryo-TEM reveals additional internalization pathways. Time course analysis of AuNP-N3 interaction
withHydra vulgaris. Polypswere incubated for the indicated periodswith 25 nMAuNP-N3. (A) Single distinguishable AuNP-N3
appear attached to nanosized vesicles outside the cell membrane, within the glycocalix (Glx). (B) Later on the vesicles are
found traversing the cell membrane (B,C) to reach (D) the cytoplasm. (E) At 24 and 48 h time point most of the AuNP-N3 are
detected inside lysosomes (Lys). (F,G) At 48 h nanosized vesicles loaded by NPs are also found outside the cell membrane. (H)
An estimation of the lysosome containing NPs (expressed as percentage ( SE) show that they increase from 8 to 24 h of
incubation, when most of uptaken NPs are delivered to lysosomes for degradation. The estimation was done at each time
point on 20 TEM images collected from three diﬀerent animals. Scale bars: (A,C,D,F,G ) 0.2 μM; (B,E) 1 μM.
A
RTIC
LE
MARCHESANO ET AL . VOL. XXX ’ NO. XX ’ 000–000 ’ XXXX
www.acsnano.org
G
Figure 7. Schematic representation summarizing inward and outward traﬃcking routes of AuNPs. Following AuNP exposure to
Hydra, several inward routes may be exploited by ectodermal cells, leading to AuNP internalization, illustrated on the left panel:
(i) direct membrane translocation, (ii) loading on nanovesicles, (iii) endocytosis (macropynocytosis) through large membrane
invaginations. These processes occur within 30 min to 24 h, when a massive recruitment of particles from diﬀerent cytoplasmic
districts into vesicle/vacuole structures is observed. From 24 to 48 h a dynamic exchange of particles between diﬀerent cell
compartments (late endosome/phagosome-lysosome) takesplace andAuNPs appear also tomoveout of vesiclemembranes. After
48 h of incubation AuNPs are found at a great extent in lysosomes, but also on exosome-like vesicles. We suggest that following
endosomal recruitment several outward routes may take place: (i) through exosomes (possibly derived by late endosomes),
(ii) directmembrane exocytosis of NP-loaded vesicles, (iii) fusion of lysosomeswith cellmembrane. In the scheme the black and red
arrows indicate the inward and outward routes, respectively, the dotted arrows indicate possible intracellular traﬃcking.
Figure 6. Exocytosis of AuNP-N3. Polyps were “pulsed” 24 h with AuNP-N3, extensively washed, and “chased” by incubation
for additional 48 h in fresh medium, before processing for TEM analysis. (A) AuNP-N3 are found on the apical part of the cell,
entrapped into nanosized vesicles that are released out of the animal (B,C). In image D a low magnitude image shows the
whole animal tissue section in the act of AuNP-N3 clearance. Other similarmembrane sheddingwithout NP are present on the
animal surface, proving the normal occurrence of this phenomena. The same region at higher magniﬁcation is shown in
image E. (F) Other tissue regions showing NP clearance. In this case a larger membrane area is involved, probably reﬂecting
lysosome exocytosis. Scale bars: (A!C) 0.2 μM; (D) 1 μM; (E,F) 0.5 μM.
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409 of the exocytosis, elemental analysis by mean of ICP-
410 AES (inductively coupled plasma atomic emission
411 spectroscopy) was performed on animals pulsed 24 h
412 with 25 nM AuNPs (corresponding to 1.25 mg), then
413 washed and chased in fresh medium for 24 and 48 h.
414 The Au content (calculated on 150 treated animals) at
415 the end of the pulse (24 h) was estimated as 93.7 μg,
416 namely 7.5% of the total dose used for treatment.
417 Following washing, the Au content decreased down
418 to 26.1 and 23.1 μg, respectively at 24 and 48 h time
419 points, indicating a 75% release of the internalized
420 material. Interesting, this massive release occurred
421 within the first 24 h of chasing, as after 48 h a quite
422 similar Au value was measured. From analysis of the
423 supernatants collected during the “chase” phase, low
424 but detectable Au amounts (0.8 μg) were found only at
425 24 h postwashing, confirming AuNP exocytosis mainly
426 occurring within this temporal window (see Table 2T2 ).
427 Although the number of animals employed for the ICP
428 was elevated (150), and the experiments were run in
429 duplicate, the measure of Au content by ICP-AES pro-
430 duces an estimation of the general trend of the en-
431 docytosis/exocytosis, and the calculated gold amounts
432 should not be considered as absolute to calculate the
433 real extent of these processes. Overall these findings
434 confirm the kinetics of AuNP entry/exit suggested by
435 the TEM images: AuNPs are moderately recruited into
436 vesicles within the first 24 h of incubation, and then
437 sorted out (1) to lysosomes for external release during
438 the following 24h, (2) tomore stable structures, possibly
439 representing storage vacuoles, discharging their con-
440 tent over a longer period. The unavailability ofmolecular
441 markers specific for Hydra storage/garbage vesicles
442 makes it impossible to further characterize the nature
443 of such structures.
444 CONCLUSIONS
445 The complexity of the molecular interactions under-
446 lying the endocytosis suggests that a great evolution-
447 ary eﬀort has been spent to regulate the cellular re-
448 sponse to a variety of diﬀerent environmental stimuli.
449 In multicellular organisms the endocytic and secretory
450 pathways evolved to control all aspects of cell physio-
451 logy and intercellular communication (immune response,
452development, hormone-mediated signal transduction,
453neurotransmission). Nanoparticles, being crystalline
454solids, can have inherently diﬀerent properties from
455other molecules, which might dictate diﬀerent me-
456chanisms regarding transmembrane transport, intra-
457cellular sorting and excretion. While much of the
458knowledge regarding the cellular uptake and fate of
459gold nanoparticles has been acquired through in vitro
460cell culture studies, and relies on the response of single
461cells to AuNPs, here we captured these dynamics
462in vivo, on a simple animal structured as a living
463bilayered tissue, presenting physiological connections
464among all cells exposed to NPs. We present direct TEM
465evidence of several ongoing mechanisms underlying
466inward and outward traﬃcking of AuNP tailored with
467diﬀerent molecules. The positive surface charge does
468control the early interaction with the cells, greatly
469enhancing the eﬃciency of uptake of AuNP-N3 com-
470pared to AuNP-siRNA, while the mechanisms of uptake
471are shared by the two diﬀerent functionalizations. In-
472terestingly, beside expected endocytosis and macro-
473pynocytosis (trapping of large ﬂuid pockets by forma-
474tion and enclosure of membrane invaginations), we
475showed at least two unusual internalization routes: (1)
476direct membrane translocation for both AuNP-N3 and
477AuNP-siRNA; (2) cell entry mediated by nanovesicles,
478enabled by the combination of the HP-TEM technique
479and the low AuNP concentrations. The nanovesicles
480may represent glycocalix structural components ex-
481ternally released (and thus NPs passively bind and
482follow the fate of such structures) or, alternatively, con-
483sidering their size and morphology, they may repre-
484sent exosomes, that is, endosomal-derived vesicles
485shipping extracellular messages, which may entrap
486AuNPs. The role of the exosomes in cell and animal
487physiology (immune response, cell signaling) has re-
488cently emerged,35 thus their labeling with AuNPs may
489provide a unique tool to elucidate their biogenesis and
490fate. TEM imaging performed at 24 and 48 h timepoints
491showed several cell compartments containing the NPs,
492spanning from early- to late-endosomes, to lysosomes. In
493addition, AuNPs were found in the act of endosome
494escaping and traversing intracellular membranes (i.e.,
495AuNP-siRNA present on membranes of interstitial cells),
496depicting multiple highly dynamic processes elicited in
497response to AuNPs, over the ﬁrst 24 h. The elemental
498analysis conﬁrmed the kinetic of internalization and in
499addition showed thatwithin48h,most of the internalized
500gold was cleared out the animal.
501The dynamic and kinetic of the whole journey of
502gold nanoparticles within an animal, is here reported
503for the ﬁrst time. On one hand, they perfectly mirror
504previous data obtained in mammalian cells, showing
505the conservation of such mechanisms throughout
506the animal kingdom, but, on the other hand, they
507extend the knowledge of new inward and outward
508mechanisms negotiating the entrance, traﬃcking,
TABLE 2. ICP-AES (Inductively Coupled Plasma Atomic
Emission Spectroscopy) Resultsa
time (h postwashing) intracellular Au content (μg) extracellular Au (μg)
0 93,74 ( 1.55 0
24 26,14 ( 1.20 0.819 ( 0.012
48 23,14 ( 0.42 0
a ICP-AES was performed on animals pulsed 24 h with 25nM AuNPs (corresponding
to 1.25 mg), then washed and chased in fresh medium for 24 and 48 h. At each time
point 150 animals (and 1 mL of their incubation medium) were collected and
processed for ICP-AES. Experiments were performed in duplicate. Values are
indicated as micrograms ( SE.
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509 and clearance of gold nanoparticles in animal cells.
510 This may have a profound impact in the design of
511nanodevices for biomedical application and in basic
512cell biology.
513
514 MATERIALS AND METHODS
515 Nanoparticle Synthesis. Hydrogen tetrachloroaurate (III) hydrate
516 (HAuCl4) was supplied by Strem Chemicals, and O-(2-aminoethyl)-
517 O0-(2-azidoethyl)pentaethylene glicol was supplied by Iris Biotech.
518 Citrate, γ-tiobutirolactone, triethylamine, dimethyl sulfoxide,
519 sodium dodecyl sulfate, and sodium hydroxide were pur-
520 chased from Sigma-Aldrich.
521 Synthesis of Citrate-Gold Nanoparticles (Au NPs). Gold na-
522 noparticles with an average diameter of ∼14 nm were synthe-
523 sized by the citrate reduction method as described.26 Briefly,
524 hydrogen tetrachloroaureate (III) hydrate (StremChemicals) (0.2
525 g; 0.589mmol) was dissolved in 500mL ofMilli-Q water, heated,
526 and stirred under reflux. When the solution boiled, sodium
527 citrate dihydrate (0.598 g; 2.03 mmol) was added resulting in a
528 red solution. The solution was kept under ebullition and protected
529 from light for 30 min, and then cooled down and kept protected
530 from light. The synthesized AuNPs were characterized by UV!vis
531 due to its surface plasmon resonance (λmax, 519 nm) and by
532 transmission electron microscopy.
533 Synthesis of N-(20-azido-3,6,9,12,15,18-hexaoxoicosane)-4-
534 mercaptobutanamide (HS-(CH2)3-CONH-EG(6)-(CH2)2-N3). For
535 the synthesis, 0.6 mmol of R-amine-ω-azido hepta(ethylene
536 glycol) were added to 12.5mL of dimethylsulfoxide under argon
537 atmosphere in a poly(ethylene glycol) bath at 50 !C and under
538 continuous stirring. Subsequently, 0.63 mmol of γ-tiobutirolac-
539 tone and 5.7 mmol of triethylamine were added. After 5 h, the
540 mixture was cooled down and lyophilized obtaining yellow oil.
541 The yield of the reaction was 93%, without any further purifica-
542 tion step. The product was characterized by FT-IR: 3301 cm!1
543 (NH st), 2870 cm!1 (!CH st), 2530 cm!1 (SH st), 2106 cm!1 (N3
544 st), 1663 cm!1 (CdO st). 1H-RMN 300 MHz (δ): 2,00 (m, 2H); 2,25
545 (t, 2H, J = 7,30 Hz); 2,65 (t, 2H, J = 7,00 Hz); 3,01 (s, 1H, SH); 3,32 (t,
546 4H, J = 5,00 Hz); 3,37 (t, 2H, J = 5,22 Hz); 3,59 (s, 22H); 6,60 (t, 1H,
547 J = 4,76 Hz), and mass spectroscopy [M!Hþ], 451.1.
548 Functionalization of AuNPsAuNP-N3. AAuNPsolution (10.7nM)
549 and HS-(CH2)3-CONH-EG(6)-(CH2)2-N3 (28 μM) was prepared the
550 presence of SDS (0.028% v/v). NaOHwas further added to a final
551 concentration of 25mM, and themixturewas incubated for 16 h
552 at room temperature with strong stirring (it is important to
553 follow this order of addition in order to avoid aggregation). The
554 excess of PEGylated chain was washed away by centrifugation
555 at 14000 rpm at 4 !C for 30 min times three. Z potential values
556 for this sample provided a value of þ21 mV (pH 7, 1 mM KCl).
557 MALDI-TOF analysis confirmed the presence of PEG-N3 ([M!Hþ],
558 451.1). The DLS measurement of AuNP-N3 was 15.5 nm.AuNP-
559 siRNA. AuNPs functionalizedwithHS-(CH2)3-CONH-EG(6)-(CH2)2-
560 N3, HS-EG(8)-(CH2)2!COOH, and siRNA were prepared following
561 the protocols previously published.25 Briefly, a mixture of 10 nM
562 of citrate!gold nanoparticles, 7 μM SH-EG(8)-(CH2)2-COOH and
563 7 μM SH-(CH2)3-CONH-EG(6)-(CH2)2-N3, and 0.028% SDS were
564 prepared. NaOH was further added to a final concentration of
565 25 mM and the mixture was incubated for 16 h at room tem-
566 perature. The excess of PEG chains was removed by centrifuga-
567 tion at 14.000 rpm for 30 min at 4 !C, and the supernatant was
568 discarded. This washing process was repeated three times, and
569 the pellet of AuNPs was dissolved in pure water.
570 For siRNA functionalization, the HS-siRNA previously treated
571 with DTT and puriﬁed was incubated at a constant concentra-
572 tion of 5 nmol/mL with RNase free solution of AuNP previously
573 functionalized with PEG (10 nM) containing 0.028% SDS (w/v).
574 Subsequently, the salt concentration was increased to 0.1 M
575 NaCl with brief ultrasonication following each addition to in-
576 crease the coverage of oligonucleotides on the nanoparticle
577 surface. Following 16 h incubation at 4 !C, the particles were
578 puriﬁed by centrifugation at 14000 rpm 30 min at 4 !C and
579 resuspended in DEPC-water 3 times.
580 The siRNA attached to the AuNP-siRNA was determined by
581 quantiﬁcation of the excess with the nucleic acid intercalator
582GelRed (Biotium), measuring its ﬂuorescence at 602 nm. It was
583found that 41.3 ( 0.8 strands/AuNP were bound.
584The sequence of the siRNA used targeting the Hydra myc 1
585gene (Accession No. GQ856263) is as follows. Sense: 50-thiol
586AAGAUGCUCACGCGUCAAGAAUU-30 . Antisense: 50-UUCUUGA-
587CGCGUGAGCAUCUU-30 .
588Animal Culturing and in Vivo Experiments. Hydra vulgaris (strain
589Zurich, originally obtained by P. Tardent), were cultured in
590Hydramedium (SolHy) comprising 1mMCaCl2, 0.1mMNaHCO3,
591pH 7.0, fed on alternate days with Artemia nauplii at 18 !C with
59212:12 h light. Polyps from homogeneous populations, three
593weeks old, were selected for experiments, performed in an air-
594conditioned environment at 22 !C. The tests were initiated by
595collecting groups of 10 animals in plasticmultiwells, followed by
596the addition of 70 nM AuNP (either AuNP-N3 or AuNP-siRNA) in
597300 μL of SolHy to each well and incubation for the necessary
598time periods. Nanoparticle uptake was monitored in vivo by a
599stereomicroscope (Olympus ZSXRFL2). Following extensive
600washes, in vivo imaging was accomplished by an inverted micro-
601scope (Axiovert 100, Zeiss) equipped with a digital color camera
602(Olympus, DP70). For imaging acquisition and analysis the soft-
603ware system Cell F (Olympus) was used. At the time indicated
604above, animals were taken and processed for TEM analysis.
605Hydra Cell and Tissue Analysis. Hydra polyps were macerated
606into a suspension of fixed single cells as reported.37 Animals
607were anaesthetized in 2% urethane in SolHy for 2 min. The
608relaxed andelongatedHydrawere fixedwith Lavdowsky's fixative
609(ethanol/formaldehyde/acetic acid/water as 50:10:4:40), rehy-
610drated, and mounted on microscope slides in glycerol 50% in
611PBS (8 g/L NaCl; 0.2 g/L KCl; 1.44 g/L Na2HPO4 3 7H20; 0.24 g/L
612KH2PO4).
613Tissue sectioning: Treated animals were soaked overnight in
61430% sucrose in PBS and then embedded in the frozen section
615medium Neg-50 (Richard-Allan Scientiﬁc). Cryosections of 10
616μm thickness were obtained by a cryostat (Leitz, digital 1760),
617collected on adhesion microscope slides (SuperFrost Plus,
618Menzel) mounted in DAKO mounting medium (DAKO) or
619dehydrated in ethanol, equilibrated in xylene and mounted in
620D.P.X (Sigma) before imaging.
621Transmission Electron Microscopy Analysis. Following exposure to
622nanoparticles, animals were extensively washed, then treated
623with 2% urethane in SolHy to prevent contraction and fixed for
6242 h in 2% glutaraldehyde in SolHy. Samples were washed at
625least four times with SolHy and postfixed for 45 min with 1%
626buffered OsO4. After a series of four washes in SolHy, animals
627were dehydrated in a graded ethanol series (30%, 50%, 70%,
62890%, 100%), incubated 3 # 15 min with propylene oxide and
629then overnight in a 1:1mixture of propylene oxide/Epon 12 resin.
630Before they wereflat embedded, the animals were incubated 2#
6312 h in Epon 12 resin. Serial thin sections (70 nm) prepared from
632animal tentacles and body regions below the head level were cut
633with a diamond knife and mounted onto 150!200 mesh Hex
634grids. Thin sections were stained with uranyl acetate and lead
635citrate. Ultrathin sections were examined with a Leo 912 AB
636transmission electron microscope operating at 80 kV.
637Sample Preparation for High-Pressure Freezing Procedure
638(HPF). Hydra polyps immersed in SolHy were dissected into
639appropriate pieces to fit into cup-shaped HPF specimen carriers.
640Tissue pieces were pipetted with SolHy into a 0.2- or 0.3-mm
641deep carrier and covered with an additional carrier. Finally, the
642obtained sandwiches were cryo-immobilized by HPF. Frozen
643sandwiches were transferred into appropriate containers for
644storage in liquid N2 for later use or subjected to freeze substitu-
645tion (FS). The frozen samples were transferred under liquid N2
646into cryovials containing frozen FS cocktails (anhydrous acetone
647plus 1% OsO4 and 0.1!0.2% uranyl acetate). Subsequently, the
648lids were screwed loosely onto the vials to permit safe evapora-
649tion of excess N2 gas. The vials were placed into the precooled
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650 FS device, and after about 1 h the lids were tightened and
651 FS was performed for at least 8 h at!80 to!90 !C; warming up
652 to!55 !C at a rate of 5!10 !C per hour, subsequent postfixation
653 and staining at!55 !C for 6 h, followed bywarming up to!30 !C
654 at a rate of 5!10 !C per hour where samples were left for an
655 additional 3 h.38 Finally the samples were washed 3# with
656 acetone (10min each), 16 h in 10%epoxy resin (Epon) in acetone,
657 6 h in 30% Epon in acetone, 16 h in 70% Epon in acetone, 6 h in
658 100% Epon in acetone, and finally 16 h in 100% Epon in acetone.
659 Then the samples were placed in fresh resin and placed in an
660 oven at 60 !C overnight.
661 Sample serial thin (70 nm) sections of tentacles and body
662 regions were cut with a diamond knife and mounted onto
663 150!200 mesh Hex grids. Ultrathin sections were examined
664 with transmission EM Libra 120 EFTEM (Zeiss, Oberkochen,
665 Germany) at 80 eV.
666 Elemental Analysis by Inductively Coupled Plasma Atomic Emission
667 Spectroscopy (ICP-AES). To estimate the extent of endocytosis and
668 exocytosis of AuNP-N3 in Hydra, living polyps were treated 24 h
669 with AuNP, washed, and processed for elemental analysis to
670 evaluate the amount of Au present inside the animals and
671 released in the medium. A total of 1500 Hydra polyps were
672 incubated in 3 mL of SolHy with 25 nM AuNP-N3 for 24 h. At this
673 time point 150 polyps were extensively rinsed and homoge-
674 nized for ICP-AES. The remaining animals were kept in fresh
675 medium and saved at 24 and 48 h postwashing. For each time
676 point the same amount of polyps (150) and incubation media
677 were saved. Experiments were done in duplicate. For ICP-AES
678 measurements, all the sampleswere treatedwith 400 μL of aqua
679 regia overnight and then diluted with Milli-Q water to 20 mL to
680 reach a final concentration of acid 2% (v/v).
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N
anoparticles exhibit excellent phys-
icochemical properties for applica-
tion in drug delivery, namely, their
reduced sizes, rendering them capable of
interacting with biomolecules in a one-
to-one scale, and the high surface-to-volume
ratio allowing for surface functionalization
with a plethora of molecules for speciﬁc
targeting and drug payloads.1,2 Among
the numerous nanoparticle formulations
designed to improve siRNA3,4 delivery and
eﬃciency, those based ongoldnanoparticles
(AuNPs) have been extensively investigated
without undesirable immune response or
oﬀ-target eﬀects.5!15 To our knowledge, with
the exception of one report on AuNPs for
systemic administration of siRNA in humans,16
over the last 6 years, formulations using
AuNP-siRNA have solely been tested in cell
cultures targeting reporter genes, such as
luciferase or green ﬂuorescence protein.17
However, as with any drug treatment, gene
therapy vehicles need extensive testing in
archetypal animal models before translation
into the clinics, and this requires the coordi-
nated eﬀort of interdisciplinary research
groups.18
Here we used a functional comparative
approach to assist the smart design, synth-
esis, and testing of a library of multifunc-
tional nanodevices for RNAi, resulting in a
nanocarrier based on AuNPs as the delivery
system, with demonstrated functionality
both in vitro and in vivo for RNAi-based
therapy. Several biochemical moieties, cell
penetrating and cell adhesionpeptideswere
selected to enhance cellular recognition and
uptake and confer speciﬁc downregulation
of gene expression. The c-myc protoonco-
gene, a key gene playing a pivotal role in cell
cycle and tissue homeostasis,19 was selected
as RNAi target; poly(ethylene glycol) (PEG)
molecules were incorporated to guarantee
nanoparticle stability and avoid unspeciﬁc
interactions, and three in vitro/in vivomodel
systems were selected: human cells (HeLa),
freshwater polyps (Hydra vulgaris), and
* Address correspondence to
c.tortiglione@cib.na.cnr.it,
jmfuente@unizar.es.
Received for review July 6, 2012
and accepted August 12, 2012.
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ABSTRACT Over the past decade, the
capability of double-stranded RNAs to
interfere with gene expression has driven
new therapeutic approaches. Since small
interfering RNA (siRNAs, 21 base pair
double-stranded RNA) was shown to be
able to elicit RNA interference (RNAi),
eﬀorts were directed toward the devel-
opment of eﬃcient delivery systems to
preserve siRNA bioactivity throughout the
delivery route, from the administration
site to the target cell. Here we provide evidence of RNAi triggering, speciﬁcally silencing c-myc
protooncogene, via the synthesis of a library of novel multifunctional gold nanoparticles (AuNPs).
The eﬃciency of the AuNPs is demonstrated using a hierarchical approach including three
biological systems of increasing complexity: in vitro cultured human cells, in vivo invertebrate
(freshwater polyp, Hydra), and in vivo vertebrate (mouse) models. Our synthetic methodology
involved ﬁne-tuning of multiple structural and functional moieties. Selection of the most active
functionalities was assisted step-by-step through functional testing that adopted this hierarchical
strategy. Merging these chemical and biological approaches led to a safe, nonpathogenic, self-
tracking, and universally valid nanocarrier that could be exploited for therapeutic RNAi.
KEYWORDS: gold nanoparticles . RNA interference . animal models .
biofunctionalization . c-myc . cancer
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mouse (C57BL/6j) (Figure 1). This chemical and biological
strategy allowed us to compare the eﬀect of the siRNA
linkage to the NPs and the eﬀect of cell penetration and
adhesion peptides, ﬁnally leading to an optimally de-
signed nanocarrier for RNAi therapeutic purposes.
RESULTS AND DISCUSSION
Stable AuNPswith an average diameter of 14( 1 nm
were synthesized by reduction of sodium tetra-
chloroaurate(III) hydrate with sodium citrate dehydrate
(Figure S1 of Supporting Information). To increase the
stability, biocompatibility, and grant chemical func-
tionality, AuNPs were functionalized with two types
of thiolated poly(ethylene glycol) (PEG) spacers: a com-
mercial carboxylated spacer, SH-EG(8)-(CH2)2-COOH,
and an azide-containing spacer custom synthesized
in our lab, SH-(CH2)3-CONH-EG(6)-(CH2)2-N3. The car-
boxylated spacer provides the anchoring moieties for
the covalent binding of amine-containing molecules
through carbodiimide chemistry, while the azide-
containing spacer confers positive Z-potential values,
which is a crucial factor for cell uptake. Combined
functionalization of the AuNPs with both spacers was
ﬁnely tuned by controlling both speciﬁc spacer com-
position and degree of saturation (Figure S2). In order
to elucidate the most eﬃcient strategy to bond siRNA
to AuNPs, two types of AuNPs stabilized by diﬀerent
degrees of PEG saturationwere selected: (i) NP-ionwith
100% coverage (25% azide-containing spacer and 75%
carboxylated spacer); (ii) NP-cov with 25% coverage
(50% of either spacer). These AuNP formulations re-
presented the basic nanoparticles for downstream
functionalization with c-myc siRNA, using either ionic
interaction (ION) or covalent binding (COV). Both were
initially tested for biocompatibility and toxicity in two
human cancer cell lines (MCF-7 and HeLa). Cell survival
rates following AuNP exposure were determined via
MTT, with no cytotoxicity detected up to 48 h of
incubation with either NP-ion or NP-cov (Figure S5).
Further functionalization of these nontoxic AuNPs with
c-myc siRNA and the HIV-derived TAT peptide was
performed.20 In the ION method, quaternary ammo-
nium groups (R4N
þ) were bound to AuNPs through
carbodiimide chemistry between the carboxylated
spacer and (2-aminoethyl)trimethylammonium hydro-
chloride. Ionic interactions between the negatively
charged siRNA backbone and both the azide and
quaternary ammonium positively charged groups en-
sured binding of siRNA onto the NP surface for the
whole pH range. In the COV method, thiolated
siRNA was bound via a thiol bond to AuNPs with a
nonsaturated PEG layer. The TAT peptide was bound
to NP-ion and NP-cov by EDC/NHS coupling between
the carboxylated spacer and the amine terminal
group of the KKKGRKKRRQRRR (KKK-TAT) peptide.
The binding eﬃciency of each functional group was
determined by Bradford assay, alongside detailed
Figure 1. In vivo gene silencing through nanoparticle-mediated RNAi. The nanocarrier is a AuNP functionalized withmultiple
biomolecules: PEG, cell penetration and cell adhesion peptides, and siRNA. Two diﬀerent approaches were employed to
conjugate the siRNA to the AuNP: (1) covalent approach, use of thiolated siRNA for gold!thiol binding to the nanoparticle;
(2) ionic approach, interactionof thenegatively charged siRNA to themodiﬁed surface of theAuNP through ionic interactions.
A hierarchical scheme employed three biological systems of increasing complexity: cultured cells (HeLa), freshwater polyp
(Hydra vulgaris), andmouse (C57BL/6j) to screen the synthesized nanocarrier library and select the ideal engineeredAuNP for
the delivery of siRNA to block gene function.
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AuNP assay characterization (Supporting Information).
All AuNP bioconjugates presenting at the surface
siRNA and/or TAT/RGD and/or quaternary ammonium
groups (R4N
þ) in various combinations were chara-
cterized by transmission electron microscopy (TEM),
UV/vis spectroscopy, surface plasmon resonance
(SPR) shift, and zeta-potential (see Figure 2). To deter-
mine cell uptake and intracellular fate, HeLa cells
were incubated with the functionalized AuNPs for
18 h and processed for TEM analysis. Results show
that both NP-ion and NP-cov conjugates were found
isolated or as small aggregates in the cytoplasm
(Figure 3b,c).
To permit rapid screening of the large variety of
functionalized AuNPs in terms of c-myc RNAi, the
c-myc gene sequence was cloned into a psiCHECK-2
vector downstream of the Renilla luciferase reporter
(Figure S4). This construct was stably expressed in HeLa
cells, and the decrease in luciferase activity, as conse-
quence of RNAi, was quantiﬁed by a luminescence
assay. Figure 3d shows normalized luciferase activity
of each AuNP conjugate, where both synthetic ap-
proaches used to bind siRNA onto the AuNP (ION
versus COV) show comparable silencing eﬃciency,
matching that attained via the transfection of naked
siRNA with lipofectamine. Control experiments utilized
Figure 2. Physicochemical characterization of AuNPs. TEM analysis of (a) NP-cov@myc-siRNA, (b) NP-cov@TAT@myc-siRNA,
(c) NP-ion@R4N
þ@myc-siRNA, (d) NP-ion@R4N
þ@TAT@myc-siRNA. The stabilization eﬀect of the diﬀerent functional groups
on the multifunctional AuNPs can be observed via examination of the optical properties by UV!vis spectroscopy (e,f):
absorption band of the resulting AuNPs appeared at(520 nm due to the surface plasmon resonance (SPR) of the AuNPs. The
spatial arrangement of AuNP can be inferred bymeasuring the shift of a characteristic SPR band dependent from size, shape,
aggregation state, and medium polarity. The SPR of the AuNPs shown in e and f insets exhibited a red shift from 520 to
525 nm: a 3 nm shift for TAT/RGDpeptides binding and a 5 nm shift for siRNA binding indicating successful binding of several
groups. (g) Quantiﬁcation of the PEG chains, TAT and RGD peptides, and siRNA strands is shown for all bioconjugates,
together with the Z-potential measurements.
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a nonrelated siRNA (cont-siRNA) that does not induce
downregulation of luciferase or c-myc. These results
clearly show the eﬀective capability of the functiona-
lized AuNPs to speciﬁcally and selectively silence
c-myc gene expression. With regard to NP-ion design,
Figure 3d depicts the importance of including R4N
þ
moiety to introduce ionic interactions between the
positively charged NPs and the negatively charged
siRNA. Absence of R4N
þ did not induce any silencing,
suggesting a possible proton-sponge eﬀect played
by the carboxylic and quaternary ammonium groups,
which could be responsible for endosome rupture
and release of the trapped materials (siRNA) into
the cytoplasm.21 Also, addition of the TAT peptide
branched on NP-ion@R4N
þ@myc-siRNA showed neg-
ligible eﬀects when compared to the same NP with-
out TAT, probably due to steric hindrance of siRNA.
Concerning the NP-cov@myc-siRNA, their eﬃciency in
achieving RNAi might result from increased stability of
the siRNA covalently bound to the gold core compared
to their stability when adsorbed by electrostatic inter-
action on the NP surface. However, the possibility that
the strong eﬃciency of this adduct might depend
on cytoplasmic release of the siRNA (due to the redu-
cing environment of the cytoplasm acting on the thiol
bonds) and prompt availability to trigger the RNAi
machinery cannot be excluded. When branched on
NP-cov@myc-siRNA, the TAT peptide again decreased
the RNAi eﬃciency from 73 ( 11 to 43 ( 7%. These
data support the hypothesis that the TAT peptide may
act as a suppressor of the RNAi response, as previously
reported,22 which might be related to the fact that this
virally derived peptide has evolved to naturally bypass
cell defense mechanisms. In summary, despite the low
AuNP concentration used (2.1 nM AuNPs, 2 pM siRNA),
following conﬁrmed cell uptake via TEM (Figure 3b,c),
it was able to trigger a very eﬃcient RNAi, likely due to
the ampliﬁcation of the siRNA signal in vivo, as else-
where reported.23
Prior to testing the eﬃciency of the multifunctional
nanocarrier for c-myc RNAi on an archetypal animal
model, we used a simpler and more singular inverte-
brate model, Hydra vulgaris (Cnidaria, Hydrozoa), to
allow for further ﬁne-tuning of the nanocarrier. Thus,
following successful silencing in the cell model, the
eﬃciency of both NP-ion andNP-covwere evaluated in
the Hydra in vivo model. The increase in complexity of
the animal model, in fact, could enable us to select the
more appropriate nanocarrier to test inmouse.Hydra is
a freshwater polyp whose structural anatomy reﬂects
a tissue grade of organization (body composed of two
cell layers; absence of either proper organs, or central
Figure 3. Internalization and eﬃciency of c-myc RNAi induced by functionalized AuNP in HeLa cells. (a) Renilla luciferase was
used as the primary reporter gene, and the c-myc gene was cloned into a multiple cloning region located downstream of the
Renilla gene. Initiation of the RNAi process by synthetic myc-siRNAs results in cleavage and subsequent degradation of the
fusion mRNA. Measuring decreases in Renilla activity provides a convenient way of monitoring the RNAi eﬀect. This vector
also contains a second reporter gene, Fireﬂy luciferase, which functions as an internal control for reporter gene activity
(scheme adapted from Promega psiCHECK vectors). (b,c) TEM images of cells treated with NP-cov@myc-siRNA (b) and NP-
ion@myc-siRNA (c) show NPs present in the cytoplasm as single units, supporting the correct delivery of siRNA to initiate
RNAi. (d) Quantitative assessment of RNAi eﬃciency. HeLa cells were transfected with the recombinant vector psiCHECK-2,
encoding for the fusion protein Renilla luciferase-myc. Decrease of Renilla luciferase activity induced by c-myc-siRNA was
expressed as percentage of normal luciferase activity. Unrelated siRNA (cont-siRNA) bound on the AuNPs; naked or
lipofectamine delivered siRNA were included as negative and positive RNAi controls, respectively. Data marked with
asterisks are statistically signiﬁcant relative to the corresponding NP-ion/cov with control siRNA as calculated by paired
Sample t test (**, P e 0.0001; *, P e 0.001).
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nervous system), but exhibiting behavior and physiol-
ogy proper of animals (Figure 4a and Figure S6 of
Supporting Information). Reliable methods have been
developed for a comprehensive analysis of nanoparti-
cle impact in Hydra, spanning from in vivo analysis
induced by nanoparticle treatments (structural mor-
phological changes, impact on reproductive rate, eﬃ-
ciency of regeneration) to in vitro approaches of cell
biology, microscopy, and molecular biology to investi-
gate the internalization routes and the genotoxic
eﬀects.24,25
Moreover, the Hydra c-myc (Hymyc) homologue
gene function has been recently identiﬁed,26,27 allow-
ing to functionally test the RNAi eﬃciency. NP-ion
and NP-cov were initially tested for biocompatibility
and toxicity by measuring the impact on population
growth rate,25 showing the absence of toxic eﬀects
(Figure S7). Optical microscopy showed that both
NP-ion and NP-cov were internalized at low rate by
ectodermal cells, facing the animal outer plane
(Figure 4b and Figure S3), and TEM analysis was
necessary for subcellular localization of AuNPs. In
Figure 4c, TEM images on thin sections from animals
incubated 30minwithNP-cov@myc-siRNA shownano-
particles bound to the membrane glycocalix, as
single units or small clusters passing through the
bilayer structure of the cell membrane. After 24 h of
incubation, AuNPs were found in the cytoplasm, clus-
tered or monodispersed, demonstrating their capabil-
ity to cross biological membranes and shuttle siRNA
into the cytoplasm (Figure 4d). Hymyc silencing eﬃ-
ciency was assessed using the AuNPs recommended
following HeLa silencing (NP-ion@R4N
þ@myc-siRNA,
NP-ion@R4N
þ@TAT@myc-siRNA, NP-cov@TAT@myc-
siRNA, NP-cov@myc-siRNA). The qRT-PCR results in
Hydra further restricted the selection of bioactive AuNP
conjugates previously identiﬁed in HeLa cells: only two
of those nanoparticles induced Hymyc gene silencing,
NP-ion@R4N
þ@myc-siRNA and NP-cov@myc-siRNA,
which rise up to 80% of gene downregulation in the
case of the covalent conjugate (Figure 4e). TAT peptide
(initially employed to enhance the cell permeability),
but causing a decrease in the RNAi eﬃciency of the
NP-cov conjugates in HeLa cells, completely inhibited
Figure 4. Hymyc RNAi in Hydra vulgaris. (a) Representative images of living polyps of Hydra vulgaris (scale bar 0.5 mm).
(b) Bright-ﬁeld image of Hydra treated 24 h with NP-cov@myc-siRNA (scale bar 200 μm). Nanoparticles appear as dark spots
on the Hydra ectodermal cells. Same uptake was observed for NP-ion@myc-siRNA (Supporting Information Figure S3). (c,d)
TEM images of Hydra tissues, prepared from polyps treated with 15 nM of NP-cov@myc-siRNA for 30min (c) and 24 h (d). NPs
are detected as single unit or small clusters into the cytoplasm for correct delivery of siRNA. Scale bar: 0.2 μm (c) and 0.5 μm
(d). (e) Molecular assessment of RNAi eﬃciency by qRT-PCR using 15 nM AuNPs and 25 polyps in 100 μL of Hydra medium.
Hymyc relative expression upon incubation with NP-ion and NP-covwas compared to naked siRNA. Relative gene expression
changes fromNPs not carrying c-myc siRNA are shown as gray bars, while those induced by Hymyc siRNA functionalized NPs
are colored red. Data aremeans of three independent experiments from three biological replicates; error bars show standard
deviation. Data marked with asterisk are statistically signiﬁcant relative to the corresponding NP-ion/cov without siRNA as
calculated by paired sample t test (*, P e 0.005).
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the RNAi process in Hydra, further suggesting that TAT
RNAi suppressor activitymay be conserved throughout
the animal kingdom.22 Those AuNPs unable to induce
gene silencing in cells were also ineﬀective in Hydra,
conﬁrmed by analysis of gene expression (Figure 4e).
Finally, the two AuNPs identiﬁed as inducing c-myc
silencing in both HeLa and Hydra, NP-ion@R4N
þ@myc-
siRNA and NP-cov@myc-siRNA, were tested in the
more complex in vivo mouse model. Both AuNPs
were administered to 10!12 week aged female mice
(n = 6!8 animals) by intratracheal instillation. While
intravenous administration is themostpopular choice in
clinical studies, an oral route inhalation or intratracheal
instillation mode, together with intranasal drug deliv-
ery, convection-enhanced diﬀusion, and intrathecal/
intraventricular drug delivery systems has been gain-
ing considerable attention. Intratracheal instillation
of nanoparticles becomes an important criterion of
consideration to overcome the physiological barriers
of the lung and to achieve locally high drug concentra-
tions for pulmonary diseases. In our case, the choice
was also dictated by the siRNA loaded on the AuNP,
targeting the c-myc gene. As this oncogene is deregu-
lated in lung cancer, in a future study of lung cancer
treatment, this administrationmodemight allow prop-
er deliver of therapeutic siRNA to the target organ.
After 7 days from instillation, mice were dissected
for bronchoalveolar lavage (BAL cells) and lung
tissue extraction. In general, NPs of size <100 nm and
diﬀerent zeta-potential display toxic eﬀects, due to
trade-oﬀ between drug potency and immunologic
surveillance.28,29 In fact, the inﬂuence of size, solubility,
and surface modiﬁcation on the biocompatibility of
nanoparticles and their use in biological applications is
well-known. NPs have a proclivity in vivo and in vitro to
bioaccumulate within various types of cells with a
special aﬃnity for macrophage-type cells and reticu-
loendothelial cells throughout the body. In order to
select safe material for drug delivery, toxicity studies of
both NP-cov and NP-ion sets were performed in mice
following 1, 3, and 14 days of treatment by the evalua-
tion of the number of macrophages, neutrophils,
and lymphocytes, in which an increase indicates an
inﬂammation process. Results showed negligible ad-
verse eﬀects using a low instillation dose (16 nM)
(Supporting Information, Figure S8). However, the
qRT-PCR performed on four lung samples of each
groups, instilled with this dose of NPs, showed very
low gene downregulation (Figure 5c), probably due to
a lack of NPs' selectivity to the target cells. The func-
tional studies performed in in vitro cell culture and in
living Hydra provided feedback for improving the de-
sign and synthesis of AuNPs@siRNA targeting mouse.
To this aim, the cell adhesion peptide RGD was incor-
porated on the AuNP to reinforce cell!NP interaction
and drive lung-speciﬁc uptake. RGD integrin ligand is
well-known for its capability to bind to the integrin
Rvβ3 receptor family,30 involved in a wide range of
cell!extracellular matrix and cell!cell interactions. Pre-
vious studies have demonstrated RGD eﬃciency to
promote NP!cell adhesion events.31 RGD-containing
peptides were conjugated to both NP-ion and NP-cov,
Figure 5. c-myc RNAi inmouse. (a,b) TEM images of lung epithelial cells. Mice (C57BL/6j strain)were treatedwith 16 nMof NP-
cov@RGD@myc-siRNA by intratracheal instillation. At 4 h (a) after instillation, NPs are located in ruﬄes of lung epithelial cell
membranes and a fewNPs are in the vesicles. At 18 h (b), huge amounts of NPs are found in vesicles or free in cytoplasm (scale
bars 500 nm). (c) Molecular assessment of RNAi eﬃciency. To quantify eﬃciency of silencing, total RNAs from lung tissue (four
mice treated with each NP type) were extracted after 48 h and analyzed by qRT-PCR. The c-myc expression levels were
determined using β-actin as reference gene. Data marked with asterisks are statistically signiﬁcant relative to the
corresponding NP-ion/cov without siRNA as calculated by paired sample t test (*, Pe 0.001; **, Pe 0.01). (d,e) c-myc protein
expression on alveolar epithelial cells in lung tissue after 48 h treatment. (d)Mice instillatedwith 16 nMNP-cov@RGD, (e)mice
instillated with 16 nM NP-cov@RGD@myc-siRNA. The c-myc protein was detected by Alexa-488-conjugated anti-c-myc
antibody (green), and cell nuclei were DAPI stained (blue). Scale bars 200 μm.
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in the presence or absence of c-myc siRNA, by EDC/
NHS coupling between the carboxylated spacer and
the primary amine in the RGD peptide (Supporting
Information). Mice were treated as previously indi-
cated. TEM analysis on lung epithelial cells revealed
the eﬃcient uptake of NPs conjugated with RGD
with suﬃcient cytoplasmic availability (Figure 5a,b) to
initiate RNAi. The qRT-PCR results showed a 65.2 (
6.7% c-mycdownregulation inducedbyNP-cov@RGD@
myc-siRNA and 34.9 ( 19% c-myc silencing by NP-
ion@R4N
þ@RGD@myc-siRNA. These results conﬁrm the
speciﬁcity of the RNAi approach. Immunolocalization of
the MYC protein on alveolar epithelial cells in lung
tissue from mice treated with NP-cov@RGD@myc-siR-
NA conﬁrmed decreased MYC protein accumulation in
lung tissue, unequivocally demonstrating the bioactiv-
ity of the multifunctional NP (Figure 5d,e).
Remarkably, the same NP-cov@siRNA adduct was
shown to elicit highest RNAi in HeLa cells, Hydra
vulgaris, and mouse, with the only exception of the
RGD presence when testing on mouse, as it is not
expressed in Hydra. From an evolutionary point of
view, having found that gene silencing in this primitive
animal is accomplished by the same nanocarrier work-
ing on human cell cultures and mouse, underlines not
only the conservation of key molecular pathways
throughout animal evolution but also the conservation
of the basic chemicophysical interactions between
nanoparticle and the living world, Hydra bridging the
gap between cell cultures and complex models.
CONCLUSION
In this study, we show that two balanced formula-
tions (ionic and covalent approaches), in terms of
stability/electrostatic interactions, designed to pro-
duce smart multifunctional nanostructures succeeded
to generate new innovative and versatile tools for
eﬃcient RNA interference in eukaryotic systems. Using
three biological models of increasing complexity
(cultured cells, invertebrate, and mammal), both de-
sign and validation of multifunctional nanocarriers
capable of selectively and speciﬁcally delivering siRNA
in vivo were demonstrated. This functional screening
approach allowed us to ﬁnely tune concentrations,
bonding, and the combination of diﬀerent chemical
groups on the nanoparticle surface, addressing current
ethical issues on unnecessary, cost-eﬀective, and time-
consuming vertebrate testing. These multifunctional
nanocarriers are robust enough to preserve stability
without showing acute toxicity or cell viability impair-
ment while simultaneously able to bypass biological
barriers to perform RNAi activity without oﬀ-target
eﬀects. Our universal nanocarrier represents a valid
gene delivery platform that can be exploited for clinical
application in the near future. While treatment of a
lung cancer mouse model might represent the ﬁrst
therapeutic test of the nanocarrier developed here, the
simple change of the siRNA sequence might target the
same device to a huge range of diseases, strengthen-
ing the way to clinical application of RNAi.
METHODS
We divided the methods into similar parts for each system
(except for the synthesis). Full description of methods can be
found in Supporting Information.
Synthesis and Functionalization of Gold Nanoparticles. AuNPswith a
diameter of 14( 1 nmwere synthesized by the citrate reduction
method described by Lee and Meisel.32 A mixture of AuNPs,
0.028% SDS, and SH-EG(8)-(CH2)2-COOH (Iris-Biotech) and
SH-(CH2)3-CONH-EG(6)-(CH2)2-N3 in the adequate ratio for NP-
ion and NP-cov was mixed under basic conditions for 16 h.
PEGylated AuNPs were obtained after purification by centrifuga-
tion. Number of PEG molecules was carried out by Ellman's
method. Further chemical functionalization with quaternary
ammonium ((2-aminoethyl)trimethylammonium chloride hy-
drochloride), TAT, and RGD peptides was carried out by EDC
(1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (Sigma) and
sulfo-NHS (sulfo-hydroxysuccinimide) (Sigma) chemistry at pH
6.1 (25mMMES). Quantificationof TATpeptideswasobtainedby
Bradford assay (CA). AuNP functionalization with siRNA (Thermo
Scientific Dharmacon) was taking place using unmodified siRNA
for NP-ion by mixing them with NP-ion@R4N
þ@TAT during 16 h
at 4 !C. For NP-cov, thiolated siRNA was incubated with NP-
cov@TAT containing 0.028% SDS and 0.1 M NaCl. Excess siRNA
was removed by centrifugation at 4 !C. siRNA quantification was
carried out by fluorescence measurement (Perkin-Elmer LS55)
using a GelRed (Biotium) acid nucleic intercalator (see Support-
ing Information, Table 1, for siRNA sequences).
Hydra Culturing. Hydra vulgaris (strain Zurich, originally ob-
tained by P. Tardent) were asexually cultured in Hydra medium
(1 mM CaCl2, 0.1 mM NaHCO3, pH 7). The animals were kept at
18 ( 1 !C and fed three times per week with freshly hatched
Artemia salina nauplii. In vivo imaging was accomplished at
several magnifications by using both a stereomicroscope and
an inverted microscope (Axiovert 100, Zeiss).
Transmission Electron Microscopy. To visualize the cellular up-
take of NPs, HeLa cells were incubatedwith all NPs for 18 h. Mice
were treated with NPs for 4 and 18 h. Mice were sacrificed and
mice lungs fixed in 2.5% glutaraldehyde for TEM. For Hydra,
polyps were treated with 2% urethane in Hydra medium and
then fixed for 2 h in 2% glutaraldehyde in Hydra medium.
Samples were postfixed in 1% buffered OsO4 followed by 0.5%
uranyl acetate for 1 h and then taken through alcohol dehydra-
tion increments and left in resin (propylene oxide Epon 812
resin mix (1:1) for cells and propylene oxide/Epon 12 resin mix
(1:1) forHydra) overnight. Cell layers were captured in pure resin
and cured overnight in an oven. Hydra were incubated 2 # 2 h
in Epon 12 resin. Blocks were then cut into ultrathin sections,
stained with 2% methanolic uranyl acetate and Reynolds lead
citrate, and viewed under a Leo 912 AB TEM (120 kV for cells and
80 kV for Hydra).
Toxicity. Cellular cytotoxicity was assessed by standard MTT
assay (Invitrogen). Hydra growth rate was calculated to monitor
NP toxicity, as previously described.25 Toxicity in mice was
assessed by enumeration of total differential cells in bronch-
oalveolar lavage cells. Several nanomaterials studied in the size
range from ca. 5 to 20 nm (TiO2, Fe, Cu, Ag) induced higher
neutrophil recruitment in BAL fluid, compared to control.33 Low
amounts of neutrophiles and lymphocytes indicate minimal
inflammatory response or toxicity.
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Assessment of RNAi in HeLa Cells. c-myc RNAi was evaluated by
using the psiCHECK Vector system (Promega), which allows one
to monitor change in expression of a reporter gene (Luciferase)
fused to a target gene. MYC-Luciferase vector construction:
the whole human v-myc myelocytomatosis viral oncogene
homologue (c-myc) gene was PCR amplified from cDNA retro-
transcribed from HeLa cells total RNA (see Supporting
Information) and the resulting product cloned in frame with
Luciferase reporter gene contained into the vector psiCHECK-2,
and maintained in Escherichia coli DH5R strains. Cell culture:
HeLa cells were grown in Dulbecco's modified Eagle's medium
(DMEM, Lonza) with 10% heat inactivated fetal bovine serum,
2 mM glutamine, 100 U/mL penicillin, and 100 μg/mL strepto-
mycin and maintained at 37 !C in 5% CO2. Cells were seeded
at a density of 5 # 103 cells/well in 96-well plates and grown
for 1 day prior to transfection of the MYC-Luciferase vector
(0.125 μg per well) using Lipofectamine 2000 (Invitrogen) and
Opti-MEM reduced serum medium (Invitrogen) according to
the manufacturer's recommendations. RNAi efficiency of differ-
ent NP conjugates (2.1 nM AuNPs, 2 nM siRNA) was tested by
treating the cells for 48 h and by quantification of luciferase
expression using a dual-luciferase reporter assay (Promega)
assay according to the manufacturer's protocols. Data are
average ((SD) of three experiments.
RNAi Experiments in Hydra. Groups of 10 animals, collected in
plastic multiwells, were incubated in 100 μL of Hydramedium in
the presence of AuNPs (15 nM), and the treatment was renewed
after 24 h to account for possible siRNA degradation. At 48 h,
animals were washed and processed for RNA extraction and
qRT-PCR. Animals interfered by naked siRNA, nonfunctionalized
NP, or untreated were used as controls. Briefly, total RNAs were
purified using Trizol (Invitrogen), retrotranscribed using Super-
Script II retrotranscriptase (Invitrogen), and used for qRT-PCR
analysis (see Supporting Information for detailed methods and
primers employed).
RNAi Experiments in Mouse. C57BL/6J mice were anesthetised
by intraperitoneal injection of a mixture of Medetomidin
(0.5 mg/kg body mass), Midazolam (5.0 mg/kg body mass),
and Fentanyl (0.05 mg/kg body mass). The animals were then
intubated by a nonsurgical technique. Using a cannula inserted
10mm into the trachea, a suspension containing 16 nMAuNP in
50 μL of pyrogene-free distilled water was instilled, followed by
100 μL of air. After instillation, animals were antagonized by
subcutaneous injection of a mixture of Atipamezol (2.5 mg/kg
body mass), Flumazenil (0.5 mg/kg body mass), and Naloxon
(1.2 mg/kg body mass) to guarantee their awakening and well-
being. Animals were treated humanely and with regard for
alleviation of suffering; experimental protocols were reviewed
and approved by the Bavarian Animal Research Authority.
Preparation of BAL Cells/Fluid. BAL fluid was obtained by inject-
ing and recovering of two 0.5 mL aliquots of PBS via a tracheal
cannula. Cells in the lavage fluids were counted using a hemo-
cytometer, and the differentials were determined by utilizing
light microscopy to count 200 cells on cytospin preparations.
Molecular Analyses of Gene Expression in Mouse. Immunolocaliza-
tion: Lung tissues were sliced and blocked by adding 1% BSA in
PBS for 30min.Mouse anti-c-myc (Molecular Probes) was added
(dilution 1:1000) for 1 h, washed in PBS with agitation for 5 min
three times, and incubated with goat anti-mouse IgG coupled
with Alexa-488 (Molecular Probes) at 2 μg/mL for 30min. Nuclei
were DAPI stained before slide mounting with 50 μL of fluor-
mount mounting medium. Total RNAs were extracted from
mouse lungs, retrotranscribed, and analyzed by qRT-PCR (see
Supporting Information for detailed methods and primers
employed).
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Abstract
Hydra is a unique model for studying the mechanisms underlying stem cell biology. The activity of the three stem cell
lineages structuring its body constantly replenishes mature cells lost due to normal tissue turnover. By a poorly understood
mechanism, stem cells are maintained through self-renewal while concomitantly producing differentiated progeny. In
vertebrates, one of many genes that participate in regulating stem cell homeostasis is the protooncogene c-myc, which has
been recently identified also in Hydra, and found expressed in the interstitial stem cell lineage. In the present paper, by
developing a novel strategy of RNA interference-mediated gene silencing (RNAi) based on an enhanced uptake of small
interfering RNAi (siRNA), we provide molecular and biological evidence for an unexpected function of the Hydra myc gene
(Hymyc1) in the homeostasis of the interstitial stem cell lineage. We found that Hymyc1 inhibition impairs the balance
between stem cell self renewal/differentiation, as shown by the accumulation of stem cell intermediate and terminal
differentiation products in genetically interfered animals. The identical phenotype induced by the 10058-F4 inhibitor, a
disruptor of c-Myc/Max dimerization, demonstrates the specificity of the RNAi approach. We show the kinetic and the
reversible feature of Hymyc1 RNAi, together with the effects displayed on regenerating animals. Our results show the
involvement of Hymyc1 in the control of interstitial stem cell dynamics, provide new clues to decipher the molecular control
of the cell and tissue plasticity in Hydra, and also provide further insights into the complex myc network in higher
organisms. The ability of Hydra cells to uptake double stranded RNA and to trigger a RNAi response lays the foundations of
a comprehensive analysis of the RNAi response in Hydra allowing us to track back in the evolution and the origin of this
process.
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Introduction
Despite its simple body plan and structural anatomy, the
Cnidaria Hydra, a dipoblastic animal at the base of metazoan
evolution, is an excellent model system to investigate the
mechanisms controlling stem cell proliferation and differentiation
and the balance between the two phenomena. While in most of
animals the self-renewing property is confined to one or more
tissues, in Hydra most of the cells continuously divide and are
displaced towards the animal extremities where terminal differen-
tiation occurs before cell loss. The constant growth process
requires a homeostatic regulation within and between different cell
lineages and a steady state of production and loss of cells [1–4].
The polyp is composed of two epithelial layers, an outer ectoderm
and an inner endoderm, shaping a tube-like body, with a single
opening (mouth) at one end and a foot to anchor to a substrate at
the opposite end. Each layer, which is a single cell deep, comprises
a cell lineage. All other cell types are lodged in the interstices
among the epithelial cells of both layers, and are part of the
interstitial cell lineage (see Figure S1). Interstitial cells occur singly
(1 s) or in clusters of 2, 4, 8 and 16 cells (2 s, 4 s, 8 s, 16 s). All
these classes are actively proliferating, with a cell cycle length of
about 1 day [5]. Single interstitial cells or clusters of 2 form
neurons (sensory and ganglion cells) and secretory cells (zymogen
and mucous cells), while clusters of 4, 8 and 16 interstitial cells
(nematoblasts) differentiate different types of nematocytes. Mul-
tipotent interstitial stem cells, which do not differentiate but simply
proliferate, must exist to provide for growth of the interstitial cell
population and to provide a continuing supply of differentiating
nematocytes, nerve cells, gland cells and gametes [6]. Clearly, a
variety of control mechanisms are needed to maintain steady state
levels of mature cells, as well as to stimulate the rapid production
of specific cell types as needed. This might requires the
participation of many factors, including positive and negative
regulators of growth and differentiation, which determine survival,
growth stimulation, growth arrest, differentiation.
In vertebrates, one of many genes that participate in regulating
cell homeostasis is the protooncogene c-myc. The MYC family of
transcription factors controls disparate aspects of cell physiology
including cell growth, cell cycle progression, biosynthetic metab-
olism, and apoptosis [7–9] and, as expected, its deregulated
expression occurs in the majority of human cancers. Recently, in
Hydra magnipapillata, a c-myc homologue (Hymyc1) has been isolated
and fully characterized [10], and by in silico genomic analysis three
additional myc-like or -related genes have been predicted. Among
them, HyMYC1 and HyMYC2 deduced protein sequences
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display the principal topography of MYC proteins, i.e. bHLH- Zip
domains and MYC boxes I to III, and are clearly orthologues of
vertebrate myc, while the predicted proteins of the two others
(HyMYC3 and HyMYC4) present bHLH-Zip domains but are
highly divergent in the N-terminal regions, suggesting myc-related
roles. Hymyc1 is expressed in proliferating fractions of the
interstitial stem cell system, namely single and pairs of interstitial
stem cells, proliferating nematoblasts, gland cells. Recombinant
hybrid proteins between Hymyc1 and viral myc genes displayed, in
assays of cell transformation, oncogenic potential, suggesting
structural and functional conservation of HyMYC1 protein
domains. By contrast, the functional role played in the interstitial
stem cell lineage in Hydra is unknown. To this aim, we have
developed a new RNA interference (RNAi) approach to
downregulate Hymyc1 expression. By using small interfering RNAs
(siRNA) [11] specifically designed to target Hymyc1, we overcome
the main issue of their delivery to target tissues by modifying their
highly negative charge towards positive values. We have previously
shown the capability of Hydra to actively uptake positively charged
nanoparticles suspended in the culture medium [12]. Here we
show that acidic condition enhances the entry of siRNA duplexes
into the polyps triggering the Hydra RNAi response and leading to
specific post transcriptional Hymyc1 inhibition. Under normal
feeding regime and physiological culturing condition, a large scale
screening of RNAi phenotype was possible, while avoiding
previously used invasive delivering methods to alter gene
expression, such as electroporation [13–15]. We provide molec-
ular evidence of Hymyc1 reduced expression level, while analysis at
cellular level led to decipher an unexpected function in the
homeostasis of interstitial stem cells. Hymyc1 inhibition impairs the
balance between stem cells self-renewal/differentiation, as shown
by the accumulation of intermediate and terminal differentiation
products (nematoblasts, nematocytes and secretory cells). The
biochemical repression of Hymyc1 activity achieved by using
10058-F4 inhibitor, a disruptor of c-MYC/MAX dimerization,
produced similar effects on Hydra polyps, confirming the specificity
and the validity of our RNAi approach.
The kinetic of Hymyc1 RNAi was also evaluated, together with
the effect displayed on the regenerative capability of the polyp.
Together with the establishment of a reliable loss of function assay
to analyse gene function in Hydra, the specific myc silencing opens
new avenues to decipher the molecular control of the cellular
plasticity underlying growth and proliferation in Hydra, providing
further insights into the complex myc network also in higher
organisms.
Results
Hymyc1 downregulation through siRNA
In a previous study [12] we showed that at acidic pH fluorescent
semiconductor nanoparticles, showing positive surface charge, are
actively internalized by Hydra ectodermal cells, while negatively
charged nanoparticles are not uptaken. With the aim to
downregulate Hydra myc1 gene we tested the possibility to perform
RNA interference mediated by small interfering RNAs. 21 bp long
RNA oligonucleotides with symmetric 2 nt 39 overhangs targeting
the coding region of the Hymyc1 gene (myc-siRNA) were designed
according to specific rules found to enhance the silencing effect of
siRNA [16–18] and chemically synthesized. An estimation of their
surface net charge was achieved by zeta potential measurements, a
method widely used to quantify the electrokinetic potential in
colloidal systems [19]. Zeta potential measurement of siRNA
duplexes as function of pH showed that they present positive net
charge at pH 4 in Hydra culture medium (see Figure S2 of
Supporting Information), while at physiological pH, as expected,
they are negatively charged. The silencing properties of myc-siRNA
were thus tested at pH 4, by soaking the animals in their culture
medium in presence of 70 nM myc-siRNA, a concentration
comparable to that used in other studies of siRNA mediated gene
silencing [20], while lower doses were found ineffective. The use of
Alexa fluor 488 end labelled myc-siRNA enabled us to track in vivo,
by fluorescence microscopy, the capability of naked siRNAs to
cross Hydra cell membranes at pH 4 (Figure 1A–1B), with a greater
efficacy compared to pH 7 (Figure 1C–1D), indicating that the
effective delivery of the siRNA in vivo was enhanced by the acidic
condition. Analysis of single cell suspensions shows delivery of
labelled myc-siRNA to both epitheliomuscular and interstitial cells
(Figure 1H–1M), while confocal microscopy analysis confirmed
the localization within nests of nematoblasts (Figure 1E–1G),
where Hymyc1 is expressed. The silencing effect was evaluated at
molecular level by quantitative Real Time PCR (qRT-PCR).
Treatment with myc-siRNA for two days (2 d) caused a significant
reduction of Hymyc1 transcript levels at pH 4, but not at pH 7
(Figure 2A) suggesting that enhanced acidic-mediated uptake of
RNA duplexes is required to induce specific gene silencing. The
post-transcriptional silencing induced by myc-siRNA was con-
firmed at protein level by Western Blot analysis. Following
preliminary semi-quantitative RT-PCR analysis (Figure 2B, upper
panel), polyclonal antibodies raised in rabbit against HyMYC1
recombinant protein detected a drastic decrease of HyMYC1
protein in myc-siRNA treated animals by 2 d, compared to
endogenous levels of Hydra actin (Figure 2B, lower panel). The
specificity of the RNAi approach was assessed by testing unrelated
siRNAs, such as Luciferase siRNA (luc-siRNA), designed on the
firefly luciferase GL2 gene. Results showed that Hymyc1 transcrip-
tion and translation were unaffected in luc-siRNA treated animals
(Figure 2B). By qRT-PCR the potential adverse effects played by
the acidic pH on gene expression were also analysed. As it might
be argued that the acidic condition could play adverse effects on
gene expression, we analysed the endogenous Hymyc1 expression
level in animals incubated at pH 4 for increasing periods, and
compared them to expression levels in physiological condition
(pH 7). The graph of Figure S3-A (Supporting Information) shows
similar levels of Hymyc1 transcripts both at pH 4 and pH 7,
indicating that Hymyc1 endogenous expression was unaffected by
the acidic environment. Morphological analysis of treated animals
further confirmed the absence of adverse effects played by the low
pH on polyp viability (Figure S3-B of Supporting Information).
The efficiency of RNAi as function of the duration of treatment
is shown in Figure 2C. Specific gene inhibition was detected in
myc-siRNA treated animals by 2 d of treatment, when a 60%
decrease in the Hymyc1 mRNA amount was measured. Increasing
the period of treatment up to 9 d did not further increase the
silencing efficiency, probably due to fast cell turnover of the
interstitial stem cells, continuously replacing the interfered cells or
to the animal adaptation to the treatment. The long lasting effect
of the RNAi was then investigated by performing a 4 d RNAi
treatment followed by RNAi suspension and culturing in
physiological condition, under normal feeding regime, over
different periods. The graph of Figure 2D shows that Hydra
polyps could recover from the RNAi treatment, restoring
physiological levels of Hymyc1 transcripts over the following five
days. Thus the observed downregulation depends upon the
continuous presence of siRNA oligonucleotides and indicates the
reversibility of the siRNA mediated RNAi, similarly to other
invertebrates RNAi knockdown models [21].
The efficiency of the new developed RNAi approach was tested
on an additional gene, b-catenin (b-cat), a key gene involved in
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setting up the head organizer in Hydra. b-cat is an armadillo repeat-
containing protein expressed weakly and uniformly throughout the
polyp and at higher level in developing buds [22–23]. Hydra polyps
treated for 2 d with specifically designed b-cat-siRNA revealed a
strong and significant reduction (more than 50%) of the target
mRNA (Figure S4), confirming the validity and the reproducibility
of our RNAi strategy.
Hymyc1 gene silencing promotes proliferation of single
and pairs of interstitial stem cells
In order to detect differences in the expression pattern of myc-
siRNA interfered animals whole mount in situ hybridizations using
a Digoxigenin-labelled Hymyc1 RNA probe were performed.
Despite the decreased Hymyc1 expression detected by qRT-PCR,
differences in the signal distribution pattern between healthy and
interfered animals (analysed at 2 d, 4 d and 9 d of continuous
siRNA treatment) could not be appreciated, due to the
Digoxigenin detection technique, not allowing quantitative
measurements. As shown by stained specimens both whole
mounted and cryo-sectioned (Figure 3A–3D) Hymyc1 residual
transcripts were detected in myc-siRNA treated animals in single
and pairs of interstitial cells (1 s, 2 s), nests of nematoblasts
(4 s216 s), accordingly to previous reports [10]. The same
expression pattern was detected in luc-siRNA treated animals,
confirming the absence of aspecific effects due to the siRNA
treatment (data not shown). A quantitative evaluation of the
Hymyc1 positive cells confirmed the absence of significant
differences between interfered (by myc-siRNA and luc-siRNA)
and control animals (Figure S5). This result suggests that the
activation of the RNAi machinery occurred throughout the
targeted cells, rather than on limited patches of cells where the
siRNA could be selectively delivered.
Since the multipotent interstitial cells, their differentiation
intermediates, and their product cells are all closely related
(Figure 3E), changes in their relative population sizes may yield
clues as to how these populations are controlled. A morphological
analysis both at cellular level and in intact animals was then
performed to investigate potential effects induced by Hymyc1
Figure 1. In vivo RNAi mediated by siRNA. Fluorescence imaging of Hydra vulgaris exposed to myc-siRNA at different pHs. Living polyps were
challenged with 70 nM Alexa488-end labelled myc-siRNA, in Hydra medium either at pH 4 (A, B) or at pH 7 (C, D). After 24 hr of continuous
incubation with siRNA a strong punctuated fluorescence labels uniformly the whole animal, from the head (A) along the body (B) of animals treated
at acidic pH, indicating the uptake of siRNA. In (C) and (D) are shown the body regions corresponding to A and B, respectively, of animals treated with
the same siRNA at neutral pH. The absence of fluorescence signals indicates that the acidic pH enhances siRNA delivery in Hydra. Scale bar 200 mm.
Confocal laser scanning imaging (E–G) of living Hydra treated 24 hr with Alexa488-labelled myc-siRNA revealed localization of oligonucleotides into
interstitial cells. In (E), nuclear staining of interstitial cell nest with TOPO3; in (F) siRNA green fluorescence appears as faint staining or more evident
granules; in (G), the overlay of bright field and fluorescence images revealed that siRNAs localize prevalently into the cytoplasm of interstitial cells.
Scale bars: 10 mm. Fluorescence microscopy analysis of single cells suspensions prepared from treated dissociated animals shows intracellular
localization of siRNA into interstitial (H) and epitheliomuscular (I) cells, as a punctuated pattern. The same cells were observed by phase contrast
microscopy, respectively in (L) and (M). Scale bar 10 mm.
doi:10.1371/journal.pone.0030660.g001
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silencing on the cell proliferation activity and cell type relative
distribution.
As Hydra epithelial cells proliferate with a cell cycle of about
3,5 d [24–25] and interstitial cells much faster with a cell cycle of
about 1 d [26], the cycling activity of the epithelial and interstitial
cells was assayed by continuous BrdU-labeling, over 3 and 2 d,
respectively. Figure 4A shows that the proliferation rate of
epithelial cells was not affected by myc RNAi, thus this cell type
could be used to normalize relative cell type distribution. By
contrast, proliferation of single and pairs of interstitial cells
(1 s+2 s) was enhanced in myc-RNAi animals, indicating an effect
of myc downregulation on the stem cell cycling activity (Figure 4B).
The estimation of cell proliferation rate by mean of BrdU was
carried out also in differentiating nematoblasts (4 s) and gland
cells. Results reported in Figure S6 showed that Hymyc1 RNAi
does not affect proliferation rate of these cell types, suggesting a
Hymyc1 role played specifically on 1 s+2 s cells.
To gain insight into the possible effects of Hymyc1 RNAi on the
cell cycle, mitotic index and DNA content of 1 s+2 s cells were
assessed. Counts of DAPI-stained cells by phase contrast
microscopy combined with nuclear DNA staining revealed that
the fractions of cells undergoing mitosis in myc-siRNA treated
animals were 3,7% and 3,4% upon 3 and 4 d of treatment,
respectively (n = 1000, for each treatment). Conversely, these
fractions in untreated animals were 2,7% and 2,3% after 3 d and
4 d, respectively, indicating an increase of more than 40% of the
mitotic index of 1 s+2 s cells as effect of RNAi. To check whether
or not Hymyc1 silencing controls specific cell cycle checkpoints, the
DNA content of 1 s+2 s cells from RNAi animals was determined.
We found not significant differences in the nuclear DNA profile
between untreated and Hymyc1 RNAi animals, suggesting that
Hymyc1 does not act as a regulator of one specific cell cycle
checkpoint (Figure S7 of Supporting Information).
To investigate the effects of Hymyc1 downregulation on all
interstitial cell lineage, cell type distribution was analysed in
macerates at two time points, 4 d and 9 d, and the cells counted
relative to epithelial cells, as not affected by Hymyc1 RNAi
(Figure 4A). After 4 d of siRNA treatment, the observed increased
ratio 1 s+2 s/EPI was consistent with the boost of mitotic index
and BrdU labelling previously reported (see above text and
Figure 4B). Furthermore, we found in myc-siRNA treated animals
an increase in the population of nematoblasts (4 s216 s), zymogen
and mucous cells, more pronounced at 9 d (Figure 4C, 4D), while
nerve cells were not affected, suggesting a Hymyc1 specific role in
nematocyte and gland cell differentiation pathways. The popula-
tion of mature nematocytes embedded in the battery cells was
analysed in tentacles of intact fixed animals. Hydra tentacles are
structured as cell bilayers, as the rest of the animal body, but
Figure 2. Molecular characterization of Hymyc1 RNAi. (A) quantitative RT-PCR showing Hymyc1 downregulation enhanced by acidic condition.
Animals treated by myc-siRNA at pH 4 showed 60% decrease in Hymyc1 transcription levels compared to Hydra Elongation factor HyEF1amRNA, used
as internal control (two asterisks, p,0.01 according to t-Student test). (B) Upper panel: semi-quantitative RT-PCR showing Hymyc1 downregulation
induced specifically by myc-siRNA (lane myc) and not by luc-siRNA (lane luc), or in untreated animals (lane C) used as controls. Lower panel: Hymyc1
RNAi affects also MYC protein levels. Lane labels are as in the upper panel. MYC protein levels were detected using anti-HyMYC1 antibody (1:500,
kindly provided by K.Bister, University of Innsbruck) and compared to actin proteins, using an anti-actin primary antibody (1:100, Sigma) to probe an
identical blotted gel. HyMYC1 shows an apparent mol. weight of 35 kDa, as elsewhere reported [10]. (C) Kinetics of Hymyc1 downregulation. qRT-PCR
was performed on total RNA extracted from 25 animals either untreated (namely incubated at pH 4, in absence of siRNA) or incubated with the
indicated siRNA for different periods. The most effective downregulation is detected at the beginning of the treatment, and it is specifically induced
by myc- and not luc-siRNA duplexes (two asterisks, p,0.01 according to t-Student test). (D) Reversible effect of RNAi. Animals were treated with myc-
siRNA for 4 d (time t = 0) and then cultured in physiological condition for the indicated periods of time (3 days, 5 days), when total RNAs were
extracted for qRT-PCR analysis. Suspension of RNAi treatment restored in five days myc mRNA transcript levels up to physiological values. Error bars in
A, C and D indicate standard deviations calculated from three independent experiments, each performed in triplicate.
doi:10.1371/journal.pone.0030660.g002
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contain specialized ectodermal cells, the battery cells (Figure S1)
[27–28]. These tentacle specific cells arise from terminal
differentiation of ectodermal cells, including the mitosis arrest
and the inclusion into the cytoplasm of neuronal cells and several
nematocytes, the stinging cells involved into the prey capture. This
complex system, the battery cell, is recognizable by phase contrast
optical microscopy. Results of Figure 5A show that myc-siRNA
interfered animals, both at 4 d and 9 d, presented an increased
ratio of mature nematocytes/battery cells, compared to relative
control sets of animals and a representative battery cell is reported
in Figure 5B. This effect was induced by myc-siRNA treatment in
almost all individuals, as shown by the distribution of the ratios
among ten animals (Figure S8).
The specificity of the phenotype induced by myc-siRNAi was
tested by treating animals with a biochemical c-MYC inhibitor,
the thioxothiazolidinone10058-F4 [29], which blocks c-MYC/
MAX heterodimer formation through molecular mechanisms
poorly understood so far, and it affects as well the myc gene
transcription level [30–31]. Treatment of living polyps with 10058-
F4 for 2 d induced 50% reduction of Hymyc1 expression levels, as
assayed by qRT-PCR (Figure 6A), while analysis of cell
proliferation rate showed an effect on 1 s+2 s cells (Figure 6B),
but not on other cell types (Figure S6 of Supporting Information).
Cell type distribution analysis also revealed increased proliferation
of 1 s+2 s stem cells, and increased amounts of intermediates and
terminal differentiation products (nematoblasts, nematocytes,
secretory cells) (Figure 6C). As detected in Hymyc1 RNAi polyps,
also the phenotype of the battery cells was affected, containing an
abnormal number of nematocytes (Figure 6D), indicating
unequivocally the specificity of the Hymyc1 downregulation effects,
and indirectly the structural and functional conservation of the
HyMYC1/HyMAX complex. Taken together, these findings
suggest that genetic and biochemical repression of Hymyc1 activity
affects in the same way the interstitial cell lineage homeostasis:
Hymyc1 conditional elimination enhanced stem cell proliferation,
and in turn unbalances the differentiating products.
As Hymyc1 is expressed in proliferating stem cells of the
interstitial cell lineage, we also evaluated its expression profile
during regeneration, a complex phenomena involving extensive
cell reprogramming, proliferation and differentiation processes to
rebuild a new organism from an amputated moiety [32].
Quantitative analysis of Hymyc1 expression performed over the
first 24 h post amputation indicates that Hymyc1 expression levels
were not specifically modulated during the early stages of the
regenerative process of healthy animals (Figure 7A). When
analysing myc RNAi regenerating animals, similar Hymyc1
expression levels were found (Figure 7B) indicating that the RNAi
effect was maintained during the regeneration and it could
Figure 3. Hymyc1 expression pattern is not affected by Hymyc1 downregulation. A comparison of whole mount in situ hybridization
performed on A) healthy animals and B) myc-siRNA treated animals (2 d) shows residual Hymyc1 transcripts in the RNAi targeted cells. As previously
reported [10] Hymyc1 is expressed in proliferating interstitial cells, distributed along the gastric region, shown at higher magnification in (C). A cross
section of stained animals confirms this expression pattern (D). Scale bars: 1 mm in A and B; 200 mm in C and D. A scheme of the differentiation
pathways in the interstitial stem cell system is shown in (E). Interstitial stem cells include multipotent stem cells (1 s) and committed stem cells (2 s)
that differentiate three major cell types in Hydra (nematoblasts, secretory cells, neurons, and gametes). Nematocytes, the phylum representative cells
arming the tentacles and used for pray capture, originate from nematoblasts, i.e. committed cells that after several mitotic divisions (generating nests
of 4, 8 and 16 cells connected by cytoplasmic bridges) finally differentiates into several types of nematocytes (stenoteles, desmonemes, isorriza,
depending on the nematocyst morphology). 2 s cells committed toward either nematocyte, nerve or secretory cells, are morphologically
indistinguishable. While single interstitial stem cells (1 s) continuously self renew, among the daughter cells (2 s) 60% remain stem cells, whereas 40%
become committed to different cell types.
doi:10.1371/journal.pone.0030660.g003
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possibly affect cell type distributions. To this aim, the phenotype of
the regenerating animals was analysed in more detail. In situ
hybridization on Hymyc1 interfered regenerating animals, similarly
to what observed on intact animals, did not reveal quantitative
differences in the Hymyc1 expression pattern (data not shown),
while a clear morphological phenotype was detected in the
regenerated tentacles: the average tentacle length and nematocyte
content per battery cells were significantly increased (Figure 7D–
7F) indicating that Hymyc1 RNAi effect persists throughout the
regenerative process and affects tentacle morphogenesis. These
results substantiate the view of a role of Hymyc1 in the control of
proliferation/differentiation rate in Hydra.
Discussion
The possibility to perform gain- or loss- of function approaches
to analyse gene function may add new values to the widespread
use of Hydra as a genomic model organism with a pivotal position
in the evolutionary tree. The generation of transgenic polyps by
embryo microinjection is a well-established technique [33] and
several methods have been successfully used to do RNAi in adults.
The published RNAi methods rely on long dsRNA delivered
through different techniques, spanning from whole animal
electroporation [13] to localized electroporation [15], and used
successfully for functional analysis of genes involved in head
regeneration [15–34–35]. In order to reduce major side effects as
tissue necrosis and lethality, a milder strategy for dsRNA delivery
through feeding of dsRNA producing bacteria has been developed
and used for silencing of both endodermal and ectodermal
expressed genes [36–37], while the soaking method using long
dsRNA has been employed for efficient RNAi of key develop-
mental genes in the marine hydroid Hydractinia echinata [38]. We
developed in this paper a novel approach of RNAi in Hydra, based
on siRNA oligonucleotides. First discovered in plants and in the
nematode Caenorhabditis elegans [16–39–40] the production of
siRNAs that bind to and induce also systemically [41] the
degradation of specific endogenous mRNAs is now widely
employed to inhibit gene function and holds great potentials in
the therapeutic treatment of several diseases [42–44]. At cellular
level, duplex siRNAs are negatively charged polymers and so
cannot easily penetrate hydrophobic cellular membranes without
assisting carriers such as cationic polymers, liposomes or
nanoparticles. We succeeded in our delivering method by working
in acidic conditions, which resulted in siRNA charge reversal and
great enhancement of siRNA intracellular delivery. Alexa 488
labelled myc-siRNAs were found into the cytoplasm of Hydra
ectodermal cells, within both epitheliomuscular and interstitial
cells, as granular structures with different sizes, not excluding the
presence of single units, undetectable by confocal microscopy
analysis (Figure 1). The experimental conditions used for siRNA
delivery confirm previous data on the importance of the positive
surface charge of delivery vehicles in promoting cell uptake [12–
45–46]. In Drosophila an active and specific pathway that involves
clathrin-mediated endocytosis has been found responsible for
Figure 4. Effect of myc RNAi on cell cycling activity and cell type distribution. Cell cycling activity of epithelial cells (A) and 1 s+2 s stem
cells (B) were obtained in control and treated animals by continuous incubation with BrdU, followed by maceration of ten animals at the indicated
time points and fluorescence immunostaining. Data represent the average of three different experiments. In (C) and (D) the distribution of different
cell types was assayed after 4 d and 9 d of myc RNAi, respectively. Five test animals were randomly selected from a pool of twenty five treated
animals, and macerated for cell counting. The data represent the average of five independent RNAi experiments. Bars indicate standard errors.
1 s+2 s = single and pairs of interstitial cells; nematoblasts = nests of 4 s216 s proliferating and differentiating nematoblasts; EPI = epithelial cells.
doi:10.1371/journal.pone.0030660.g004
Hymyc1 Silencing Using siRNA
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30660
siRNA uptake [47] and accumulation in vesicles, while the
mechanism of cytoplasmic release to enter the RNAi machinery
has not been identified to date. Although it might be argued that
by our approach siRNA delivery occurs more into ectodermal cells
rather than into interstitial cells, the strong molecular downreg-
ulation observed suggests that the RNAi response results from
both direct delivery to interstitial cells and spreading effect of the
RNAi response, similarly to other invertebrates [41–47]. This
hypothesis is supported by the presence in the Hydra genome of
predicted genes encoding for components required for amplifica-
tion and systemic spread of an RNAi signal, i.e. RNA-dependent
RNA polymerase (RdRP) and SID proteins (Hma1.117083 and
Hma1.114101 respectively). Moreover, the cytoplasmic bridges
present among nematoblasts might provide direct passage of
siRNA signals through connected cells to enable RNAi. We
targeted our RNAi approach to Hymyc1 gene and showed the
specificity of our method including luciferase- and b-catenin-
siRNA as negative and positive controls, respectively. While b-cat
silencing proved the robustness and reproducibility of our RNAi
method, luc-siRNA ineffectiveness in Hymyc1 downregulation
demonstrated the absence of harmful sequence independent side
effects elicited by the siRNA treatment: phenotypical, cellular and
molecular analysis showed that luc-siRNA did not alter Hymyc1
expression, nor interfered with proliferative/differentiating pro-
cesses leading to abnormal phenotypes.
Hymyc1 is homologue of the c-myc protooncogene, a key gene
conserved throughout the animal kingdom [48], controlling
several fundamental processes of the cell cycle, both intracellular
functions (cell growth, proliferation, apoptosis) and extracellular
processes that coordinate cell proliferation with the microenvi-
ronment (the stem cell niche) [49]. Although the molecular,
biochemical and functional analyses of Hymyc1 has highlighted
structural conservation in the featuring domains (i.e. bHLH-Zip
domain and myc-boxes I to III) and functional similarities to the
vertebrate derivatives [10], its physiological role in Hydra has not
been elucidated so far. By challenging living Hydra with myc-
siRNAs, we specifically downregulated Hymyc1 mRNA and
protein levels. The inhibition was achieved after 2 d of treatment,
while continuous incubation up to 9 d, under normal feeding
regime, did not cause cumulative effects, probably due to
saturation of the RNAi machinery, or to other mechanisms of
animal adaptation. Our experimental conditions ensured animal
health all along the treatment period and the absence of stressing
condition (such as starvation or chemical/physical compounds
required for efficient delivery of nucleic acids), which can
complicate the interpretation of the phenotypical effect of gene
silencing. Despite the presence of an additional myc orthologue
gene in the Hydra genome database (Hymyc2) which could possibly
interfere with Hymyc1 downregulation, a clear phenotypical effect
was detected in myc-siRNA treated animals. At cellular level, an
extensive analysis of single cells prepared by maceration revealed
abnormal distribution ratios between cellular types of the
interstitial cell lineage. As the density of the stem cell population
(i.e 1 s+2 s/EPI) is species-specific and dependent upon environ-
Figure 5. Hymyc1 RNAi induces an increase in the nematocyte content of battery cells. (A) At time 4 d and 9 d of treatment with the
indicated siRNA, animals were fixed and the number of nematocytes embedded in the battery cells, observed under the same focus plane, was
scored. Data represent the average of measures from ten animals 6 standard deviation. (B) Representative battery cells imaged from normal (left),
myc-siRNA (middle) and luc-siRNA (right) treated animals, on whole mounts. Hand drawn black lines indicate the battery cell membranes. Hymyc1
downregulation induces nematocyte differentiation and accumulation into battery cells. Scale bar: 20 mm.
doi:10.1371/journal.pone.0030660.g005
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mental stimuli, such as the feeding regime [6–25–26], we did not
report the absolute values, but pointed out to their changes
relatively to control animals. While not affecting the epithelial cell
proliferation rate, Hymyc1 downregulation induced a moderate
increase in the stem cell proliferation rate and density, which
produced dramatic effects on the related cell population sizes.
These results are in line with previous studies relating stem cell
self-renewal to the cell density, and showing that nematocyte
commitment increases as stem cell concentration increases [[5–
24–26]. The abnormal numbers of mature nematocytes embedded
in the tentacle battery cells confirmed the burst in the nematocyte
differentiation. Although we cannot exclude an effect on nerve cell
commitment, the measure of mature nerve cells, found unaffected
by Hymyc1 repression, ruled out an enhancement in nerve cell
differentiation. By contrast, the secretory cell differentiation
pathway was profoundly activated, as shown by the doubled
numbers of both zymogen and mucous cells. Interestingly, at 9 d
of treatment, the stem cell density was restored to physiological
levels, suggesting a negative feedback between stem cells, as
elsewhere proposed [6]. The specificity of the effects produced by
Hymyc1 inhibition was confirmed using a chemical inhibitor of the
MYC/MAX interaction, 10058-F4 [29]. Treatment of living
polyps with this inhibitor induced Hymyc1 downregulation, as well
as increased 1 s+2 s stem cell proliferation and enhanced
differentiation of nematoblasts, secretory cells and nematocytes.
A schematic model of the effects of both the genetic and
biochemical Hymyc1 inhibition on the proliferation/differentiation
rates is shown in Figure 8. Altogether these results suggest a role of
Hymyc1 in the negative regulation of the stem cells where it is
expressed: the decreased expression enhances stem cell prolifer-
ation and in turn the differentiation of intermediates and terminal
derivatives. The increase in stem cell density may finally inhibit the
stem cell self-renewal capability over long periods.
Of intriguing interest is the effect displayed by Hymyc1 RNAi
on Hydra regeneration. qRT-PCR showed that, 24 h post
amputation Hymyc1 transcription levels are similar to pre-
amputation. Regenerated heads also presented morphological
traits similar to the pre-amputated animals, i.e longer tentacles
armed with an abnormal number of nematocytes, suggesting the
persistence of the RNAi response. Consistent with this hypothesis
are evidences from C.elegans, in which effective interference is
observed in the progeny of dsRNA injected animals at early larval
stages [21], and from the planarian flatworm Schmidtea mediterra-
nea, where gene inhibition persists throughout the process of
regeneration [50].
The involvement of c-myc in controlling cell proliferation and
differentiation processes has been shown in several systems, by
both gain and loss of function approaches. In murine hematopoi-
etic stem cells (HSC) the group of Trumpp showed that c-myc
conditional elimination resulted in the accumulation of HSCs in
Figure 6. Molecular and morphological alteration induced by the c-myc inhibitor 10058-F4. A) Living polyps were treated with the c-myc
inhibitor 10058-F4 for 48 h at two different concentrations (30 mM and 90 mM) before RNA extraction for qRT-PCR analysis. Expression levels, relative
to HyEF1a, indicate Hymyc1 silencing in a dose dependent manner, reaching 47% downregulation at the higher dose tested. Error bars indicate
standard deviations calculated from three independent experiments, each performed in triplicate. B) Cell cycling activity of 1 s+2 s stem cells were
obtained in control and treated animals (as above, 10058-F4 90 mM) by continuous incubation with BrdU, followed by maceration of ten animals at
the indicated time points and fluorescence immunostaining. Labelling indexes of 4 s and gland cells are reported in Figure S6 of Supporting
Information. C) Single cell suspensions were prepared from polyps treated as in A and the relative cell types counted by phase contrast microscopy.
Treatment with 10058-F4 enhances stem cell proliferation and determinates the accumulation of intermediate and terminal differentiation products.
D) Polyps treated with the c-myc inhibitor as in A were fixed and whole mounted for analysis of the nematocyte content into the tentacles (as
described in Figure 5). The small molecule myc inhibitor induces an increase in the nematocyte content of battery cells, identical to the effect induced
by myc-siRNA.
doi:10.1371/journal.pone.0030660.g006
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situ due to their failure to initiate normal stem cell differentiation
[51–52]. In human pancreatic endocrine cell lines c-myc down-
regulation by RNAi induces cells to exit the cell cycle and enter the
differentiation pathway, thus c-myc plays a role in the switch
mechanism that controls the inverse relationship between
proliferation and differentiation [53]. In Drosophila mutation of
the Drosophila myc gene results in small flies due not to fewer cells
but to their cells which are smaller in size [54], suggesting that dmyc
participates in the regulation of cell mass. Although myc and the
members of the myc ‘‘network’’ are encoded in the genomes of
most metazoan phyla and many aspects of its biology may arise
from comparative analysis, the disparate cellular events seeing its
involvement make it difficult to evaluate myc’s function in its
entirety due to redundancy among family members, tissue
specificity, and complex phenotypes.
In Cnidaria, the molecular mechanism underlying RNAi have
not been elucidated so far. We show the capability of siRNA to
enter Hydra cells and to trigger a RNAi response, similarly to many
metazoans. Many other aspects of the Hydra RNAi response need
to be addressed now, from the systemic long range character of the
RNAi response, to the mechanisms underlying the uptake of
siRNA, to the deviation from standard endocytic uptake at some
Figure 7. Effect of Hymyc1 RNAi on regeneration. A) Healthy animals were bisected at time t = 0 and allowed to regenerate for the indicated
period, expressed in hours. At different times post amputation (p.a.) total RNA was extracted and analysed by qRT-PCR. Not significant differences in
Hymyc1 expression levels were detected during the regenerative process. B) myc-siRNA treatment (4 d) caused a reduction of myc mRNA levels. At
this point (time t = 0) animals were bisected and allowed to regenerate for the indicated hours. Downregulation effects persist during regeneration.
Each error bar indicates standard deviation calculated from triplicates. C–D) myc-siRNA treated animal present abnormal tentacle morphogenesis.
Representative phenotypes of head regeneration at 72 hr post amputation are shown. A myc-siRNA treated animal (D) presents tentacles of increased
length compared to untreated (C) or luc-siRNA treated polyps (not shown). Scale bars: 500 mm. E) The average of tentacle length, calculated on a
subset of 20 animals/condition, indicates the faster tentacle development induced by myc-RNAi. Asterisk indicates p,0,05, according to t-Student
test). F) The average nematocyte content of the battery cells was scored on tentacles of regenerating animals at 96 hr post amputation. myc-RNAi
promotes nematocyte differentiation.
doi:10.1371/journal.pone.0030660.g007
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point to deliver dsRNA to the cytoplasm, to date unknown in any
model of RNAi. The current design in our group of nanocarriers
to improve siRNA delivery, self-tracking and specificity will surely
provide in the near future new tools to decipher the mechanisms of
RNA interference in Hydra.
In conclusion, this study focuses on Hymyc1 silencing, through
an innovative RNAi strategy enhancing siRNA uptake in the
polyp, and describes how Hymyc1 knockdown affects the
developmental dynamics of stem and interstitial cell lineage in
Hydra. In particular, our results add significant value to
fundamental studies on the stem cell biology addressing the
mechanisms by which these cells maintain the balance between
self-renewal and differentiation. As myc deregulated expression
occurs in the majority of human cancers, understanding the
ancient roots of myc biology may be of interest for the wide
scientific community targeting c-myc for therapeutic purposes. For
scientists working on cnidarians this paper opens new avenues to
decipher the molecular control of the cellular plasticity underlying
growth and proliferation in Hydra.
Finally, the establishment of a RNAi method which avoids
invasive procedures while ensures effective delivery of siRNA
under normal culturing condition, lays the foundations of a
comprehensive analysis of the RNAi response in Hydra allowing to
track back in the evolution the origin of the RNAi response.
Materials and Methods
Culture of animals and regeneration experiments
Hydra vulgaris (strain Zurich, originally obtained by P.Tardent)
were asexually cultured in Hydra medium (1 mM CaCl2, 0.1 mM
NaHCO3, pH 7) by the method of Loomis and Lenhoff with
minor modifications. The animals were kept at 1861uC and fed
three times per week with freshly hatched Artemia salina nauplii.
Polyps from homogeneous populations, three-weeks-old and
carrying one or two buds, were selected for the experiments. For
regeneration experiments, treated polyps (4 d of treatment) were
bisected in the upper gastric region and monitored at various time
points post amputation.
In vivo RNA interference through small interfering RNAs
For RNA interference groups of 25 animals were collected in
plastic multiwells, allowed to equilibrate at room temperature in
1 ml of Hydra medium at pH4. The test was initiated by adding
70 nM siRNA to each well containing the animals, since then
continuously exposed to the siRNA oligonucleotides, under
normal feeding regime. After the washing procedures new siRNA
oligonucleotides were supplied. 21 bp long siRNA targeting
Hymyc1 were designed using on line siRNA design services and
purchased by QIAGEN. Both unlabelled and 39- Alexa fluor 488
Figure 8. Interstitial cell differentiation pathways. Schematic representation of the multiple differentiation pathways of the interstitial stem
cells in homeostatic condition (A) and the effects on stem cell proliferation/differentiation induced by genetic or biochemical Hymyc1
downregulation (B). myc-siRNA treatment or myc biochemical inactivation induce a moderate increase in the 1 s and 2 s stem cell self-renewal and
proliferation activity (red arrows). This in turn generates a higher number of both differentiating intermediates (nematoblasts) and terminal
differentiated products such as nematocytes and gland cells (blue arrows). Dashed arrows indicate the absence of morphological distinct cellular
intermediates. Hymyc1 downregulation does not affect the nerve differentiation pathway, consistent with the absence of Hymyc1 expression in this
cell type.
doi:10.1371/journal.pone.0030660.g008
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siRNA were designed on the Hymyc1 DNA target sequence: 59-
AAGATGCTCACGCGTCAAGAA-39. As control of silencing
specificity, siRNA oligonucleotides targeting the Luciferase GL2
gene were purchased by QIAGEN (cat no 1022070). Moreover, as
positive control to assess the reliability of this RNAi method, b-
catenin gene expression was interfered by using a specific 21 bp
long siRNA corresponding to nucleotides 750–770 of Hydra vulgaris
b-catenin mRNA (GenBank Accession no. U38624.1). The myc
inhibitor 10058-F4 (5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thia-
zolidinone) was purchased by Sigma-Aldrich (cat no. F3680).
Groups of 25 animals were incubated for 48 h in presence of
10058-F4 (30 mM or 90 mM), and then used for molecular and
cellular characterization, as described in the following sections.
Imaging
siRNA uptake was monitored in vivo, using a Camedia-digital
camera (Olympus) connected to a stereomicroscope (Olympus
ZSX-RFL2) equipped with fluorescence filter sets (BP460- 490/
DM505/LP510). Following extensive washes, in vivo imaging was
accomplished by an inverted microscope (Axiovert 100, Ziess)
equipped with a digital colour camera (Olympus, DP70) and
fluorescence filter sets (BP450-490/FT510/LP515). For imaging
acquisition and analysis the software system Cell F (Olympus) was
used. Confocal images were collected with a Leica TCS SP2
AOBS confocal microscope (Mannheim, Germany) with 406 oil
immersion optics. Laser lines at 488 nm and 633 nm for excitation
of Alexa fluor 488 and TOPO-ETC were provided by an Ar laser
and a HeNe laser, respectively. Detection ranges were set to
eliminate crosstalk between fluorophores. Tissue imaging of
interfered animals was performed under bright field.
Quantification of in situ hybridization signal for Hymyc1 was
accomplished as it follows: whole mounted animals were imaged
by an inverted microscope (Axiovert 100, Ziess) equipped with a
digital colour camera (Olympus, DP70). Images were taken under
the same conditions of acquisition (light and exposure time), saved
in tagged-image file format (TIFF) at a size of 130061030 pixels,
posterized by Adobe Photoshop by setting the same threshold
levels and then converted in HSB format for data processing using
the Image processing and Analysis software Image J (Version
1.45i).
Gene and protein expression analyses
Whole-mount in situ hybridization using DIG-labelled RNA
probe was carried out as described previously [55] using NBT/
BCIP (Roche) as substrate for staining. The myc riboprobe was
synthesized using the plasmid Hymyc1 (GenBank Accession
no. GQ856263) as template and used at a concentration of
0.1 ng/ml for hybridization. The Hymyc1 plasmid was produced as
described [10].
Total RNAs from treated and untreated animals was purified
using Tri Reagent (Molecular Research Center) and its concen-
tration was quantified on the NanoDrop ND-1000 spectropho-
tometer (Thermo Scientific, USA). The first-strand cDNA
synthesis was carried out with the SuperScript II Retrotranscrip-
tase (Invitrogen) and oligo dTs, using 0.5 mg of DNA-free RNA in
a final volume of 25 ml, according to the manufacturer’s
instructions. Semiquantitative RT-PCR was employed to estimate
myc mRNA levels. Each PCR reaction was carried out with
Platinum Taq DNA Polymerase kit (Invitrogen) in a total volume
of 25 ml containing 1 ml cDNA and 0.5 mM primers for Hymyc1
(forward: AGGACGAAGTTGATGTAGTTGGA; reverse: 59-
GCGAAGCAACTTTCAGTATTGTTAC-39 and Hydra Elonga-
tion factor 1a (59-ATGATTGAACCATCCCCAAA-39; 59GCT-
TCAATGGCAGGATCATT 39) as reference gene. After initial
denaturating step of 59 at 94uC, cycling steps were as follows: 30 s
at 94uC, 30 s 58uC and 30 s at 72uC. For comparative analysis,
the experiments were done in triplicate and data were collected at
different end point (25, 30 and 35 cycles).
Quantitative Real-Time polymerase chain reaction (qRT-PCR)
was performed in 25 ml of reaction mixture consisting of 16
Platinum SYBR green qPCR SuperMix-UDG with ROX
(Invitrogen), serial cDNA dilutions and 0.5 mM each primer.
The reactions were processed using the StepOne Real-Time PCR
system (Applied Biosystem) under the following cycling steps:
initial denaturation for 10 min at 94uC, followed by 40 cycles at
94uC for 15 s, 58uC for 30 s, and 72uC for 30 s, and a 20 min
gradient from 55uC to 90uC to obtain a melting curve. To
normalize RNA levels, Hydra Elongation factor 1a gene (HyEf-1a
GenBank Accession no. Z68181.1) was employed as internal
calibrator. Gene-specific primers (HyEf-1a: forward, 59CCAG-
GAGACAATGTCGGTTT 39; reverse, 59GCTTCAATGG-
CAGGATCATT 39; Hymyc1: forward, 59 TACAGAAAGC-
GAGGACGAAGTT 39; reverse, 59GCGAAGCAACTTTCA-
GTATTGTTAC 39; b-cat: forward, 59GGCGCTCTTCACA-
TTTTAGC 39; reverse, 59TGCACCTTCACGCTCAATAG 39)
were designed using Primer3 software (http://frodo.wi.mit.edu/
primer3/); the lengths of HyEf-1a and Hymyc1 amplicons were
100 bp and 157 bp, respectively. At least three independent
repeats for each experiment were carried out. Herein, the delta–
delta Ct (22DDCT) method, for comparing relative expression
results between treatments, was applied [56].
For Western blot analysis total proteins were extracted from
groups of 25 animals, using the triple detergent buffer according to
Sambrook et al. [57]. The resulting homogenate was centrifuged
for 15 min at 14000 g and the proteins contained into the
supernatants collected and quantified by the Bradford method
using BioRad reagent with BSA as a standard. Equal amounts of
proteins were separated on 12% SDS-polyacrylamide gel and
transferred onto nylon membranes (BioRad, San Diego, CA).
MYC protein levels were detected using anti-HyMYC1 antibody
(1:500, kindly provided by K.Bister, University of Innsbruck) and
compared to actin proteins, using an anti-actin primary antibody
(1:100, Sigma) to probe an identical blotted gel.
Hydra cell and tissue analysis
Analysis of siRNA treated animals was done both on whole
animals and isolated fixed cells. Animals were anaesthetized in 2%
urethane in Hydra medium for 2 min. The relaxed and elongated
Hydra were fixed with Lavdowsky’s fixative (ethanol: formalin:
acetic acid: water-50:10:4:40), rehydrated, and mounted on
microscope slides in Glycerol 50% in PBS (8 g/l NaCl; 0.2 g/l
KCl; 1.44 g/l Na2HPO4.7H20; 0.24 g/l KH2PO4). The tentacles
were examined for two types of nematocyst capsules (stenoteles
and desmonemes) under an optical microscope. The battery cell
structure, indeed, makes it possible to count the nematocytes with
phase optics (326) on the surface of a fixed tentacle facing the
objective. Each tentacle was divided into three ideal sections of
different length from the base to tip, and the number of
nematocytes present in the middle section was counted. The ratio
nematocyte/battery cell was calculated on a total of one hundred
battery cells, collected on ten different polyps. An estimate of the
tentacle length during head regeneration was calculated on images
from both untreated and siRNA treated animals using the Cell F
software (Olympus). At least 25 animals/condition were analysed.
For analysis of cell type distribution whole animals were
macerated into a suspension of fixed single cells as described [58].
Five animals per condition were macerated at the indicated time of
treatment and scored for single and pairs of interstitial cells
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(1 s+2 s), nests of four –sixteen proliferating or differentiating
nematoblasts (4 s216 s), zymogen and mucous cells, epithelial
cells (EPI). An average of 300 EPI cells was counted, per condition.
For cell nuclei detection cells were stained with 49,6-diamidino-2-
phenylindole dihydrochloride (DAPI) 0,25 mg/L before mount-
ing. For analysis of proliferation rates, intact Hydra, untreated or
treated for 48 hr with myc-siRNA, were continuously incubated
with bromodeoxyuridine (BrdU) 5 mmol/l (Sigma) for 1, 12, 24,
48 and 72 hr, immediately fixed, and macerated cells spread on
microscope slides as above described. BrdU incorporation in
proliferating cells was detected by immunolocalization using
mouse anti BrdU monoclonal antibody (1:500, Sigma), and
Novolink Polymer detection System (Novocastra Laboratories
ltd.). To further estimate cell proliferation, mitotic index was
measured on macerates through phase contrast optical microscopy
combined with Hoechst 33342 staining of nuclear DNA by
counting the percentage of cells undergoing mitosis (n = 1000 cells
for each treatment). To quantify cell cycle distribution, DNA
content profiles were determined on Hoechst 33342-stained
macerates. Fluorescence intensity of individual nuclei was
quantified by using the Fiji program from ImageJ software
package.
For tissue sectioning, test animals were soaked over night in
30% sucrose in PBS and then embedded in the frozen section
medium Neg-50 (Richard-Allan Scientific). Cryo-sections of
10 mm thickness were obtained by a cryostat (Leitz, digital
1760), collected on gelatine coated slides (Superfrost microscope
slides, Menzel) and mounted in D.P.X (Sigma) before imaging.
Statistical analysis
Tentacle length measurements, number of nematocyte per
battery cell, relative cell type counting and qRT-PCR results were
expressed as means6SD. The statistical significance of the results
was determined by analysis of Student’s t test. p values of ,0.01
were considered highly statistically significant (two asterisks). p
values of ,0.05 were considered statistically significant (one
asterisk).
Supporting Information
Figure S1 Structural anatomy of Hydra vulgaris. a)
Picture of living Hydra. The animal has a simple body plan: it is
a tube with a head at the apical end, and a foot, or basal disc at the
other. The head is in two parts, the hypostome (mouth) at the
apex, and below that the tentacle zone from which a ring of
tentacles emerge. Scale bar 200 mm b) the bilayered structure of
the animal: the body wall is composed of two self renewing cell
layers, an outer ectoderm and an inner endoderm, separated by an
extracellular matrix, the mesoglea. The arrows on the left side
indicate the direction of tissue displacement c) longitudinal sections
at level of tentacle (upper figure) and gastric region (lower figure).
On the tentacle, the ectodermal cells (ec) are called battery cells
and contain embedded several types of nematocytes (nem), one
sensory neuron facing the exterior (sn), a ganglial neuron (gn)
making connections both with other cells and to myonemes. Along
the animal body both ectoderm and endoderm layers are
composed of epitheliomuscular cells, while interstitial stem cells
and their intermediate and terminal derivatives (neurons,
nematocytes and secretory cells) are interspersed among ectoderm
and endoderm.
(TIF)
Figure S2 Zeta potential of siRNA as a function of pH.
The zeta potential of siRNA depends on the pH of the solution:
while at neutral pH siRNA show negative zeta potential values due
to the presence of phosphate groups of the RNA backbone, at
acidic pH, in Hydra culture medium, the presence of calcium
divalent ions neutralize the negative charges, conferring a positive
net charge to the molecules. The positive charge influences the
electrokinetics of the siRNA molecules, promoting their intracel-
lular uptake. Measurements were performed in Hydra medium, at
the indicated pH.
(EPS)
Figure S3 Acidic pH does not affect Hymyc1 expression
levels. A) Endogenous Hymyc1 expression levels were measured
by qRT-PCR on animals kept for the indicated periods at neutral
or acidic pH. Not significant differences were induced by the
different conditions. Data are mean of three independent
experiments. B) Image of a representative polyp incubated at in
Hydra medium at pH 4 for 4 days. The polyp appears healthy,
with long extended tentacles and presents no signs of toxicity
induced by the treatment.
(EPS)
Figure S4 Efficient silencing of b-catenin gene through
siRNA mediated RNAi. qRT-PCR was performed on total
RNA extracted from polyps treated 2 d with Hydra b-catenin
specific siRNA. A significant reduction of the Hyb-cat transcript
levels (60%), compared to HyEF1a, was induced by Hyb-cat
siRNA, showing the reliability and robustness of our approach.
Two asterisks, p,0.01, according to t-Student test.
(TIF)
Figure S5 Quantification of in situ hybridization signal
for Hymyc1 mRNA. The Image processing and Analysis
software Image J (Version 1.45i) was used to quantify the signal
intensity produced by in situ hybridization in control, myc-siRNA
and luc-siRNA treated animals, using Hymyc1 as probe. Not
significant differences were detected as effect of siRNA treatment,
indicating residual Hymyc1 transcripts in myc-RNAi animals. On
the other side, luc-siRNA animals were not affected in Hymyc1
expression, confirming the absence of putative side effects.
(TIF)
Figure S6 Effect of Hymyc1 RNAi on nematoblast and
gland cell proliferation. Cell cycling activity of A) nemato-
blasts (4 s) and B) gland cells. Control untreated animals
(incubated at pH 4) and myc-siRNA treated animals were
continuously incubated with BrdU (red line) and with the c-myc
inhibitor 10058-F4 (90 mM, green line), before maceration at the
indicated time points and fluorescence immunostaining. Data
represent the average of three different experiments. Not
significant differences were observed in the proliferation rates of
4 s and gland cells induced by myc-siRNA or 10058-F4 treatments.
(TIF)
Figure S7 Nuclear DNA content of interstitial stem cells
(1 s+2 s) in myc-siRNA treated Hydra. A) Hoechst 33342
staining and B) phase contrast image of macerated cells. 1 s and
2 s: large interstitial stem cells (note that 1 s is in mitosis); ecto:
ectodermal epithelial cell; endo: endodermal epithelial cell; gc:
gland cell. C) After three or four days of siRNA treatment, the
nuclear DNA profile of 1 s+2 s shows no significant differences as
compared with untreated polyps. Nuclei of 25 nerve cells and
differentiated nematocytes, which are terminally arrested in G1,
were used to determine the fluorescence intensity of the 2C DNA
content. Procedures: Polyps were treated for three or four days
with myc- siRNA. Then, treated and untreated animals were
macerated and spread onto microscope slides. After drying, the
maceration preparations were stained with Hoechst 33342.
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Fluorescence intensity of individual nuclei was finally quantified by
using the Fiji program of the ImageJ software package.
(TIF)
Figure S8 Distribution of the ratio nematocyte/battery
cells among different animals. At time 4 d and 9 d of
treatment with the indicated siRNA, animals were fixed and
examined under an optical microscope. Under fixed focus plane,
the ratio nematocyte/battery cell was calculated on a total of one
hundred battery cells, collected on ten different polyps. myc-siRNA
specifically induces an increase in the nematocytes embedded in
the tentacle battery cells.
(TIF)
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In the emerging area of nanotechnology, a key issue is related to the potential impacts of the novel nanomaterials on the
environment and human health, so that this technology can be used withminimal risk. Specifically designed to combine on a single
structure multipurpose tags and properties, smart nanomaterials need a comprehensive characterization of both chemicophysical
properties and adequate toxicological evaluation, which is a challenging endeavour; the in vitro toxicity assays that are often
employed for nanotoxicity assessments do not accurately predict in vivo response. To overcome these limitations and to evaluate
toxicity characteristics of cadmium telluride quantum dots in relation to surface coatings, we have employed the freshwater polyp
Hydra vulgaris as a model system. We assessed in vivo acute and sublethal toxicity by scoring for alteration of morphological
traits, population growth rates, and influence on the regenerative capabilities providing new investigation clues for nanotoxicology
purposes.
1. Introduction
During the past decade, advances in synthesis and biofunc-
tionalization of colloidal semiconductor nanocrystals have
generated an increasing widespread interest among investi-
gators in the field of biology and medicine. The multitude
of successful uses of quantum dots (QDs) as specific markers
for cellular structures and molecules, monitoring molecular
and physiological events in live cells and animals, is a
testimony of their great potential as multipurpose bioprobes
[1, 2]. However, there exists an open question regarding
whether nanoparticles per se can elicit biological responses,
which could interfere with the phenomena they are intended
to measure. Evidences are cumulating that nanoparticles
play active roles even in the absence of specific ligands
and that factors such as size and charge are crucial for the
activation of cell responses, internalization, and intracellular
trafficking [3, 4]. Thus, it is a priority for the wide scientific
community working to develop nanostructured materials
for biomedical purposes to relate the physical and chemical
characteristics of nanomaterials to their behaviour, in vivo.
While most of the published data addressing this important
issue rely on cell culture studies and are focussed on the
identification of the physicochemical parameters influencing
the impact of nanoparticle on living cells [5, 6], we propose
a new model system to work at the whole animal level. The
small freshwater polyp Hydra vulgaris (Cnidaria, Hydrozoa)
is a diploblastic animal, at the base of the metazoan
evolution, composed of just two epithelial cell layers (an
inner endoderm and an outer ectoderm facing the low
ionic strength medium) with few interspersed specialised cell
types, a neuronal net controlling functions and physiology
(Figure 1). This structural complexity, simpler than verte-
brates, with central nervous system and specialized organs,
but much complex compared to cultured cells, makes Hydra
comparable to a living tissue whose cells and distant regions
are physiologically connected [7].
The feasibility to approach biological issues using Hydra
as model system has been shown previously by our group.
In a pioneer work, we synthesised glutathione functionalised
quantum dots (GSH-QDs), studied the biological activity
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Figure 1: (a) Picture of living Hydra. The animal has a simple body plan: it is a tube with a head at the apical end and a foot or basal disc
at the other. The head is in two parts, the hypostome (mouth) at the apex and below that the tentacle zone from which a ring of tentacles
emerge. Scale bar 200 µm. (b) Schematic representation of the bilayered structure of the animal: the body wall is composed of two self-
renewing cell layers, an outer, the ectoderm, and an inner, the endoderm, separated by an extracellular matrix, the mesoglea. The arrows
on the left side indicate the direction of tissue displacement. (c) Along the animal body, both ectoderm and endoderm layers are composed
of epitheliomuscular cells, while interstitial stem cells and their intermediate and terminal derivatives (neurons, nematocytes, and secretory
cells) are interspersed among ectoderm and endoderm.
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Figure 2: Example of morphological alterations induced by the treatment of living Hydra with CdTe QDs. Animals were incubated with
increasing doses of TGA- and GSH-capped CdTe QDs, from left to right: 50 nM, 100 nM, 200 nM, 300 nM, 500 nM, 750 nM, and 1µM over
a period of 2 h and then imaged. Progressive morphological changes were scored from 10 down to 1, as previously described in[8].
evoked in living polyps, and identified GSH-targeted cells
[9]. In the following studies, we used rod-shaped CdSe/CdS
nanocrystals (QRs) not bearing functional groups to identify
the mechanisms underlying cell-QR interaction. Unexpect-
edly, Hydra treated with QRs showed a behavioural response,
a tentacle writhing activity, which was finely characterized
and shown to be calcium dependent and relying on the
presence of tentacle neurons. These results indicated that
the interactions between living organisms and newly syn-
thesised nanomaterials need to be deeply investigated before
employing any new nanostructure for biological purposes,
that is, for cell-tracking studies, drug delivery. We have also
identified both chemical and biological factors involved in
the interaction QR-Hydra [4] working both in vivo, at the
level of whole animal and isolated cells, and in vitro on
fixed specimens, concluding that the QR internalization is
the combined results of QR positive surface charge and
membrane trafficking events regulated by the presence of
annexin proteins on cell membranes.
A remarkable advantage offered by Hydra as a model
organism to be targeted by metal-based nanocrystals is
the possibility to evaluate the potential toxicity of these
nanoparticles on different aspects of Hydra physiology. The
availability of new animal models suitable for the assessment
of nanotoxicity is currently recognised as a priority. Hydra
is sensitive to a range of pollutants and has been used
as a biological indicator of water pollution [10–12]. Metal
pollutants such as copper, cadmium, and zinc have been
tested against different Hydra species, and the relative toxicity
based on the median lethal concentration (LC50) for all
species was ranked from copper, the most toxic, to cadmium
with zinc, the least toxic [13]. Drugs and pharmaceuticals
targeted at mammalian receptors have also been shown
to adversely affect Hydra, showing the feasibility to use
this aquatic invertebrate to accurately assess the potential
toxicological effect of pharmaceuticals entered into natural
waters through sewage eﬄuent and landfill leakages [12].
Several bioassays are available to assess the toxicity of a
given compound in terms of acute or sublethal toxicity.
Polyps exposure to different drugs may cause (1) alteration
of morphological traits and developmental programs, (2)
alteration of regeneration or pattern formation; the remark-
able regenerative capacity of Hydra relies on the presence
of mitotically active multipotent stem cells in the gastric
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Figure 3: Dose response toxicity curves to (a) TGA- and (b) GSH-capped QDs. 20 Hydra were treated with the indicated QD at increasing
concentrations for 2 hours and then, following extensive washing, allowed to recover in physiological solution for 24 hr (blue line), 48 hr
(red line), and, 72 hr (purple line), when morphology was appropriately scored. Median scores of morphological condition were compared
by nonparametric Friedman Test; values with a letter in common are not significantly different (P < .001). The toxicity of TGA-and-GSH
capped QDs on Hydra morphology increases with time and concentration.
region, able to regenerate a new organism within 72 hr; as
this process is controlled by temporal, positional, and mor-
phogenetic factors, the presence of toxicants in the medium
may affect the full process, and (3) alteration of population
growth rates; bioassays measuring Hydra population growth
by asexual reproduction are rapid, sensitive, and precise.
Large numbers of Hydra can be cultured due to their small
size and rapid reproductive rate [14]. The high reproductive
rate of Hydra enables subchronic toxicity test which assess
the population reproductive effects of a toxicant to be done
in short time periods.
In the present paper, we evaluated the toxicological
effects of fluorescent CdTe QDs, presenting different chemi-
cal coatings, on a whole organism, Hydra vulgaris. By using
different approaches, from in vivo evaluation of morpholog-
ical traits to the impact on growth rate and regeneration,
we determined different behaviours and toxicological effects
played by CdTe QDs, such as the influence of the surface
coating, showing the feasibility of using Hydra as fast, low-
cost, and reliable tool for nanotoxicology studies.
2. Methods
2.1. Nanocrystals Employed. The water-soluble CdTe QDs
used in this study were surface capped with thioglycolic acid
(TGA) or glutathione (GSH) and synthesized as described
in [15]. In this work, TGA-QDs (mean diameter of 3.1 nm)
present an absorption wavelength of the first electronic
transition at 537 nm, while GSH-QDs (mean diameter of
3.6 nm) at 598 nm.
2.2. Hydra Culture. Hydra vulgaris (strain Zurich, originally
obtained by P. Tardent) were asexually cultured in physi-
ological solution (SolHy: 1mM CaCl2, 0.1mM NaHCO3,
pH 7) by the method of Loomis and Lenhoff with minor
modifications [14]. The animals were kept at 18 ± 1◦C and
fed three times per week with freshly hatched Artemia salina
nauplii.
2.3. In Vivo Experiments with Intact and Regenerating
Animals. Groups of 20 animals were collected in plastic
multiwells and allowed to equilibrate at room temperature
in 300µL of physiological solution (SolHy: CaCl2 1mM,
NaHCO3 0.1mM, pH 7). The test was initiated by adding
test QDs to each well containing 10 polyps and incubating
as necessary. QD uptake was monitored in vivo, unless
otherwise stated, by continuous video recording using a
Camedia digital camera (Olympus) connected to a stere-
omicroscope (Olympus ZSX-RFL2) equipped with fluo-
rescence filter sets (BP460–490/DM505/LP510). Following
extensive washes, in vivo imaging was accomplished at several
magnifications by using both a stereomicroscope and an
inverted microscope (Axiovert 100, Zeiss) equipped with a
digital colour camera (Olympus, DP70) and fluorescence
filter sets (BP4502013490/FT510/LP515). In order to assay
acute toxicity, the morphological changes induced by QD
treatment were monitored, by using a scoring procedure
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Figure 4: Mean tentacle regeneration indices (TRI) plotted against corresponding days of regeneration. In (a), a scheme of the regeneration
is illustrated. Groups of 4 Hydra treated with TGA-QD (b) or GSH-QD (c) were bisected and allowed to regenerate for 14 days. For each
type of QD, two different concentrations were tested (50 nM, purple line, and 100 nM, green line) and compared to untreated regenerating
Hydra. Mean TRI values with diverse letter are significantly different (unpaired t-test (P < .001)).
of the progressive changes in structure. This procedure
allows to examine the ability of animals to recover from
QD-induced damage. Every day, using a stereomicroscope,
recognizable physical changes in response to different QD
ranges were recorded, according to score values (ranging
from 1 to 10) described byWilby [8]. For imaging acquisition
and analysis, the software system Cell F (Olympus) was
used. For regeneration experiments, treated polyps were
bisected in the gastric region and in vivo imaged at various
time points after amputation. A quantitative method was
used for the evaluation of distal regeneration in Hydra,
based on estimates of tentacle elongation during 14 days of
regeneration, determination of a tentacle regeneration index
(TRI), and a statistical analysis of profiles obtained from
various samples in different experiments [16]. According
to this method, for each of the N polyps, it is possible to
calculate at time t the corresponding Tentacle regeneration
index (TRI) as follows:
Rj(t) =
5∑
K=1
pk · n
j
k(t)
nmax
j = 1, 2, ...,N , (1)
where n represents the maximal tentacle number for a single
polyp under physiological conditions, that is, nmax = 8; njk(t)
represents the number of tentacles of class K (5 tentacle
classes were set, of length equal to 1/8, 1/4, 1/2, 3/4, and1)
regenerated by the jth Hydra at time t. The series of TRI
values of the jth polyp, obtained at the fixed observation
times, represents the individual regeneration profile of the
polyp. Finally, for each group of N = 4 Hydra, a mean TRI
was calculated at any observation time t in order to follow
the average regeneration rate of the group. Experiments
were performed in air-conditioned environment at 22◦C
and repeated three times for each condition tested. Median
lethal concentrations (LC50) and lethal time (LT50) were
calculated using the Spearman-Karber trim method [17].
2.4. Hydra Growth Rates. Experimental animals (four Hydra
with one bud) were treated with the indicated QD, for
4 h, then washed, and the following day placed in 3.5 cm
Petri dishes (1 Hydra/dish). Control animals at the same
developmental stage were not treated. Both experimental
and control Hydra were fed once daily, and the population
doubling time was determined as growth parameter. The
growth rate constant (k) of an exponentially growing group
of animals is defined as ln (n/n0) = kt, where n is the number
of animals at time t and n0 the number of animals at t0. For
n/n0 = 2, t = T2, the doubling time of the population T2
was determined by linear regression [18].
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Figure 5: Influence of the QD treatment on Hydra population growth rate. Population growth test started with a population of four full-
grown Hydra, incubated 2 h with the indicated QD, washed out, and monitored every day for bud detachment. Hydra were treated with
GSH-QDs, dark and light green bars, (a), or TGA-QDs, dark and light pink bars, (b), washed, and equilibrated in culture solution or not
treated (blue bars). The individuals were inspected daily and counted under a stereomicroscope. The logarithmic growth rate constant (k)
is the slope of the regression line using the standard equation of logarithmic growth: ln (n/n0) = kt. Significant differences between growth
rates of Hydra population treated with TGA-QD or untreated were obtained comparing linear regression slopes using ANOVA two-way test
(P < .005). On the right panel, n/n◦ ratio (±SD) extrapolated from growth curves at days 4 and 11 is indicated.
2.5. Statistical Analysis. LC50 and LT50 values were cal-
culated using the Spearman-Karber trim method [17].
Median scores of morphological condition were compared
by nonparametric Friedman analysis [13]. A t-test (P < .001)
was used to test for significance between TRI values within
treatments. The slope of the regression curves obtained from
single population growth rate was tested for significance
using a two-way ANOVA (P < .001).
3. Results
The two types of highly luminescent CdTe QDs were utilised,
thioglycolic acid-capped CdTe QD (from here it is indicated
as TGA-QDs) [15] and glutathione-capped QDs (from here
named GSH-QDs), and the effects on animal behaviour and
morphology where investigated over different incubation
times. Being Hydra a small water living animal, the simple
addition of QDs to the culture medium enables us to study
the interaction between QD and animals, avoiding delivering
methods or invasive procedures. TGA-QDs and GSH-QDs
were added at different concentrations to groups of living
polyps which were continuously monitored by fluorescence
stereomicroscopy to visually inspect potential QD uptake,
localisation, and cell morphology following incubation. By
fluorescence microscopy observation, the animals appeared
not fluorescently labelled, possibly due to the effect of
calcium ions present in Hydra culture solution, which have
been shown to bleach the QD luminescence [19]. As shown
in Figure 2, morphological alterations were induced by
the treatment the with both CdTe-based QDs and scored
according to previous methods [8].
A precise and accurate estimation of the median lethal
concentration (LC50) was obtained by applying the trimmed
Spearman-Karber method, which has good statistical prop-
erties, is easy to use, and is recommended for accurate and
precise calculation of LC50 values and their 95% confidence
interval end points [17]. As this method counts the dead
animals and Hydra can recover the damage, we considered
dead animals as those showing scores lower than 4. Median
scores recorded at each QD test concentration of treated
animals decreased with increasing exposure, concentration,
and time, as shown in the graphs of Figure 3.
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In Table 1, LC50 and LT50 values calculated using the
Spearman-Karber method are reported for both TGA- and
GSH-capped QDs. TGA-QDs are characterized by lower
values of both LC50 and LT50 compared to GSH-QDs,
indicating a more toxic effect played by the thioglycolic acid
surface compared to glutathione capping.
To fully characterize the toxicological impact of CdTe
QDs on Hydra, two further approaches were followed. The
first one is based on the capacity of Hydra to regenerate
missing parts of the body after amputation. During head
regeneration, the development of new tentacles can be
monitored by stereomicroscopy, and tentacles numbers and
lengths can be scored daily to assess the potential effects
played by a toxicant on this controlled process. We used
a quantitative method to assay the effect of QD treatment
on Hydra regeneration [16], calculating every day for each
condition the tentacle regeneration index (TRI), which
indicates the average tentacle length/Hydra (relative to the
maximum tentacle length, assumed as 1 when the process is
completed).
As shown by the graph of Figure 4, TRI values for
TGA-QD-treated animals were significantly lower compared
to TRI of untreated animals. These differences were more
evident during the first days of tentacle regeneration (gray
shaded in the left panel of Figure 4) and less evident during
the late stages of tentacle development. GSH-QD-treated
animals, by contrast, were characterized by TRI similar to
untreated animals, indicating for this QD type the absence
of toxic effect on Hydra regeneration.
Finally, the potential long-term toxic effects induced by
CdTe QDs on Hydra reproductive capabilities were assayed.
Growth rate of Hydra tissue is normally regulated by a
balance between epithelial cell cycle length, phagocytosis of
ectodermal cell in “excess,” and bud formation [18]. Thus,
the population growth rate is an indirect measure of the
Hydra tissue growth rate and cell viability. The growth
rates of QD-treated polyps were calculated and compared to
untreated animals, under regular feeding regime. As shown
in the graph of Figure 5(a), the growth rate of polyps treated
with GSH-QDs (two different sublethal concentrations were
used) was similar to untreated animals, indicating the
absence of toxic effects. Slight differences were observed only
at the beginning of the experiment, as shown by the ratio
n/n◦ (number of individuals/number of the founders) at day
4, but not later, that is, at day 11, when the differences were
not significant.
Constant growth rates of Hydra treated with TGA-QDs
(Figure 5(b)), on the opposite, were significantly different
from untreated Hydra. Differences in the ratio n/n◦ were
found all along the period of investigation, indicating an
adverse effect displayed by this type of QD on Hydra repro-
ductive capability.
4. Discussion
Despite the abundant data accumulated on the toxicity of
CdTe QD on cell culture systems [20–23], it is a priority of
the scientific community to assess toxicological effects at the
level of whole animal. Hydra vulgaris represents an amenable
system to study the impact of the new nanomaterials on
living organism, as it is very simple; it is structured in only
two cell layers, thus it can be compared to a living tissue, but
it presents the complex physiology and behaviour of evolved
animals. The transparency of the epithelia makes it possible
to track fluorescent nanoparticles, while its sensitivity to
metals makes it an ideal model for nanotoxicology studies.
In this study, we investigated the effect of CdTe QDs on
Hydra, using three different approaches, that is, assessing
the effect on the polyps morphology and regenerating
and reproductive capabilities. We quantitatively estimated
these effects, calculating LC50 and LT50 values, tentacle
regeneration index, and population growth rate, respectively,
for each approach. Overall our data show that TGA-capped
QDs display toxic effect compared to GSH-capped QD or to
untreated animals. As by fluorescence microscopy, we were
unable to evaluate the uptake of the fluorescent QDs into
Hydra cells; at this stage, we cannot assess whether the tox-
icity is due to an intracellular or extracellular action played
by the TGA-QDs. As we have previously shown that the
positive surface charge is the crucial factor for nanoparticle
internalization into Hydra cells [4], the observed toxicity
of TGA-QD might be due to an extracellular activity, that
is, binding and competing to divalent ions for membrane
receptors, and we are currently investigating in to this aspect.
Several studies suggested that the cytotoxic effects of
(QDs) may be mediated by cadmium ions (Cd2+) released
from the QD cores [24], and indeed Hydra has been shown
sensitive to free Cd ions [10]. However, we performed
similar bioassays using the supernatant of pelleted QD
preparation, and we could not detect any induced toxicity,
suggesting a potential role of the Cd2+ ions coordinated by
the negative groups of the capping TGA, on the QD surface,
rather than a release Cd2+ from the QD core. Thus, the
identification of Hydra Cd2+ responsive membrane proteins
would shed light on the potential mechanism of CdTe-QD-
induced toxicity. The dose-dependent correlation between
animal viability and QD administered further supports the
hypothesis that their cytotoxicity depends on the QD actions
and not on other ongoing processes, opening the path to
future investigations on the intriguing cellular and molecular
mechanisms underlying the CdTe-QD response in Hydra.
Confocal laser microscopy of single-cell preparation from
CdTe-QDs-treated animals imaged with organelle-specific
dyes might reveal lysosomal damage attributable to the
presence of reactive oxygen species (ROS), which can be
formed via Cd2+-specific cellular pathways and/or via CdTe-
triggered photo-oxidative processes involving singlet oxygen
or electron transfer from excited QDs to oxygen [20, 25].
Cell biology investigation tools to check for the presence
of necrosis processes or for the induction of programmed
cell death (apoptosis) will help to unravel the mechanism
underlying CdTe QD toxicity, which would be of invaluable
help to decipher the basis of semiconductor nanocrystal
toxicity also in higher organisms.
In summary, we have shown that, when CdTe QDs
interact with Hydra cells, this interaction induces progressive
changes of cell morphology, leading finally to cell and animal
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Table 1: Comparison of Mean (SE) lethal concentration (LC50) and lethal time (LT50) for TGA- and GSH-capped QDs.
LC50 (nM) QD LT50 (hr)
Time (h) TGA-QDs GSH-QDs TGA-QDs 300 nM 36
24 687.04 (27.9) — TGA-QDs 500 nM 24
48 232.89 (31.5) 629.99 (18.8) GSH-QDs 500 nM 63
72 153.24 (18.9) 434.29 (15.3) GSH-QDs 1000 nM 32
death. CdTe-QD-induced cytotoxicity was associated with
QD exposure time and concentration and with the surface
chemistry and coating of the QD. Animal exposure for 2 hr
to nanomolar doses of CdTe QD induced progressive mor-
phological alterations, which were scored up to 72 hrs when
the complete death was detected. Anterior-posterior polarity,
which is normally established during bud morphogenesis
and regeneration, was not affected. The induced toxicity was
more pronounced in case of TGA-QD exposure, rather than
GSH-QD, as shown by the dose responses curves. By treating
the animals with sublethal doses of QDs, both regeneration
assay and population growth rate were affected by TGA-
and not GSH-capped QD, suggesting either an increased
subcellular stability of GSH-QDs or a protective role played
by GSH against potential Cd2+-induced ROS productions.
As nanoparticles may enter natural waters through
sewage eﬄuent and landfill leakages and present unknown
risk to aquatic species including freshwater invertebrates,
we recommend that invertebrate testing is used not only
to advance the level of knowledge in nanoecotoxicology
but also for investigating the behaviour and bioavailability
of engineered nanoparticles in the aquatic environment
through standardized tests. In conclusion, we suggest that
our simple model system, up to now used mainly by a
niche of biologists to study developmental and regeneration
processes, has great potential to inspire many scientists
working in the field of nanoscience, from chemists to tox-
icologists demanding new models to study the impact of
nanoparticles on living organisms and their environment
and to investigate the molecular basis of the bio-nonbio
interactions.
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a b s t r a c t
A systematic and thorough quantitative analysis of the in vivo effects of inorganic nanoparticles is
extremely important for the design of functional nanomaterials for diagnostic and therapeutic applica-
tions, better understanding of their non-speciﬁcity toward tissues and cell types, and for assessments of
their toxicity. This study was undertaken to examine the impact of CdTe quantum dots (QDs) on an
invertebrate freshwater model organism, Hydra vulgaris, for assessment of long term toxicity effects. The
continuous exposure of living polyps to sub-lethal doses of QDs caused time and dose dependent
morphological damages more severe than Cd2þ ions at the same concentrations, impaired both repro-
ductive and regenerative capability, activated biochemical and molecular responses. Of remarkable
interest, low QD doses, apparently not effective, caused early changes in the expression of general stress
responsive and apoptotic genes. The occurrence of subtle genetic variations, in the absence of
morphological damages, indicates the importance of genotoxicity studies for nanoparticle risk assess-
ment. The versatility in morphological, cellular, biochemical and molecular responses renders Hydra
a perfect model system for high-throughput screening of toxicological and ecotoxicological impact of
nanomaterials on human and environmental health.
! 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Semiconductor nanocrystals, also known as colloidal quantum
dots (QDs), have been widely employed as components of solar
cells [1,2] and light-emitting diodes [3,4] and have a great potential
as probes for ultrasensitive molecular sensing, diagnostic imaging,
and actuators for drug delivery [5e9]. Their unique photophysical
properties, such as high brightness, resistance to photobleach, and
the ease of functionalizationwith targeting ligands for site-directed
activity are very attractive for several areas of biology andmedicine.
However, major concerns have been raised regarding the toxicity of
heavy metal based QDs, especially for those containing cadmium
(Cd) in the core, like CdSe or CdTe QDs encapsulated in various
coatings [10e13]. While risks posed on human health by Cd toxicity
have been known and thoroughly investigated for over 50 years
and extensive studies on both the genotoxic and cellular effects
have been performed on many model systems [14], the large
variety of inducible effects, from the intracellular damages, to the
induction of oxidative stress, apoptosis, disruption of intracellular
calcium signalling still remain separate pieces of a complex puzzle
[15,16]. Toxicity evaluation of Cd-based QDs appears rather difﬁcult,
and even more if considering several nanoscale depending prop-
erties to be taken into account, such as quantum size effects and
electronic interactions; particle’s size, surface coating and charge;
particular synthetic route, etc [17e21]. In the in vitro models the
cytotoxic effects of Cd-based QDs have been ascribed to the release
of Cd2þ ions from the particle core [22e24], as well as to the Cd2þ
ions present at particle surface [25,26]. Coating of these QDs with
an additional inorganic shell (i.e ZnS) or stabilizing ligands
employed during the synthesis (i.e., thioglycolic acid (TGA), gluta-
thione (GSH), mercaptopropionic acid, cysteamine) has been
shown to strongly inﬂuence the interactionwith living cells and the
toxicity of QDs [13,26e28]. Depending on the subcellular localiza-
tion of the internalized QDs, and the local pH and the redox envi-
ronment they encounter, stabilizing ligands can be removed from
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the surface via protonation or photooxidation [29,30] resulting in
the QD aggregation and/or exposure of their inorganic core to the
cytoplasmic biomolecules. Such unprotected QDs may induce the
generation of Reactive Oxygen Species (ROS), whose cellular
unbalance causes modiﬁcation and damage of lipids, proteins and
DNA, ﬁnally leading to cell death [21,28,31]. However, cell death
induced by Cd-based QDs has also been associated with apoptotic
pathways, as shown both at biochemical and molecular levels by
the deregulated expression of anti- and pro-apoptotic genes, i.e. Fas
receptor and Jun-N-terminal kinase (JNK) in neuroblastoma cells
[32], Bax, Bcl-2 and caspase in human breast cancer cells [33].
Despite the great number of cytotoxicity studies utilizing in vitro
models, in vivo studies of the inorganic nanoparticles have been
very limited [34e36]. In vivo systems are extremely complicated
and interactions of nanomaterials with biological components,
such as proteins and cells, could lead to unpredictable effects.
Aquatic invertebrates, routinely employed for environmental
pollution studies, are valuable organisms for both toxicology and
ecotoxicology studies. After release to the aquatic environment
nanoparticles can be uptaken by planktonic or sediment dwelling
invertebrates, and enter the food chain, representing a hazard for
wildlife and humans [37]. Although a few studies have been testing
Cd-based QDs in freshwater invertebrates such as Daphnia magna
[38] and the mussel Elliptio complanata [39,40], quantitative data
are still rare, and further in-depth studies are highly desirable.
Here, we have chosen the cnidarian polyp Hydra vulgaris, a well
characterized system to test environmental pollution, to assess
toxic effects of thiol-capped CdTe QDs, a well known example of
light-emitting semiconductor nanoparticles which can be directly
synthesized in water [41,42]. Hydra is a small freshwater polyp,
shaped like a hollow tube with a basal foot and an apical mouth
surrounded by tentacles. It can be easily maintained in the lab
allowing massive culturing. Polyps exposure to medium suspended
toxicants may cause alteration of morphological traits and devel-
opmental programs, adversely affect regeneration process, pattern
formation, reproductive capabilities, parameters that can be all
precisely and accurately estimated and quantiﬁed by reliable
assays. Hydra has been used in the past to study the toxicity of
efﬂuents [43] and heavy metals [44,45]. Moreover, owing to its
remarkable regenerative capacity, it was employed to examine the
teratogenic potential of several chemicals including ethinylestra-
diol and bisphenol A [46,47], nonylphenol [48] and several phar-
maceuticals [49e51]. Furthermore, the molecular tools available,
i.e. whole genomic sequence, gain and loss of function techniques,
may enable to study at molecular level the mechanisms underlying
the toxicity.
In the past few years we have tested the interaction of both
quantum dots and quantum rods coated by amphiphilic polymers
with Hydra, showing their great potential for studies of in vivo
imaging and cell tracking, as well as behavioural assays [52e55].
More recently we have reported that CdTe QDs (stabilized by either
TGA or GSH) induce clear signs of toxicity in acute lethality tests
[55]. With the aim to understand the long- term effect of CdTe QDs
on Hydra, we provide here a comprehensive toxicity study of one
speciﬁc QD type (TGA capped CdTe QDs), rather than comparing
different chemistries of QD coatings. Different organic ligands of
QDs exposed at the cell surface may elicit speciﬁc responses, which
might be difﬁcult to distinguish from the Cd responses, due to the
overlapping and cross-talking of defence mechanisms occurring
inside the cell. We evaluated the QD toxicity using multiple quan-
titative approaches, spanning from in vivo tests (evaluation of
morphological alterations, reproductive and regenerative capabil-
ities), to cell biology approaches (determination of cell proliferation
rate, nuclei apoptosis markers), up to the molecular analysis of
genes involved in the cell death by controlling apoptosis or cell
stress responses. Our results address multiple aspects of QD
induced toxicity offering a valuable scenario of the possible sig-
nalling pathways activated, and emphasizing the use of Hydra as
efﬁcient, cost effective and reliable model system to assess in vivo
ecotoxicological impact of colloidal nanomaterials.
2. Materials and methods
2.1. Culture of test organism
H. vulgaris were cultured in Hydra medium comprising 1 mM calcium chloride,
0.1 mM sodium hydrogen carbonate, pH 7 [56]. Animals were fed on alternate days
with Artemia nauplii at 18 "C with a 12:12 h light: dark regime. Polyps from
homogeneous populations, three-weeks-old and carrying one or two buds, were
selected for the experiments.
2.1.1. Toxicity of CdTe QDs to individual polyp
At an early stage, lethal toxicity studies were performed in order to assess the
animal tolerance and to accurately set the sub-lethal doses of QDs.
Increasing QD concentrations (from 1 nM to 100 nM, corresponding to 0.04 mg/
Le4.0 mg/L Cd equivalent, as determined by elemental analysis) were selected to
assess the progressive effects on the morphology and physiology of individual
polyps. Toxicity tests were carried out on groups of 25 polyps for 24, 48 and 72 h. The
animals were placed into plastic multiwells maintained at a temperature of 18 "C in
an incubator with a light regime of 12 h light and 12 h dark, refreshing the medium
every 24 h. For comparison, toxicity tests using water-soluble CdCl2 salt, prepared
from 100 mg/L stock solutions using Hydra medium as diluent were performed at
same time points to study the effects caused by Cd2þ ions. Effects were recorded by
microscopic examination of each polyp at 24 h intervals and a score was assigned
ranging from 10 for a normal polyp to 0 if it was disintegrated, as described in the
key (Table S1 of Supplementary data) constructed by Wilby [57] and used by many
authors [45,50,58]. The median scores were analysed at 24, 48 and 72 h for each
concentration of QDs and CdCl2.
2.2. Estimation of the Cd content per Hydra by elemental analysis
Five hundreds polyps were incubated for 12 and 24 h with 1 mg/mL Cd supplied
either as QDs (corresponding to 25 nM nanoparticle concentration) or as CdCl2 salt,
then washed and digested by the addition of a HCl/HNO3 3:1 (v/v) solution. The
intracellular Cd content was measured by means of ICP-AES (Inductively Coupled
Plasma Atomic Emission Spectrometer). The data obtained were reported as Cd
content per Hydra.
2.3. Hydra growth rates and regeneration
Animals (four Hydrawith one bud) were treated with 10 and 25 nM of CdTe QDs
for 24 h, then washed, and the following day placed in 3.5 cm Petri dishes (1 Hydra/
dish). Control polyps at the same developmental stage were not treated. Both
treated and untreated Hydra were fed once daily for 14 days. The growth rate
constant (k) of an exponentially growing group of animals is deﬁned as ln(n/n0) ¼ kt
where n is the number of animals at time t and n0 the number of animal at t0. For n/
n0 ¼ 2, t ¼ T2, the doubling time of the population. T2 was determined by linear
regression [59]. For regeneration experiments, groups of 25 polyps were bisected in
the upper gastric region and incubated in presence of 10 nM and 25 nM QDs. The
regenerating polyps, monitored through a stereomicroscope, were grouped in three
stages according to their tentacle morphogenetic process.
2.4. BrdU assay
To estimate the cell proliferation rate, intact Hydra, untreated or treated for 72 h
with 25 nM QDs, were continuously incubated with 5 mmol/L bromodeoxyuridine
(BrdU) (Sigma) for 12, 24, 48 and 72 h. Animals were anaesthetized in 2% urethane in
Hydra medium for 2 min, macerated by heating, immediately ﬁxed with 4% para-
formaldehyde and the cells spread on microscope slides. BrdU incorporation in
proliferating cells was detected by immunolocalization using mouse anti BrdU
monoclonal antibody (1:500, Sigma), and Novolinker polymer detection system
(Novocastra) according to the manufacturer’s instructions. Epithelial and interstitial
BrdU-labelled cells were observed and counted by phase contrast microscopy
(Axiovert 100, Zeiss) equipped with a digital colour camera (Olympus, DP70).
2.5. RNA extraction and qRT-PCR
Total RNA from treated and untreated animals was puriﬁed using Tri Reagent
(Molecular Research Center) and its concentrationwas determined on the NanoDrop
ND-1000 spectrophotometer (Thermo Scientiﬁc, USA). The ﬁrst-strand cDNA
synthesis was carried out with the SuperScript II Retrotranscriptase (Invitrogen) and
oligo dTs, using 0.5 mg of DNA-free RNA in a ﬁnal volume of 25 ml, according to the
manufacturer’s instructions. Real-time RT-PCR (qRT-PCR) was performed in 25 ml of
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reaction mixture consisting of 1$ Express Sybr" GreenER qPCR SuperMix with pre-
mixed ROX (Invitrogen), serial cDNA dilutions and 0.3 mM each primer. The reactions
were processed using the StepOne Real-Time PCR System (Applied Biosystem) under
the following fast cycling steps: initial denaturation for 2min at 94 "C, followed by 40
cycles at 94 "C for 2 s, 59 "C for 30 s. In addition,melting curves (20min; from59 "C to
90 "C) were generated to check any spurious ampliﬁcation products. To normalize
RNA levels, Hydra Elongation factor 1a gene (HyEf-1a, GenBank Accession no.
Z68181.1) was employed as internal calibrator. Nucleotide sequences and alignments
were obtained from Hydra genome database (http://Hydrazome.metazome.net).
Speciﬁc primers of Hydra homologues genes of Superoxide dismutase (HySOD),
Caspase 3 (HyCasp3), c-myc (Hymyc1), FoxO, Hsp70, Bcl-2 (Bcl2-like 4), were
designed using Primer3 software (http://frodo.wi.mit.edu/primer3/) and are listed in
the Table S2 of Supplementary Data. Gene expression was evaluated in QD treated
and untreated polyps; at least three technical repeats from three biological replicates
were carried out. Herein, the deltaedelta Ct (2-DDCT)method, for comparing relative
expression results between treatments, was applied [60].
2.6. Assessment of apoptosis
Apoptotic cell death was evaluated by 40-6-Diamidino-2-phenylindole (DAPI)
staining and conﬁrmed by Terminal deoxynucleotidyl Transferase-mediated dUTP
nick end labeling (TUNEL) assay [61]. Brieﬂy, untreated and QD treated polyps were
macerated and the single cell suspension was ﬁxed with 4% paraformaldehyde and
spread on slides. After extensive washing in PBS, macerates were stained with DAPI
for 2 min and washed in PBS. Slides were observed with phase-contrast ﬂuorescent
microscopy to detect picnotic nuclei. More than 300 cells were counted for each
treatment and the percentage of apoptotic nuclei was determined. In Situ Cell Death
Detection Kit Fluorescein (Roche) was used for TUNEL assay to conﬁrm the nuclear
shrinkage in macerates. In particular, ﬁxed cells were permeabilized for 2 min with
0.1% Triton X-100/0.2% sodium citrate solution. Slides were incubated with 50 ml
TUNEL reaction mixture in a humid dark chamber for 60 min at 37 "C, extensively
washed in PBS and counterstained with DAPI solution. The presence of apoptotic
cells was conﬁrmed by counting ﬂuorescein-labelled nuclei by ﬂuorescent
microscopy.
2.7. Caspase assay
Caspase-3 activity was measured using the Ac-DEVD-AMC (N-Acethyl-Asp-Glu-
Val-Asp-7-amino-4-methylcoumarin) ﬂuorogenic substrate (Alexis). Total protein
extraction from untreated and QD-treated polyps was carried out in 25 mM HEPES
pH 7.5, 5 mMMgCl2, 1 mM EGTA, protease inhibitors (leuptin, pepstatin and aprotinin
10 mg/ml each), and 1 mM Pefabloc. Protein content was measured using Bradford
assay (Bio-Rad, CA). Standard curves for Caspase-3 substrate were prepared with
serial dilution of AMC (aminomethylcoumarine, Calbiochem). Protein extracts for
each treatment were incubated with 100 mM Ac-DEVD-AMC substrate in 25 mM
HEPES pH 7.5, 0.1% CHAPS, 10 mM DTT and protease inhibitors for 1 h at 37 "C.
Caspase-3 activity was measured by monitoring the release of ﬂuorogenic AMC
using a microplate reader (Inﬁnite M1000, TECAN).
3. Results
3.1. Hydra exposure to CdTe QDs: impact on the morphology and
survival rate
TGA capped QDs (3.2 nm mean diameter with an absorption
wavelength of the ﬁrst electronic transition at 550 nm) were
synthesized as previously reported [41]. Living animals were
soaked in culture medium supplemented with increasing QD doses
(from 1 nM to 100 nM) and monitored at 24, 48 and 72 h of incu-
bation. Progressive physical damages were observed, as shown by
representative images of Fig. 1A. Morphological alterations were
estimated using a score system ranging from 10 (indicative of
healthy condition) to 0 (animal fully disintegrated), as previously
reported [57] (Table S1 and Fig. S1 of Supplementary Data). Median
scores recorded at each QD test concentration decreased for treated
animals with increasing concentration and incubation time
(Fig. 1B). Similar toxicity curves were obtained by exposing animals
to water-soluble CdCl2 salt, at concentrations comparable to Cd
contained in the QD. According to the ICP-AES analysis, 10 nM and
25 nM concentration of QDs equals to 0.4 mg/L and 1 mg/L Cd,
respectively. By comparing statistically the median scores of
animals exposed to similar Cd doses, supplied either as CdCl2 (plane
line) or CdTe QDs (dotted line), signiﬁcant lower values were
produced by QDs at each time point and test concentration relative
to Cd salt (Fig. 1C), indicating a more toxic effect of QDs. Mortality
data from these experiments were analysed to determine median
lethal times (LT50) and median lethal concentrations (LC50), pre-
sented in Fig. 1D. These values were calculated by applying the
trimmed Spearman-Karber method, which offers good statistics, is
easy to use, and is recommended for accurate and precise calcu-
lation of LT50 and LC50 values and their 95% conﬁdence interval
end points [62]. The calculated values at 24 h time point, clearly
indicated amore toxic effect caused by QDs compared to equivalent
CdCl2 doses, conﬁrming morphological analysis. Overall, the two
different methods used to examine toxicity of CdTe QDs, based on
structural changes and on mortality, enabled to determinate sub-
lethal doses to assess QD long term effects.
Due to the luminescence quenching effect played by the Hydra
culture medium (containing 1 mM calcium ions) on CdTe QDs [63],
we could not observe their internalization into Hydra tissues via
in vivo optical detection. As it has been widely discussed that the
primary determinant of CdTe QDs toxicity might be Cd2þ ions
released from QDs [17,23,24], by means of ICP-AES we measured
the intracellular Cd concentration of animals treated either with
QDs or with equivalent amount of CdCl2. Fig. 1E shows the Cd
content per Hydrameasured after 12 and 24 h of incubation: for QD
treated polyps most of the uptake occurs over the ﬁrst 12 h of
incubation, as shown by similar Cd amounts found also at 24 h. For
CdCl2 treated animals the measured Cd content was nearly three
times higher, suggesting different internalization route and toxicity
mechanisms for CdTe QDs and Cd2þ ions. In order to further assess
the stability of CdTe QDs in Hydra medium, an estimation of the
amount of Cd2þ ions released into solution was performed
following QD centrifugation and analysis of both the QD and the
remaining supernatant solution after 12 and 24 h of incubation.
Results of these measurements (shown in Fig. S2 of Supplementary
Data) indicate that only small percentages of Cd2þ ions are released
into solution at these two time points (12% and 14% of the total
measured Cd, respectively), indicating a good stability of QDs in
Hydra medium. This further conﬁrms that the observed toxicity
effects were mostly due to the intact QDs rather than to the small
amounts of released Cd2þ ions. From here onwards the toxicity
studies were performed on CdTe QDs, without comparing them to
CdCl2.
3.2. Hydra exposure to CdTe QDs: impact on regeneration and
reproductive capabilities
The QD toxicity screening in vivo, at whole animal level, was
completed by the assessment of the impact on the regenerative and
reproductive capabilities. Hydra polyps are characterized by the
remarkable capacity to regenerate amputated body parts: during
the ﬁrst 48 h post-amputation (p.a.) morphogenetic processes take
place, followed by cell proliferation to restore adult size. Healthy
polyps were bisected and allowed to regenerate in presence of sub-
lethal doses of QDs. A clear dose dependent inhibition of regener-
ation was observed (Fig. 2A): stumps exposure to high QD dose
(25 nM) impaired most of polyp head regeneration at stage
0 (stumpswith no emerging tentacles) and caused 35% ofmortality,
while exposure to 10 nM QDs slightly impaired patterning during
the ﬁrst 48 h, but this effect was later completely recovered. The
observed differences in the efﬁciency of regeneration (for the 25 nM
treatment) were highly signiﬁcant as shown by the statistical
analysis (Chi-square equal to 73.4, with six degree of freedom,
P < 0,0001).
Besides the effect on regeneration, the reproductive capability of
QD treated polyps was estimated. In Hydra, the epithelial cells
structuring its body continuously divide, migrate towards the
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Fig. 1. Toxicological impact of CdTe QDs on Hydra’s morphology and viability. A) Examples of morphological alterations induced by continuous exposure to CdTe QDs. The green
arrow represents the score system [57] used to evaluate progressive morphological changes of polyps exposed to CdTe QDs, ranging from 10 (healthy animals) to 0 (disintegrated
polyps). The complete description of the structural changes associated to the numerical score is provided in Table S1 of Supplementary Data. B) Toxicity curves of Hydra polyps
exposed to different concentrations of Cd in QDs or CdCl2. For both treatments, toxicity increases with time and concentration. For each test concentration and time point median
values were calculated on groups of 25 animals. A representative experiment from triplicates is shown. C) For each concentration, a statistical analysis of signiﬁcance between QD
and CdCl2 treatment indicates a higher toxic effect of QDs compared to the same amount of CdCl2 (KruskaleWallis non parametric Anova and Dunn’s post hoc tests, p < 0.0001). D)
Comparison of median lethal concentration (LC50) and median lethal time (LT50) for QDs and CdCl2. Scores %5 were reversible and sub-lethal, while scores &4 were considered
lethal. As the test is based on mortality data, and CdCl2 at 0.4 mg/L does not cause mortality, for the CdCl2 treatment the LT50 were calculated relative to 1 mg/L and 2 mg/L
concentration. Data are means ('SD) of three independent experiments (n ¼ 60). E) The intracellular Cd amount was evaluated by elemental analysis. Hydra polyps were incubated
with either QDs or CdCl2 salt at an equivalent Cd concentration (1 mg/L) for 12 and 24 h. The Cd content is reported as mass per Hydra. (For interpretation of the references to colour
in this ﬁgure legend, the reader is referred to the web version of this article.)
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animal ends, contributing to the formation of new individuals,
budding from the gastric region, and detaching from the mother in
about 3 days (Fig. 2B, upper panel) [59]. Environmental factors,
such as the presence of pollutants or the feeding regime, can affect
this process. Thus, the population growth rate is an indirect
measure of the Hydra tissue growth rate and cell viability. A group
of founder animals (n") either untreated or incubated for 24 h with
10 nM or 25 nM QDs, were monitored over two weeks, and the total
number of individuals (n) used to calculate the growth rate
constant (k) over the duration of the experiment (t), was deﬁned by
the equation ln(n/n") ¼ kt. In Fig. 2B the growth rate curve of
animals treated with 25 nM QDs was found signiﬁcantly different
from the others (untreated animals, or treated with the 10 nM QDs),
over the initial days of monitoring, impacting on the total pop-
ulation along the overall period. Comparing the growth parameters
at each inspection time (lower panel of Fig. 2B) signiﬁcant differ-
ences were found in the k values and in the budding rates at the
beginning (day 3) but not at the end (day 14) of the observation
period, indicating that the treated population founders were
impaired in the budding process. As the QDs were diluted to the
progeny, from the second generation onwards, the reproduction
process was progressively less affected up to the normal physio-
logical rates (k values become not signiﬁcantly different in about
one week).
3.3. Cytotoxic effects of CdTe QDs: cellular and biochemical
evidences
As the growth rate is related to the epithelial cell cycle, we also
investigated the potential effect of QDs on cell proliferation activity.
Hydra polypswere co-incubated with 25 nM QDs (the dose affecting
reproduction) and BrdU (see Materials and methods); the prolif-
eration rates of both epithelial and stem cells were calculated over
72 h by BrdU immunodetection. Results presented in Fig. 3A and B
show a signiﬁcant decrease in the cell proliferation activity of
epithelial and interstitial cells of treated animals, starting 24 h after
QD incubation. This effect on cell division accounts for the
decreased population growth observed in Fig. 2B.
As nuclear shrinkage, chromatin condensation and DNA damage
are associated with multiple pathways leading to cell death, we
analysed by confocal laser scanning microscopy possible effects of
QD treatment with nuclear morphology. A quantitative analysis
performed on single cell suspensions obtained from treated
animals, shows that the nuclear damage is time and dose depen-
dent, as cells treated with 25 nM QDs for 72 h show the highest
percentage (20%) of damaged nuclei (Fig. 3C). The presence of
apoptotic nuclei also in untreated polyps is due to the physiological
role played by the programmed cell death in maintenance of the
steady state in continuously renewing tissues, such as all Hydra
Fig. 2. Inﬂuence of CdTe QDs on Hydra regeneration and reproduction A) Impact of CdTe QDs on regeneration. Groups of 15 animals were bisected at subhypostomal level and
allowed to regenerate (scheme at the top panel) in presence of 10 nM or 25 nM QDs, or in normal medium. At 48 h and 72 h post-amputation animals were inspected for viability and
regeneration stage: stage 0 indicates a complete inhibition of regeneration; stage 1 indicates the presence of tentacle buds; stage 2 indicates new emerging tentacles. Animals
treated with 25 nM QDs are signiﬁcantly impaired in the regeneration process. Data are means of three independent experiments. Chi-square equal to 73.4, with six degree of
freedom, was highly signiﬁcant (P < 0.0001). The post hoc test indicated that the high QD dose condition (25 nM) determined the signiﬁcant contribution to the Chi square value. B)
Impact of CdTe QDs on reproduction. Hydra population growth test started with a population of four full-grown Hydra, either untreated or incubated 24 h with 10 nM and 25 nM
CdTe QDs, washed out and monitored every day for bud detachment (scheme at the top panel). Different parameters concerning the population growth rate are presented: k is the
logarithmic growth rate constant and represents the slope of the regression line obtained from the standard equation of logarithmic growth: ln(n/n") ¼ kt. T2 is the population
doubling time, obtained by the standard equation when n/n" ¼ 2. The budding rate was calculated as the average number of buds detached per Hydra per day. The graph in the
middle panel shows the ln(n/n") values at each time point. In the lower panel the growth parameters ('SE) at day 3 and day 14 are compared. The 25 nM QD treatment impaired the
population growth (see the differences in the n/n" , k and the budding rate at day 3 at the beginning of the monitoring period), while later on the animals recover (constant growth
values similar at 14 day).
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tissues, as reported elsewhere [64]. A representative image of
a fragmented nucleus (Fig. 3E, white arrow) compared with the
normal nucleus (Fig. 3E, red arrow) shows its localization inside an
epithelial cell, which indicates that an apopototic cell has been
engulfed by an epithelial ectodermal cell. To gain deep insights into
the mechanisms causing the QD induced cell death, we investi-
gated the elicitation of the apoptotic pathways both at the
biochemical and cellular level. To test for caspase activity associated
with apoptosis, protein extracts were prepared from QD treated
and untreated animals and incubated with the ﬂuorogenic
substrate Ac-DEVD-AMC, which is speciﬁcally cleaved by Caspase 3
in Hydra [65]. Fig. 3D shows that extracts of untreated Hydra had
a lower level of caspase activity compared to QD treated Hydra
extracts, causing the induction of a twofold increase in Ac-DEVD-
AMC cleavage activity both at 48 and 72 h of the 25 nM QD treat-
ment. At cellular level DNA fragmentation resulting from apoptotic
signalling cascades was detected by TUNEL assay. In Fig. 3F,
confocal laser scanning imaging of single cell suspensions pro-
cessed for TUNEL assay and DAPI staining clearly indicate an
apoptotic nucleus inside an endodermal cell.
3.3.1. Genotoxic effect of CdTe QDs
Recent ﬁndings showed the CdTe QD mediated activation of
different genetic cascades leading to cell death. General stress
responsive genes or more speciﬁcally those acting in the apoptosis
signalling pathway have been found induced by CdTe QDs in
several biological systems [26,33,40,66]. The conservation of key
molecular pathways in Hydra genome led us to study the
Fig. 3. Effect of CdTe QDs on cell proliferation and death A) Cell cycling activity of epithelial cells (EPI) and B) cell cycling activity of interstitial stem cells (i-cells) were estimated in
untreated and 25 nM QD treated animals by continuous incubation with BrdU, followed by maceration of ten animals (showing morphological score >6) at the indicated time points
and the colorimetric immunostaining (see Materials and Methods). QDs impaired the proliferating activity of both epitelial and interstitial cells, as shown by the lower percentage of
BrdU labelled nuclei. Data represent the average of three different experiments. C) Cellular assessment of apoptosis induction by QDs. Following 48 h and 72 h incubationwith 25 nM
QDs polyps were macerated in single cells and the percentage of apoptotic cells was determined by counting the DAPI-stained fragmented nuclei. D) Biochemical assessment of
apoptosis induction by QD. Caspase enzyme activity was measured on extracts of QD-treated (10 nM and 25 nM) and untreated control tissues incubated with the caspase substrates
Ac-DEVD-AMC. The enzyme activity was signiﬁcantly higher in polyps treated with the highest QD dose. E) Confocal microscopy imaging of single cells prepared from QD treated
Hydra. The morphology observed by phase contrast indicates an ectodermal epitheliomuscular cell. Fluorescence imaging following DAPI staining shows a normal nucleus (red
arrow) and a typical apoptotic picnotic nucleus (white arrow). A digestive vacuole is also DAPI positive, due to the presence of DNA from ingested preys. F) TUNEL assay on single cell
suspensions prepared from QD treated Hydra. On ﬂuorescence images the white arrow indicates an apoptotic nucleus, TUNEL positive (left panel, green channel) and fragmented
(central panel, DAPI staining, blue channel), while the red arrow indicates a normal nucleus (TUNEL negative, non fragmented). Both nuclei are located inside an endodermal cell,
which engulfed an apoptotic cell. Other reacting signals arise from DNA containing digestive vacuoles (abundant in endodermal cells), as shown by merging phase contrast and
ﬂuorescence images (right panel). Scale bar in E and F: 20 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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Fig. 4. Genotoxic effect of CdTe QDs on Hydra A) Schematic representation of molecular pathways involved in the cell response to environmental stimuli. Cell exposure to CdTe QDs
may elicit a number of reactions which may lead to death or stress adaptation. These processes are mediated by signaling pathways which induce deregulation of various stress-
inducing or protective molecules. Key components of the apoptotic pathways are shown on the left panel and depend on the activation of the death receptor. Genes selected in this
study, namely the c-myc, Bcl2 and caspase 3, are indicated in violet. Gene accession numbers for the Hydra homologues (Hymyc1, Bcl-2 like 4, and HyCaspase 3) are reported in
Table S2 of Supplementary data. Selected stress responsive genes are depicted in orange (Hsp-70, FoxO), together with their relationship with components of other signalling
pathways (plain arrowed red line indicates activation, dotted line indicates inhibition). On the right panel key reactions of the oxidative pathways are presented, from the
membrane lipid peroxidation to the conversion of oxygen radicals into non-toxic products by the SOD gene (coloured in light blue). B) Temporal expression patterns of selected
stress responsive genes in QD treated polyps by qRT-PCR analysis using Elongation factor 1-alpha (Ef-1a) as reference gene. Animals were treated with 10 nM and 25 nM QDs for the
indicated periods, and processed for RNA extraction and qRT-PCR analysis using speciﬁc primers (see Table S2 of Supplementary Data). The general trend is an early (8 h) upre-
gulation of apoptotic genes induced by the 10 nM QD dose, and a late response (from 24 h) of the protective Hsp-70 gene, suggesting a possible animal recovery. Data represent
mean ' SE of three technical repeats from three biological replicates. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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transcriptional modulation possibly played by QD treatment on
genes involved in such vital processes as oxidative stress detoxiﬁ-
cation, apoptosis and cell proliferation. Among the complex gene
networks acting independently or cross-talking in response to
environmental (chemical, physical, mechanical) stimuli or biolog-
ical stressors, we focussed our attention on an array of genes
already isolated and characterized in Hydra: the transcriptional
factor Hymyc1, involved in stem cell proliferation/differentiation
[67,68]; the anti-apoptotic gene Bcl2-like 4 [69] which controls
mitochondrial outer membrane permeabilization; the effector
protease Caspase-3 [65], the stress responsive transcription factor
FoxO [70], and the detoxifying Superoxide Dismutase (SOD) [71].
Their role in the diverse stress responses is schematically shown in
Fig. 4A. Animals were incubated with QDs for increasing periods
ranging from 1 h up to 48 h, and then processed for qRT-PCR
analysis, using speciﬁc primers (see Table S2 of Supplementary
Data). Results of Fig. 4B show that SOD transcript levels were not
affected by the QDs, while all the other genes clearly showed
a deregulation over the ﬁrst 8 h of treatment. In detail, the
apoptotic Hymyc1 and HyCasp3 genes showed an overlapping
expression pattern, being both upregulated after 8 h of exposure to
10 nM QDs. Bcl2-like 4 expression levels were also enhanced,
throughout an extended temporal window (4 h-24 h). FoxO was
found similarly activated after 8 h of exposure, by both QD doses,
although once again the 10 nM QD amount caused the maximum
effect. Finally, the anti-apoptotic gene Hsp-70 showed increased
expression along the period 4 h-24 h, and from 24 h onward an
extraordinary enhancement. Considering the anti-apoptotic roles
played by the Hsp-70 gene family, this strong upregulation might
suggest the cellular shifting from apoptosis pathway to normal
cycle for functional recovery. Overall, the general trend of this gene
proﬁling indicates an enhancement of stress responsive genes at
8 h elicited by the lowest investigated QD concentration (10 nM)
pointing out on an effect on gene expression even in absence of
morphological alterations.
4. Discussion
For the widespread application of QDs in biology and medicine,
the understanding of their potential toxicity effects on human and
environment is crucial. Due to the presence of Cd in the most
common types of QDs like CdSe and CdTe, the obvious concerns
regarding their in vivo use for human purposes have emerged in
many studies focused on elucidation of mechanisms underlying
their toxicity [21,23,25,26] and discussed in recent excellent
reviews [12,72]. The common conclusion from the different studies,
most of them performed in vitro, was the ﬁnding of QD induced
responses similar to the cellular responses to free Cd2þ ions:
depletion of endogenous antioxidants, enhanced production of
ROS, lipid peroxidation, DNA damage, induction of apoptosis,
disruption of intracellular calcium signalling [15,16]. The differ-
ences in QD types, synthetic routes, as well as cell lines or in vivo
systems tested (molluscs, crustaceans, ﬁsh, mouse), make it difﬁ-
cult to assemble the large variety of data available from the liter-
ature into a general view. Following our recent study addressing the
acute toxicity of Hydra to CdTe QDs [55], we present here
a comprehensive analysis at animal, cellular, biochemical and
molecular levels aimed on the identiﬁcation of the whole response
of H. vulgaris chronic exposure to CdTe QDs. Different to the most of
higher vertebrate animals where cell stemness is conﬁned, in
adults, to a few anatomical districts, in Hydra all cell layers struc-
turing the body are continuously dividing, so that a stress stimulus
applied for a short period (2 h, as in the acute toxicity treatments)
may generate immediate animal recovering after removal of stress,
due to the continuous cell renewal. The chronic treatment makes it
possible to constantly expose all renewing cells to the stressor, and
to assess the effects over a long time scale.
Progressive structural damages and lethality observed after
continuous incubation with increasing doses of CdTe QDs, allowed
for accurate estimation of typical LT50 and LC50 toxicity parame-
ters, and for their comparisonwith those of CdCl2. Surprisingly, QDs
showed higher toxicity compared to the same amounts of CdCl2, in
line with some recent reports on bacteria, zebraﬁsh and algae,
which suggested nanoscale effects to explain the higher QD toxicity
[13,73,74]. As the release of Cd2þ ions from the QD cores was often
considered to be the main cause of CdTe QDs cytotoxicity, we
measured the intracellular Cd concentration of polyps treated with
either CdCl2 or CdTe QDs by elemental analysis. Our results showed
a lower intracellular amount of Cd supplied as QDs, mostly uptaken
over the ﬁrst 12 h, compared to the amount found in polyps treated
with CdCl2, uptaken at high rate. These data indicate (i) stability of
QDs in Hydra medium, because if degradation would occur a high
intracellular Cd content would be found, which was not the case;
and (ii) higher QD toxicity, because a low intracellular Cd amount
found in QD treated animals caused more severe damage than the
high dose found in CdCl2 treated animals, which is also shown by
the median scores values at 24 h and 48 h in Fig. 1. They further
show that the internalization routes for Cd2þ ions and CdTe QDs
may be different, and possibly rely on speciﬁc protein transporters
for the former and occur through active membrane transport for
the latter [75] and that the mechanisms behind the toxicity to Cd
supplied as Cd2þ ions or as CdTe QDs, although possibly over-
lapping at some point, are distinct. The sub-lethal doses estimated
by morphological analysis were further applied for evaluation of
long term effects on physiologically important phenomena, such as
development and regeneration of Hydra. Interestingly, both Hydra’s
reproductive rates and regenerating efﬁciency were impaired by
the 25 nM but not 10 nM QD concentration, and were found to
depend upon a decreased proliferation activity of all (epithelial and
interstitial) Hydra cell layers. The decreased cell proliferation rates
accounts for the delayed budding process at the beginning of the
population growth test, which was slowly recovered until normal
rate as the QD containing cells were sloughed off and replaced by
new cells, and for the adverse effect on regeneration. This
remarkable property relies on the reactivation of developmental
programs, including cell division, whose impairment together with
other possible ongoing cytotoxic effects may explain the decreased
regeneration efﬁciency. The ﬁnding that only the 25 nM dose
impacted these phenomena suggested a threshold toxicity value for
this kind of QDs. The following cellular and biochemical assays
conﬁrmed this hypothesis. The elicitation of the apoptotic pathway
was demonstrated by a quantitative analysis of the fragmented
nuclei, engulfed by epithelial cells, present in higher percentages in
animals treated with the higher QD dose, from 48 h onward. These
cells were TUNEL positive, supplying further evidence for the
initiation of the apoptotic pathway. A third approach conﬁrmed this
hypothesis: caspase 3 enzymatic activity was found enhanced by
25 nM QD treatment condition, thus indicating at the biochemical
level the occurrence of apoptosis, as well. Finally, the conservation
of the key regulatory genetic pathways in Hydra’s genome enabled
the molecular characterization of QD treated polyps, through the
assessment of transcriptional modulation of general stress
responsive and apoptotic genes, which is known to occur as early
response to the stimulus. Gene proﬁling by qRT-PCR from 1 to 48 h
of incubation showed, except for SOD-1, enhanced transcript levels
for the apoptotic genes Hymyc1, Caspase 3, Bcl2, and for the stress
responsive FoxO and Hsp70. This enhancement, picking mostly at
8 h and for the 10 nM treatment, indicates an early response to
a toxic stimulus, leading to a programmed cell death. Interestingly,
from 24 h onwards, all gene expression levels were brought back to
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normal, except the anti-apoptotic Hsp70 known to inhibit different
stress response pathways (Fig. 4), which showed strong upregula-
tion (about 20 times) at 48 h. Overall this modulationmight suggest
Hydra’s controlled response, whose temporal dynamic can be
divided in two phases: an immediate early response, over the ﬁrst
hours of challenging, to enhance the transcription of apoptotic
genes, whose products (i.e. effector caspase 3) would act later (from
48 h onward), and a late response, from 24 h onward, switching on
genes (i.e. Hsp70) to enable functional recovery. This interpretation
ﬁts well within the morphological scores of the animals sacriﬁced
for gene proﬁling, ranging from 7 at 24 h (shortened tentacles, body
slightly contracted) to 5 at 48 h (totally contracted, tentacles
visible), the two stages still allowing animal recovery after stress
suspension. The remarkable aspect of this molecular characteriza-
tion is the gene modulation exerted by the low (10 nM) QD dose,
which is consistent with the elicitation of apoptotic genes (Hymyc-
1, Casp-3, FoxO, Bcl-2) early in the treatment. Following continuous
QD incubation the animal may shifts to adaptation mechanisms,
activating maintenance genes, such as Hsp70. Higher doses of QDs
(25 nM) were not- or less effective in the induction of apoptotic
genes, mirroring the cellular need to rapidly cope for the stressors
(i.e activation of necrotic mechanisms), rather than to activate
slower genetic responses.
5. Conclusion
By using H. vulgaris as an aquatic invertebrate model organism,
a comprehensive analysis of the effects displayed by CdTe QDs was
performed at manifold levels.Hydra assays are fast, reliable and less
expensive than cell culture systems, and yet provide an extraordi-
nary wide repertoire of responses, in vivo, and in vitro, which allows
us to study factors inﬂuencing toxicity of nanoparticles for human
and environment health. Moreover, the high sensitivity to heavy
metals makes Hydra an amenable tool for assessment of inorganic
nanoparticle’s toxicity in natural ecosystems, modelling biological
barriers for their absorption, distribution, and persistency in the
food chain. We found clear signs of cytotoxicity for CdTe QDs,
resulting in endpoints of toxicity being distinct and even more
potent than of dissolved Cd2þ ions at equivalent doses. QD treat-
ment adversely affected reproduction, regeneration, cell prolifera-
tion, and exerted genotoxic effects, such as chromosomal
fragmentation, alterations in gene expression proﬁles. The modu-
lation of gene expression in absence of evident morphological
damages underlines the necessity of genotoxicity studies for
a thorough examination of QD impact on living systems.
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Abstract 
 
In the emerging area of nanotechnology a key issue is related to the potential impacts of the novel nanomaterials on the 
environment and human health so that this technology can be used with minimal risk. Specifically designed to combine 
on a single structure multipurpose tags and properties, nanomaterials need a comprehensive characterization of both 
chemicophysical properties and toxicological evaluation, which is a challenging endeavor: the in vitro toxicity assays 
that are employed for nanotoxicity assessments do not accurately predict in vivo response. To overcome these 
limitations and gain a deeper understanding of nanoparticle-cell interactions, we have employed cnidarian models, in 
particular the freshwater polyp Hydra vulgaris, not opposed to more complex and evoluted systems, but to add valuable 
information, at an intermediate level between prokaryotes and vertebrates, on both cytoxicity and on pollution affecting 
the environment. By testing CdSe/CdS core shell nanocrystals in vivo, at whole animal level, we investigated the 
impact of their properties on uptake, accumulation, biodistribution, elicitation of behavioural responses. Spanning from 
animal to cell biology, we provide an analysis on metal based and semiconductor NC, discussing the crucial role played 
by the synthesis route and chemical surface on the toxicity for living organisms. 
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1. INTRODUCTION  
 
The intriguing field of bionanotechnology opens promising scenarios in research and clinical practices. In particular, 
recent advances in synthesis and biofunctionalization of colloidal semiconductor nanocrystals have generated an 
increasing widespread interest among investigators in biology and medicine. Specifically, due to their unique optical 
and electronic properties, which have already suggested their use in tunable polarized lasers and organic–inorganic 
hybrid solar cells, quantum rods (QRs) are expected to have great potential as multipurpose bioprobes in biomedical 
applications. However, critical issues concerning the effect of nanobiomaterials on cells and living organisms remain to 
be resolved. Latest evidences are cumulating that nanoparticles plays active roles even in absence of specific ligands 
and that factors such as size and charge are crucial for activation of cell responses, internalization, and intracellular 
trafficking [1, 2]. Thus it is a priority for the wide scientific community working to develop nanostructured materials for 
biomedical purposes to relate the physical and chemical characteristics of nanomaterials to their behaviour, in vivo. 
Increasing data addressing this important question relies on cell culture systems, and are focussed on the identification 
of the physicochemical parameters influencing the impact of nanoparticle on living cells [3, 4] we propose a new model 
system to work at whole animal level. The ancient freshwater polyp Hydra vulgaris, a member of the Cnidarian, has a 
tube-like shape, consisting of two epithelial cell layers (an inner endoderm and an outer ectoderm facing the low ionic 
strength medium) separated by a distinctive extracellular membrane (mesoglea) (Figure 1 A, B). The remaining cell 
types are lodged in the interstices of the epithelial cells (interstitial cell lineage). Interestingly, this structural 
complexity, simpler than vertebrates, with central nervous system and specialized organs, but much complex compared 
to cultured cells, makes Hydra comparable to a living tissue which cells and distant regions are physiologically 
connected [5]. Our previous studies demonstrated Hydra vulgaris represents a unique system to study the interaction 
between nanoparticles and living systems. 
 
 
 
 
 
   
                                                          
Figure 1. a) A living Hydra in culture medium. The animal has a simple body plan: it is a tube with a head at the apical 
end, and a foot, or basal disc at the other. The head is in two parts, the hypostome (mouth) at the apex, and below that 
the tentacle zone from which a ring of tentacles emerge. Scale bar 500 µm. b) Cross-section of the bilayered structure 
of the animal, adapted from [6] : the polyp is composed of two self renewing cell layers, an outer the ectoderm and an 
inner endoderm, and separated by an extracellular matrix, the mesoglea. The arrows on the left side indicate the 
direction of tissue displacement. c) Along the animal body both ectoderm and endoderm layers are composed of 
epitheliomuscular cells, while interstitial stem cells and their intermediate and terminal derivatives (neurons, 
nematocytes and secretory cells) are interspersed among ectoderm and endoderm. 
 
A remarkable advantage offered by Hydra as model organism to be targeted by metal based nanocrystals is the 
possibility to evaluate the potential toxicity of these nanoparticles on different aspects of Hydra physiology. The 
availability of new animal models suitable for the assessment of nanotoxicity is currently recognised as a priority. 
Hydra is sensitive to a range of pollutants and has been used as a biological indicator of water pollution [6-8]. Metal 
pollutants such as copper, cadmium and zinc have been tested against different Hydra species, and the relative toxicity 
based on the median lethal concentration (LC50) for all species was ranked from copper, the most toxic, to cadmium 
with zinc least toxic [7]. Interestingly, interfacing Hydra polyps with nanocrystals, we found that the surface charge of 
nanoparticles determines the efficiency of uptake. In particular, by tuning the number of amino-PEG molecules attached 
at the rod surface and thus by manipulating the resulting surface charge at different pHs, we tuned the capability of 
Hydra ectodermal cells to internalize QRs, from very high at acidic pH to zero at neutral pH. Only under acidic 
conditions Hydra ectodermal cells bind and sequester into cytoplasmic granular structures positively charged QRs, 
while at neutral pH this does not occur [2].  
In the present paper we evaluated in Hydra vulgaris the internalization and toxicological effects of negatively charged 
fluorescent CdSe/CdS core shell QRs. As the impact of QR administered to Hydra by soaking has already been 
investigated, here we assessed the impact of the same semiconductor nanocrystals (CdSe/CdS) on the digestive cells of 
Hydra, which are often the final target for ecotoxicological purposes. By using different approaches, from in vivo 
evaluation of morphological traits to the evaluation of the growth rate and regeneration mechanisms, we show that QR 
do not display toxic effects as they are stably accumulated into storage vesicles, and thus they have great potential to be 
used as  markers for cell tracking and biological investigations. 
 
 
 
 
 
 
 
 
 
 
 
2. METHODS 
 
Nanocrystals employed 
Amino-PEG coated CdSe/CdS core/shell QRs were a kind gift of Teresa Pelelgrino (National Nanotechnology 
Laboratory, Lecce, Italy). The QR here used (Length: 35 ± 2nm; diameter: 4,2± 0,4 nm) (Fig. 2 A) were prepared by the 
seeded growth approach as recently reported [8, 9]. Surface coating with diamino-PEG molecules was achieved by 
means of EDC crosslinking chemistry as previously described [2] 
Hydra culture  
Hydra vulgaris (strain Zurich, originally obtained by P. Tardent) were asexually cultured in physiological solution 
(SolHy: 1mM CaCl2, 0.1mM NaHCO3, pH 7) by the method of Loomis and Lenhoff with minor modifications [10]. 
The animals were kept at 18 ±1°C and fed three times per week with freshly hatched Artemia salina nauplii.  
In vivo experiments with intact,regenerating and macerated animals 
Groups of 20 animals were collected in plastic multiwells, allowed to equilibrate at room temperature in 300!l of 
physiological solution (SolHy: CaCl2 1mM, NaHCO3 0.1mM, pH 7). The test was initiated by adding test QRs to each 
well containing 10 polyps and incubating as necessary. QR uptake was monitored in vivo, unless otherwise stated, by 
continuous video recording using a Camedia-digital camera (Olympus) connected to a stereomicroscope (Olympus 
ZSX-RFL2) equipped with fluorescence filter sets (BP460- 490/DM505/LP510). Following extensive washes, in vivo 
imaging was accomplished at several magnification by using both a stereomicroscope and an inverted microscope 
(Axiovert 100, Ziess) equipped with a digital colour camera (Olympus, DP70) and fluorescence filter sets (BP450-
490/FT510/LP515). In order to assay acute toxicity, the morphological changes induced by QD treatment were 
monitored, by using a scoring procedure of the progressive changes in structure. This procedure allows to examine the 
ability of animals to recover from NP-induced damage. Every day, using a steromicroscope, recognizable physical 
changes in response to different NP ranges were recorded, according to score values (ranging from 1-10) described by 
Wilby (1988) [11]. For imaging acquisition and analysis the software system Cell F (Olympus) was used. For 
regeneration experiments, treated polyps were bisected in the gastric region and in vivo imaged at various time points 
post amputation. Macerations of Hydra polyps were obtained as described in [12]Experiments were performed in air-
conditioned environment at 22°C, and repeated three times for each condition tested. 
Hydra growth rates  
Experimental animals (four Hydra with one bud) were treated with the indicated NP, for 4 h, then washed, and the 
following day placed in 3,5 cm petri dishes (1 Hydra/dish). Control animals at the same developmental stage were not 
treated. Both experimental and control Hydra were fed once daily and the Population doubling time was determinated 
as growth parameter. The growth rate costant (k) of an exponentially growing group of animals is defined as ln(n/n0)=kt 
where n  is the number of animals at time t and n0 the number of animal at t0. For n/n0 = 2, t = T2, the doubling time of 
the population. T2 was determined by linear regression [13].  
Trasmission electron microscopy 
Hydra polyps were treated with 2% urethane in SolHy (1 mM CaCl2, 0.1 mM NaHCO3, pH 7.0) to prevent specimens 
contraction during fixation and then fixed for 2hrs in 2% glutaraldehyde in SolHy. Samples were then washed at least 
four times with SolHy and postfixed for 45’ with 1% buffered OsO4. After a series of four washes in SolHy, animals 
were dehydrated in a graded ethanol series (30%-50%-70%-90%-100%). Samples were incubated 2x15’ with Propylene 
oxide and then overnight in a 1:1 mixture Propylene oxide/Epon 12 Resin. Before flat embedding animals were 
incubated 2x2hr in Epon 12 Resin. Sample serial thin (70nm) section of tentacles and hypostoma were cut with a 
diamond knife and mounted onto 150-200 mesh Hex grids. Thin sections were stained with uranyl acetate and lead 
citrate. Ultrathin sections were examined with Leo 912 AB transmission electron microscope operating at 80 k. 
 
 
 
 
 
 
 
3. RESULTS 
 
The effects of amino-PEG coated CdSe/CdS quantum rods (from here simply named QRs) on animal behaviour, 
morphology, growth and regeneration capability was investigated over different incubation times. Being Hydra a small 
water living animal, the simple addition of QRs to the culture medium enables to study the interaction between 
QR/animal, avoiding delivering methods or invasive procedures. To allow nanoparticle internalization either into the 
ectoderm or in the endoderm, QRs were added at different concentrations at different pH conditions to groups of living 
polyps. Treated animals were continuously monitored by fluorescence stereomicroscopy to track QR uptake, 
localization and morphological alterations. As previously reported, after 24h of incubation in a suspension of QRs at 
nanomolar concentration (7 nM) at acidic pH conditions, rinsed polyps appeared strongly labelled (Fig 1). In particular, 
QR uptake by soaking, initially restricted to tentacle battery cells (30 min post incubation), takes place also in the 
ectodermal producing a homogenous body staining (Fig. 2 B and C) [2]. The tripeptide Glutathione, (GSH) is the 
physiological stimulator of the Hydra feeding response [14]. Thus, in presence of micromolar doses of GSH (within the 
range 1-10 micromolar) Hydra polyps are induced to open their mouth allowing the outer medium to enter the body 
cavity. Thus, following GSH addition at physiological pH (Fig. 2 D), negatively charged QRs did not enter the 
ectoderm and were largely ingested, accumulated as aggregates into the body cavity (Fig. E) and internalized 
exclusively by the endodermal layer ( Fig. 2 F). 
 
 
Fig. 2 In vivo labelling of Hydra polyp with high fluorescent QRs. A) Representative structure of Nanorods. B and C) 
Pictures of a living Hydra after 24 hour incubation with QRs; by soaking, the polyp strongly internalized QRs in the 
epithelial layer of the body. D) Representative image of GSH-treated Hydra. GSH addition on the Hydra medium 
induces a reversible mouth opening (white arrows). E) Aggregation of QRs immediately after Ingestion. F) QRs 
biodistribution in the endodermal layer of the gastic region at 24h after ingestion. QRs are homogeneously dispersed 
among the endoderm. 
 
The cross-sections made from fixed treated polyps revealed that the internalization occur rapidly in the endodermal cell 
layer, facing directly the body cavity that in turn receives the QRs from the culture solution (Figure 3 B and C). 
Remarkably, 24 h post treatment, fluorescent material migrates through the endoderm cell layer underlying cellular 
dynamics among the endoderm. 
 
 
 
 
 
 
  
 
Fig. 3 Biodistribution of QRs in Hydra tissue sections after NP ingestion. A) histological cryosection at level of gastric 
region shows the tissue organization of Hydra allowing to distinguish the ectoderm (ecto), the mesoglea, the 
endoderm (endo) and the body cavity (lumen). B) Fluorescent image of the cryosection; the diffuse red colour is due 
to tissue autofluorescence, while the red punctuated signals (white arrows) indicates the QR presence. C) A higher 
magnification of B reveals QRs localize into endodermal cells. 
 
To investigate the intracellular localization of QRs, whole animals were incubated with QRs for 4 h, extensively 
washed and then macerated. The maceration method permits to rapidly and completely dissociate Hydra tissue into 
individual cells. Each cell type preserves the original shape and is promptly distinguishable by microscopy analysis 
[12]. 
 
Fig. 4 Cellular localization of QRs in Hydra. A) Phase contrast image of intact epithelial cells obtained by maceration; 
black arrows indicate the presence of different vesicle-like structures. B) Red-fluorescent QRs (white arrows) are 
accumulated into epithelial cells after 24 h incubation. C) Merged image of A and B indicates that QRs are located in 
vescicles dispersed in the cytoplasm. D) QRs localization by TEM microscopy. The nanocrystals are dispersed in 
cellular vesicles of Hydra ephitelial cells . 
D 
As shown in Fig 4 (A, B, C), QRs were dispersed as highly fluorescent spots in the cytoplasm of epithelial cells; in 
particular QRs appeared to be compartimentalized in vesicle-like structures as indicated by the black arrows in Fig. 4 
(A, C). To validate this hypothesis, we further investigated intracellular localization by trasmission electron 
microscopy. As illustrated in Fig. 4 D, rod nanocrystals were retained in cytoplasmatic vesicles of Hydra ephitelial 
cells. 
 
 
 
Fig. 5 Regeneration of Hydra polyps labelled with fluorescent QRs.  A) schematic representation of polyp regeneration. 
Hydra has the ability to regenerate completely the head and the body after bisection. B and C) Bright-field and 
fluorescent images of a QR labelled Hydra’s head after amputation, respectively. D and E) Bright-field and 
fluorescent images of a QR labelled Hydra’s head and foot after amputation, respectively. F and G) Bright-field and 
fluorescent images of a regenerating Hydra. After three days post-amputation, the polyp contains a high concentration 
of fluorescent QRs. 
 
 
Finally, to evaluate the toxicity associated with the internalization of QRs, we incubated Hydra polyps in presence of 
different concentration (from 1 nM up to 200nM) of nanoparticles for 24 h, 48 h and 72 h. According to the Wilby’s 
criteria based on phenotypical observations, no significant alterations in the morphology of the animals were found 
(data not shown), suggesting QRs have no or limited negative effects on Hydra after ingestion. To definitely 
characterize the toxicological impact of rod-shaped nanocrystal on Hydra, regeneration and growth rate of polyps were 
investigated after treatments with 7 nM QRs. Overall, Hydra has the capability to regenerate missing parts of the body 
after amputation (Fig. 5, A). Head regeneration is a critical aspect of Hydra biology and the development of emerging 
tentacles can be monitored by stereomicroscopy to estimate the potential effects of toxicants on this tightly controlled 
process. As showed in Fig. 5 C and E, after bisection QRs are still present in the treated animal body during the first 
phases of regeneration. More interestingly, three-day head regenerating Hydra appeared highly fluorescent by 
microscope analysis (Fig. 5 G) indicating that QRs are retained during regeneration processes. Significantly, treated 
polyps regenerated heads and tentacles similar to the control animals indicating QRs did not produce adverse effects 
during Hydra regeneration. 
 
 
Figure 6. Influence of the QR treatment on Hydra population growth rate. Population growth test started with a population 
of four full-grown Hydra, incubated 24 h with 7nM QR, washed out and monitored every day for bud detachment. 
The individuals were inspected daily and counted under a stereomicroscope. There are not significant differences 
between treated (blue line) and untreated (red line) population growth rates. The logarithmic growth rate constant (k) 
is the slope of the regression line using the standard equation of logarithmic growth: ln(n/n0) = kt. 
 
In order to assess the potential long-term lethal effects induced by QRs, Hydra capabilities to growth and to reproduce 
were assayed. Growth rate of Hydra tissue is normally regulated by a balance between epithelial cell cycle length, 
phagocytosis of ectodermal cell in “excess”, and bud formation [13]. Thus, the population growth rate is an indirect 
measure of the Hydra tissue growth rate and cell viability. The growth rates of QR treated polyps were estimated and 
compared to untreated animals, under regular feeding regime. As shown in the graph of Fig. 5 the growth rate of polyps 
treated with 7 nM QRs was similar to untreated animals, suggesting once again the absence of significant toxic effects 
in Hydra population.  
 
4. DISCUSSION 
 
Due to their unique physicochemical properties, nanocrystals attract increasing interest in a wide range of biomedical 
applications, from cell biology to medical diagnostic. However, main critical issues regarding the health and 
environmental effects have to be resolved before employing semiconductor nanocrystals for biomedical purposes. 
While in vitro assays are widely exploited for toxicological studies they do not accurately address the complexity of the 
in vivo response. Alternatively, we have previously proposed as a new model system the freshwater polyp Hydra 
vulgaris, to investigate the in vivo response to different nanomaterials. The recent full genome sequencing of Hydra will 
allow to explore this response also at molecular level, disclosing many aspects concerning NP internalization, cellular 
processes and molecular effectors involved in the detoxification and/or compartimentalization of nanocrystals [15]. We 
previously studied the uptake of unfunctionalized rod shaped CdSe/CdS nanocrystals, and shown that positively 
charged QRs are internalized into the ectoderm while the negatively charged ones do not. Growth rates of Hydra 
labelled into ectoderm by QR are similar to growth rates of untreated animals, suggesting that these nanocrystals have 
no toxic effects on the reproductive capabilities of the animals. Here, we investigated the impact of the negatively 
charged QRs when they are ingested and showed the kinetics of this response. Following GSH administration and 
mouth opening, medium suspended QRs were abundantly accumulated in the body cavity of the polyps. The 
endodermal cells lining the gastric cavity of the polyps rapidly uptake QRs, probably by the pinocytosis processes 
typical of the digestive cells [16]. Due to the lack of photostable fluorescent markers, the cellular mechanisms of 
endocytosis in Hydra have not been clarified to date. The kinetics of QR internalization showed that QRs migrate from 
the body cavity into the endodermal cells. The mechanisms underlying this dynamic might be due to an array of events, 
from migration of free nanoparticles, or relocation of cells containing nanoparticles among the endoderm, to 
autophagocytosis events known to regulate tissue and body maintenance of the polyp. The subcellular QR localization 
was also investigated, by mean of TEM analysis. Our findings demonstrated that nanorods are prevalently located in 
cytosplasmatic vesicles, stably maintained over the cell divisions to daughter cells, which characterization requires 
further work.  
In ecology, aquatic invertebrates have been largely employed as biological indicators to test the presence of 
environmental contaminants. In particular Hydra is highly susceptible to many toxicants and pollutants [17] and may be 
a valid biological model to measure the toxicity of metal-based nanomaterials in solution. 
In order to evaluate the toxicological impact of QRs on Hydra, morphological traits, regeneration capabilities and 
growth rate were assessed. According to Wilby's score method measuring morphological changes of polyps in presence 
of toxicants, we did not observe any phenotypical alteration in the tentacles and in the body column after NP 
internalization, suggesting QRs have no lethal effects either by soaking and ingestion. Moreover, here we have 
demonstrated that Hydra polyps retain QRs during the regeneration, allowing these dynamic processes to be easily 
tracked without adverse effects. Similarly, QR uptake does not influence the growth rate of hydra population, 
suggesting that the reproductive capabilities of treated animals are not affected by the presence of QRs. In summary, 
none of the investigated parameters were affected by the QR ingestion, suggesting a protective role of the polymer and 
PEG chain on the CdSe core, possibly preventing the Cd leakage and the derived toxicity. 
In conclusion, our study indicates that the uptake process in the endoderm, as that previously observed into the 
ectoderm, occurs during the first hours post-incubation. Moreover, low QR dosage (7 nM) ensures a suitable amount of 
fluorescent nanocrystals to enter Hydra cells, enabling cell labelling and tracking. The absence of detectable toxic 
evidences over short and long periods together with the possibility to be used at low concentrations, make PEG-coated 
CdSe/CdS QRs an useful and promising tool to be employed for biological application in living organism. 
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